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    SYNOPSIS 
Quality assurance in lower gastrointestinal endoscopy (LGE) is gaining increasing 
attention. Simultaneously, there is an increasing demand for LGE. The overall aims of this 
thesis were to identify methods of improving both the availability and the technical quality 
of LGE in the National Health Service, United Kingdom. 
This thesis attempts to bring some of these concepts together in a series of studies as listed 
below: 
Study 1:  The aim of this study was to assess patient satisfaction with LGE, and to 
determine factors that affect patient satisfaction. A new patient satisfaction questionnaire 
was developed and internally validated. The most important factors affecting patient 
satisfaction in this study were the technical skills of the endoscopist and the degree of 
discomfort/ pain experienced by the patient. This study has also shown that there are no 
differences between medical, nurse and non-medical endoscopists in terms of patient 
satisfaction with lower gastrointestinal endoscopy. Based on this understanding of factors 
affecting patient satisfaction with LGE, we performed the following studies (2, 3, 4 and 5) 
to determine methods of assessing technical quality of LGE and the best sedative regimen 
to ensure higher patient satisfaction. 
Studies 2 and 3: The aims of these studies were to assess the technique of endoscopic 
clipping with follow up abdominal x-ray for objective validation of completion in 
colonoscopy and flexible sigmoidoscopy. Both studies have shown that this technique is 
useful not only for assessment of completion but also for validation of pathology miss 
rates in LGE. This is a proof of concept study and further validation against current 
standards would be required. 
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Studies 4 and 5:  These two randomised controlled trials were performed to determine the 
best sedative/analgesic regimen for colonoscopy. The first study has shown that Entonox 
is associated with better pain relief, faster recovery of psychomotor function and higher 
patient satisfaction, as compared to conventional intravenous sedation. The second study 
has shown that there is no difference between Entonox and Propofol sedation in terms of 
pain relief, recovery of function, and time to discharge and patient satisfaction. However, 
propofol sedation is more resource intensive and makes patient manoeuvring more 
difficult. A further conclusion from the subset analysis of these studies is that there is no 
difference between doctors, nurses and non-medical colonoscopists in terms of patient 
satisfaction, pain relief, time for procedure or discharge and recovery of function. 
Study 6:   The aims of this study were to develop, train and validate artificial neural 
network (ANN) algorithms capable of accurately identifying individual patients attending 
routine colorectal clinics likely to have a positive diagnosis (cancer, polyp, or colitis) 
necessitating a lower gastrointestinal endoscopy. This study has shown that artificial 
neural networks offer the possibility of personal prediction of outcome for individual 
patients presenting in clinics with colorectal symptoms, making it possible to make more 
appropriate requests for lower gastrointestinal endoscopy. 
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1.1 Lower Gastrointestinal Endoscopy: an introduction  
1.1.1 History of endoscopy development 
The original gastrointestinal endoscopes were hollow reeds or bamboo canes that 
were illuminated by candles
1
. These developments have been attributed to both the 
ancient Greeks and the Egyptians
1
. The precise origin of endoscopy remains in 
doubt, although Hippocrates was responsible for the first proctoscopy recorded in 
around 460-370 BC
1, 2
.  
Although tubes of different types were subsequently designed, several hundred years 
passed before they could be made practical and useful. The next major 
advancements were the development of a rigid sigmoidoscope in 1795 by Philip 
Bozzini
3
 and the development of the first rigid oesophagoscope in 1868
4
 by 
Kussmaul. These instruments were extremely primitive in comparison with those in 
use today and only allowed a limited examination. The early pioneers faced two 
obvious albeit formidable problems:
 
the gut is not straight and the colon is dark
5
. 
Although directly and immediately unrecognised
 
at the time, the illumination 
problem was solved around 1878
 
by Thomas Alva Edison, who was able to make 
bulbs small enough to use inside the endoscope. This was followed by further 
sporadic episodes of open tube endoscopy procedures. For example, Killian (1898) 
used an open tube with illumination and a head mirror with topical anaesthesia
6
. The 
next crucial step was the development of Nitze optical system, which was 
incorporated into the first cystoscope
7
. However, the Nitze optical system suffered 
from serious limitations.  
In 1954, the problem of illuminating the dark interiors of the gastrointestinal tract 
was solved by H.H. Hopkins with the development of a new optical system using 
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flexible fibres in 1954
8
. The first set of instruments based on this system were 
released in 1960s leading to a new epoch in rigid instrumentation
9
. This was the first 
of the two key inventions that led to dramatic improvements in the quality of 
endoscopy, leading us to the advanced endoscopes of the modern era. The only 
limitation remaining was the inability to negotiate the tortuosity of the 
gastrointestinal tract satisfactorily. The first approach to this problem was the 
development of an instrument with articulated lenses and prisms, which was 
incorporated into the first semi-flexible gastroscope by Wolf and Schindler
5
. 
The most notable
 
development in the history of endoscopy then occurred in 1958:
 
the 
flexible fibreoptic endoscope of Larry Curtiss, then a graduate
 
student in physics, 
and Basil Hirschowitz, a trainee in gastroenterology
10
.
 
What made this instrument 
possible was the availability of highly
 
transparent optical quality glass. Over the next 
30 years, the
 
fibrescope evolved to a level of technical sophistication that
 
seemed 
insurmountable.  
However, obsolescence was assured subsequently with the
 
invention of the charge 
coupled device (CCD) in 1969. Ten years
 
later, this technology was incorporated 
into an endoscope
11
. 
 
Because the CCD produced an electronic image, endoscopy 
suddenly
 
had a wider audience- a television audience. The construction of the 
endoscope initially was such that only the endoscopist saw mucosal images, and 
trainees could only view the image by adding a teaching aid to the endoscope. 
However, this resulted in a poor view of the mucosa for both the trainer and the 
trainee, and a significant increase in the weight of the endoscope. The development 
of video endoscopy by Welch-Allyn in 1983 using CCD  produced high resolution 
images that ensured the territory previously the domain of the endoscopist could be 
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seen by trainees, assistants, and observers
12
. Moreover, the image
 
was digital, and 
hence instantaneously an interface between the endoscope
 
and the computer was 
established.  
From 1968 to 1990 there was an
 
explosion of technical achievements that 
transformed the practice
 
of gastroenterology. The potential of the biopsy channel 
was exploited rapidly, and numerous therapeutic procedures followed – including 
the first snare polypectomy by Niwa in 1970
12
. This remarkable 22 year period
  
from 
1968 to 1990 was so formative that its been described as the golden era of 
gastrointestinal endoscopy
5
. 
For the purposes of this thesis, we define lower gastrointestinal endoscopy (LGE) as 
either colonoscopy or flexible sigmoidoscopy. 
1.1.2 Indications 
1.1.2.1 Indications for colonoscopy 
Colonoscopy is now considered to be the gold standard exam and is superior to 
either CT colonography or double contrast enema alone
13
. Colonoscopy achieves 
more than barium enema or virtual colonography because of greater accuracy and its 
biopsy and therapeutic capabilities. Table 1.1 below shows the principal indications 
for colonoscopy. 
Table 1.1 Colonoscopy: Indications and yield
13
 
High Yield Indications Low Yield Indications 
Anaemia/bleeding/occult blood loss 
Persistent diarrhoea 
Inflammatory disease assessment 
Genetic cancer risk 
Abnormality on imaging 
Constipation 
Flatulence 
Altered bowel habit 
Pain 
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1.1.2.2 Indications for flexible sigmoidoscopy 
Flexible sigmoidoscopy (FS) is preferred for many reasons. The foremost being the 
fact that it can be performed as an outpatient procedure without any sedation in a 
short period of time. In fact it can become part of the patients first outpatient visit, 
where after being assessed by the physician, the patient can go on to have FS at the 
same setting. Though some of the indications for FS can be similar to colonoscopy, 
it is important to remember that FS is limited to the left colon only. Hence, FS is not 
a suitable substitute for colonoscopy or barium enema.  
There is increasing interest in the adoption of FS as the sole screening test for 
colorectal cancer. This comes from the evidence that nearly 70% of all colorectal 
cancers occur in the left colon. Atkin et al in a large multicentre randomised 
controlled trial have confirmed this and have suggested that FS should replace 
Faecal Occult blood testing as the screening tool. Table 1.2 shows the indications for 
flexible sigmoidoscopy.  
Table 1.2 Indications for flexible sigmoidoscopy 
Diagnostic Therapeutic 
Assessment of anal canal type 
bleeding 
Assessment of diverticular disease 
when the diagnosis is in doubt 
Colorectal cancer screening 
Preoperative evaluation prior to 
anorectal surgery 
Surveillance of previously 
diagnosed left colonic cancer or 
polyp 
Therapeutic procedures such as 
endoluminal stenting, balloon 
dilatation for strictures 
Decompression of sigmoid 
volvulus or pseudo-obstruction 
Treatment of radiation proctitis 
Removal of foreign bodies 
Treatment of bleeding from left 
colon 
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1.1.3 Contraindications for colonoscopy and flexible sigmoidoscopy 
Currently, there are remarkably few contraindications for colonoscopy (table 1.3). 
The contraindications can be divided into absolute and relative contraindications. 
Relative contraindications include situations in which risk is substantially increased. 
In these conditions, it may be acceptable to perform the colonoscopy only if the 
information thereby obtained is extremely vital for the ultimate outcome. 
Table 1.3 Contraindications to colonoscopy and flexible sigmoidoscopy
14
 
Absolute Relative 
Competent patients refusing 
consent 
Known perforation of bowel  
Fulminant colitis 
Toxic megacolon 
Known colonic obstruction 
Acute peritonitis 
Acute diverticulitis (diagnosis 
established) 
Haemodynamic instability 
Recent myocardial infarction 
(within 3 months) and Pulmonary 
embolism 
Immediate postoperative phase 
Very large or symptomatic 
Abdominal aortic aneurysm 
Pregnancy 
Poor bowel preparation 
Lack of informed consent 
 
There is no absolute contraindication to colonoscopy or FS in pregnancy
14
, but is 
best avoided in patients with a history of miscarriage, on commonsense grounds. 
The contraindications for flexible sigmoidoscopy are similar to colonoscopy, and 
hence discussed together. 
Furthermore, a potential concern for with either colonoscopy or flexible 
sigmoidoscopy is the use of the endoscopes in infected patients and hence the 
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possibility of subsequent transmission of infection to the next patient. However, if 
universal precautions are adhered to and all recommended techniques used for 
decontamination, then the risk of transmission is virtually negligible. Surprisingly, 
very little data exists in this regard. In 1993 one report suggested that the reported 
frequency was 1 in 1.8 million procedures
15
. There is also the potential for 
transmission of infective particles with exceptionally long incubation periods
15
 
(vCJD, for example). The British Society of Gastroenterology has published clear 
guidelines on the decontamination of Equipment for Gastrointestinal Endoscopy
16
 
and these must be adhered to all times for prevention of endoscopy related 
transmission to infection. Hence, gastrointestinal infection is not necessarily a 
contra-indication for either colonoscopy or FS. 
Another concern with colonoscopy (and to lesser extent with flexible 
sigmoidoscopy) is the occurrence of transient bacteraemia. There is no clear 
evidence whether this can lead to clinically significant conditions like septicaemia, 
and endocarditis. The British Society of Gastroenterology (BSG) has published 
guidelines for antibiotic prophylaxis in patients undergoing gastrointestinal 
endoscopy
17
, which incorporate the National Institute of Clinical Excellence (NICE) 
guidelines as well
18
. In general, antibiotic prophylaxis is no longer recommended for 
the prevention of infective endocarditis in patients with cardiac risk factors who 
undergo endoscopy. The arguments against routine prophylaxis include questionable 
significance of bacteraemia from endoscopy, equivocal evidence regarding the role 
of prophylactic antibiotics in prevention of endocarditis, risks of adverse effects, 
evolving problems of resistant bacteria (e.g. MRSA) and practical difficulties in 
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patients with penicillin sensitivity. With regards to FS, there is no role for 
prophylactic antibiotics due to the limited nature of the procedure. 
1.1.4 Complications of LGE 
1.1.4.1 Complications of colonoscopy 
Colonoscopy is generally a safe procedure and, fortunately, complications are rare. 
The most serious risk with colonoscopy is perforation of the colon. The quoted rate 
is around 1:500 to 1:1000, depending on whether it is a diagnostic or therapeutic 
colonoscopy
19
.  Perforation usually occurs due to mechanical or pneumatic pressure 
or from biopsy. Some studies have shown that it is more common in patients who 
are either over-sedated or under general anaesthesia or in the presence of poor bowel 
preparation, or with acute bleeding
13
. The site of perforation is usually either areas of 
weakness of the colon wall (e.g., diverticulae, transmural inflammation) or distal to 
obstructing points
20
 (e.g., neoplasm, stricture). Pneumatic perforation of the colon or 
ileum results from distension by insufflated air. Perforation secondary to 
polypectomy is usually due to thermal injury. Large perforations are rare and 
abdominal viscera become visible immediately. However, with smaller perforations, 
a high index of clinical suspicion is essential. Clinically perforation should be 
suspected if patients have disproportionate pain or marked and persistent abdominal 
symptoms. Delayed perforations are associated with minimal features like fever, 
raised white cell count or persisting abdominal pain. The management depends on 
the size of perforation, time interval post colonoscopy, degree of contamination, 
clinical features (peritonitis or not) and general health of the patient. In the absence 
of gross contamination, conservative treatment with intravenous antibiotics and 
close observation can be considered for most patients. Surgical intervention may 
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needed if there is gross contamination, peritonitis, perforation of tumours, or if 
conservative treatment fails.  
The next common complication is bleeding which complicates approximately 1 of 
every 1000 colonoscopic procedures
13
. Most cases resolve spontaneously. Following 
polypectomy, bleeding may occur immediately, but, in 30-50% of cases
13
, it can be  
delayed for 2-7 days until the eschar sloughs. It is common for such bleeding to stop 
spontaneously. Treatment options include transfusions, endoscopic therapy, 
angiography, and, rarely, laparotomy.  
Documented instances of transmission of infection from one patient to another or to 
endoscopic personnel with either a colonoscopy or flexible sigmoidoscopy are 
extremely rare. Bacteria reported to have spread include Salmonella species, 
Pseudomonas species, and Escherichia coli
13
. To date, no reports of transmission of 
HIV have been made. Disinfection of scopes and accessories is the main preventive 
measure. Universal precautions against contact with patient's blood or bodily fluids 
should always be employed
13
. 
The combination of pain, peritoneal irritation, leukocytosis, and fever after 
colonoscopy may represent a post-polypectomy burn injury. This condition is called 
the post-polypectomy syndrome or post-polypectomy electro-coagulation 
syndrome
21
. Post-polypectomy syndrome was reported in six patients out of 16,318 
colonoscopies performed between 1994 and 2002 in a large integrated health 
system
22
. Earlier reports estimated it to occur in 0.5 to 1.2 percent of patients 
undergoing polypectomy
21, 22
. Post-polypectomy syndrome develops when electrical 
current applied during polypectomy extends past the mucosa into the muscularis 
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propria and serosa, resulting in a transmural burn without perforation. Serosal 
irritation leads to a localised inflammatory response that manifests clinically as a 
localised peritonitis. Post-polypectomy syndrome occurs most often after the 
removal of large (>2 cm) sessile polyps, which usually require large amounts and 
long duration of thermal energy 
23
. Inadvertent capture of a piece of normal adjacent 
mucosa within the snare loop during snare placement over a polyp can result in this 
condition when cautery transects both portions of tissue (mucosa and polyp). Plain 
abdominal radiographs are not useful in this setting. CT scan of the abdomen may 
reveal focal mural thickening and pericolic fluid at the site of recent polypectomy as 
well as soft-tissue stranding of the pericolic fat, without any evidence of 
pneumoperitoneum or large hematoma
24, 25
. Conservative management is generally 
successful and includes hospitalisation, intravenous fluids with or without antibiotics 
with good outcomes.  
Although a truly uncommon complication, the presumed mechanisms of splenic 
rupture during colonoscopy include direct trauma to the spleen, marked angulation 
of the splenic flexure, excessive splenocolic ligament traction, and decrease in the 
relative mobility between the spleen and the colon
24
. Haemodynamic instability, 
clinical features of acute abdomen, leukocytosis, and/or acute anaemia in patients 
with persistent abdominal pain after colonoscopy demand immediate attention. 
Intestinal perforation or bleeding must first be excluded, after which CT scans can 
be used for further evaluation
25
. Splenic rupture is rare with flexible sigmoidoscopy, 
primarily because generally no attempts are made to pass the endoscope beyond the 
splenic flexure.  
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Sedatives used during colonoscopy may cause complications from allergic reactions 
or, more importantly, from doses that may be excessive for certain individuals and 
lead to respiratory depression. Serious events may complicate up to 0.5% of 
procedures
13
. More than 50% of deaths associated with endoscopy are related to 
cardiopulmonary events
26
. Adverse effects of benzodiazepines, other than 
respiratory depression, include anxiety and occasional injection-site reaction; the 
latter is more frequent with diazepam than with midazolam
27
. Other adverse effects 
of narcotics include nausea, vomiting, and hypotension
27
. Naloxone and flumazenil 
readily reverse the adverse effects of narcotics and benzodiazepines, respectively, 
within minutes. The proper technique and sequence of administration of these drugs, 
together with continuous monitoring of the sedated patient, can help minimize 
complications.  
1.1.4.2. Complications of Flexible sigmoidoscopy  
Potential complications of FS include perforation, bleeding, transmission of 
infection, colitis /diverticulitis and rarer complications like post-polypectomy 
syndrome. An expert review initially identified a serious complication rate of 1 in 
10,000 whereas other series have shown rates of 0 to 4 per 1000. For screening FS, 
the rate of complications was shown to be around 21 per 100,000 procedures in a 
large study involving more than 100,000 participants.  
Perforations are rarer with flexible sigmoidoscopy as compared to colonoscopy. The 
quoted rate for FS is around less than 1:10000 procedures. The large study 
mentioned above found a perforation rate of less than 1in 50,000 or even 1 in 
100000. these rates are significantly lesser than colonoscopy perforation rates. The 
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mechanism of injury remains the same as in colonoscopy. The main difference 
between the two is that the bowel is generally unprepared in FS and hence the higher 
theoretical possibility of contamination. In practice, perforations are rare and 
management remains the same as in colonoscopy perforation.  
Bleeding following FS has an incidence of <1:5000 procedures. The aetiology and 
management remains the same. Most bleeds settle spontaneously; however, it is 
usual to repeat the flexible sigmoidoscopy to ensure that the polyp base is not 
bleeding further. Therapeutic manoeuvres like endoscopic clipping, thermal probe or 
argon can be useful to arrest bleeding if it persists. Surgery is rarely indicated.  
Transmission of infection with FS is rare; the incidence and findings are the same as 
for colonoscopy. Universal precautions as suggested by the British Society of 
Gastroenterology should be adhered to at all times to minimise such complications. 
Colitis following FS has been reported but only in the form of case reports. The 
suggested mechanism is the contact of colonic mucosa with chemicals used for 
washing of endoscopes. Diverticulitis following FS is a recognised complication; but 
the incidence is very low and not established. Small, contained perforation of a 
diverticulum is the usual mechanism involved. Treatment generally remains 
conservative; gross contamination is usually the result of large perforation and 
should be dealt with accordingly. 
Sedation is generally not administered during FS and hence sedation-related 
complications are rare. Even if sedation is required for FS, smaller doses are given, 
thereby minimising the risks. 
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1.2   Assessment of quality of LGE 
1.2.1 Technical Quality of Lower gastrointestinal endoscopy (LGE) 
LGE is the preferred method to evaluate the colon in most adult patients with bowel 
symptoms, iron deficiency anaemia, abnormal radiological studies of the colon, 
positive colorectal cancer screening tests, surveillance in inflammatory bowel 
disease and those with suspected masses. Although LGE has been performed for 
more than 30 years, there has been a recent surge of interest in the evaluation of its 
quality. This stems from the fact that there is growing evidence of variation in the 
quality of LGE. Rex et al first showed that the sensitivity of colonoscopy for cancer 
was 97% among gastroenterologists but only 87% among non-gastroenterologists in 
Indiana (USA)
28
. In a tandem colonoscopy study
29
, in Indiana, involving 26 
endoscopists, the range of miss rates for adenomas among different endoscopists 
ranged from 17% to 48%. However, the study with the biggest impact, especially in 
the United Kingdom, has been the study by Bowles et al
30
, who showed that the 
average caecal intubation across a large region in the UK was only around 57%. This 
paper highlighted several variations in quality of colonoscopy and has been the 
trigger for improvements in quality of colonoscopy.  
Not all the variations in quality of LGE impact outcomes. For instance, missing tiny 
hyperplastic polyps may not be important. On the other hand, some of the variations 
produce outcomes that are clearly adverse. Low completion rates result in both 
missed pathology as well as increased costs due to additional tests. Therefore, the 
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next obvious step is to perform continuous quality assessments and aim for 
improvements.  
There are multiple indicators of quality of LGE including completion, pathology 
miss rates/ adenoma detection rates and others. The effectiveness of LGE depends 
on adequate visualization of the colon, diligence in examining this mucosa and 
interpreting the findings and patient acceptance of the procedure (patient 
satisfaction).  In other words, the three key technical quality indicators of LGE 
include completion rates, pathology miss rates and patient satisfaction rates, though 
there are other factors as well. 
1.2.1.1 Assessment of completion of colonoscopy 
The aim of colonoscopy is to intubate the caecum and also ensure that the whole of 
the colon is carefully seen. Techniques of caecal intubation are described 
elsewhere
31
 and are beyond the scope of this review. Caecal intubation is routinely 
documented by naming the identified caecal landmarks, which include the ileocaecal 
valve, tri-radiate fold and the appendiceal orifice. In cases of uncertainty, 
visualisation of the ileum may be necessary. However, despite using the technique of 
identifying all the three landmarks, the false positive rate is around 10-20%
32
. 
Tabibian and colleagues 
32
 using endoscopically placed clips showed that in 20% of 
the cases where the endoscopist believed that the caecum had been reached and used 
the clip for confirmation, the caecum had not been reached. In another study, using 
three-dimensional electromagnetic  imaging, Adam and colleagues
33
 showed that in 
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8 of 85 cases, where the endoscopist believed that a complete colonoscopy had been 
performed, the endoscope was shown not to have reached the caecum.  
How do we objectively assess completion of colonoscopy to the caecum? 
1.2.1.2 Objective assessment of completion of colonoscopy 
Documentation of caecal intubation is essential for ascertaining completion and 
continuous quality improvement. This documentation needs to be objective and 
easily retrievable at a later date, if completion needs to be verified. Table 1.4 shows 
the different available options for objective documentation of completion of 
colonoscopy. 
Photography of the caecum has been recommended by for documentation of 
completion and is perhaps the simplest available technique. However, still 
photography of the caecum may not be convincing in all cases because caecal 
anatomy can be variable and the quality of photographs can be poor. Furthermore, it 
may be difficult to interpret these photographs of caecum at a later date, making it 
impossible to confirm completion. A previous retrospective study
34
 of consecutive 
caecal photographs taken by 6 different endoscopists demonstrated several relevant 
findings regarding caecal photography. First, there were marked differences between 
multiple expert endoscopists reviewing the same caecal photographs as to how 
convinced they were that the photographs represented the caecum. Second, the 
success of individual endoscopists in obtaining convincing caecal photographs was 
variable. However, these differences were not as great as the disparities between 
reviewers examining the same photographs. Finally, the study demonstrated that still 
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photographs of the caecum are only partially successful in documenting caecal 
intubation. However, caecal photography remains the most commonly used 
technique, primarily due to the ease of use, availability and a lack of a useful 
alternative.  
The other established method of documenting completion in colonoscopy is the use 
of caecal videotaping. Caecal videotaping can be highly convincing as a method of 
documentation of caecal intubation. The advantages include low cost and relatively 
easy availability of the technology. On the other hand, videotaping seems 
impractical and tedious both in terms of recording and saving as well in retrieving 
the segments when required.  
Routine ileoscopy/ intubation of the terminal ileum with either biopsy or 
photography has also been proposed as a method of objectively documenting 
completion in colonoscopy. However, there are concerns regarding a routine biopsy 
of the terminal ileum (TI) for the sole purpose of completion rate documentation. 
There is a theoretical risk of iatrogenic prion transmission with surgical and 
endoscopic instrumentation. In particular, variant Creutzfeldt-Jakob disease (vCJD) 
is resistant to conventional sterilization techniques and also has been shown to 
accumulate at a high concentration in the lymphoid-rich TI of patients infected with 
vCJD
35-37
. There are also considerable costs involved in obtaining, preparing, and 
analysing tissue samples, and 1 study estimated TI biopsy specimen–processing 
costs in the region of $430 (£240)
38
. This financial burden is unlikely to be offset by 
any additional diagnostic information generated from histologic assessment of TI 
biopsy specimens, because the diagnostic yield from routinely acquired TI biopsy 
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specimens is low. Data from prospective and observation studies suggest that the 
detection rate of significant pathology from routine TI biopsy in unselected patients 
is between 2% and 7%
39
. On the other hand, photographs of the terminal ileum are 
sometimes convincing if they show villi, circular valvulae conniventes, and 
lymphoid hyperplasia, but they are less likely to be effective compared with the 
above-mentioned photographs. Recently, Baraza et al
40
 have shown that terminal 
ileal imaging is not a reliable mode of documenting complete colonoscopy. The 
overall accuracy of positive identification was only 53.4%. Though water 
insufflation and chromoscopy improved the accuracy to 68.3% and 63% 
respectively, the accuracy is still limited, and hence neither can be recommended for 
replacement of the use of the caecal landmarks. 
Other techniques of confirmation of caecal intubation include transillumination of 
light through the abdominal wall and ballottement of the abdominal wall and 
identification of confluence of taeniae coli (Crow’s foot or Mercedes Sign). The 
latter are extremely unreliable and are only suggestive of caecal intubation. Cirocco 
et al
41
 showed that transillumination can be a very unreliable indicator of the 
colonoscope position, as the light seen in the right iliac fossa may be emitted from a 
colonoscope tip positioned in the sigmoid or transverse colon. These techniques are 
now considered obsolete and unreliable. In conclusion, none of the available 
techniques is practical for objectively documenting completion of colonoscopy. 
However, caecal intubation continues to be crucial for maximising the sensitivity of 
colonoscopy and convincing documentation of caecal intubation would provide a 
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way to monitor the quality of colonoscopy for the purposes of continuous quality 
improvement.  
 
Table 1.4 Methods of validating completion in colonoscopy 
Technique Accuracy/
Sensitivity 
Advantages Disadvantages 
Caecal 
photography 
51.4%
42
 Ease of use 
Current standard 
Easy to store 
Low sensitivity and 
specificity 
Movement artefacts 
Difficult to interpret 
Ileal biopsy High Very high accuracy Needs ileal 
intubation 
Risk of vCJD 
transmission 
Increased workload 
for pathology 
Low yield of ileal 
pathology (7%) 
Ileal 
photography 
(IP) 
53.4%
40
 
(accuracy) 
Permanent record of 
completion 
Needs ileal 
intubation 
Difficult technique 
to learn 
Increased time 
Underwater IP 68.3.%
40
 
(Accuracy) 
Increased accuracy Cumbersome 
Needs ileal 
intubation 
IP with 
Chromoscopy 
63% 
(accuracy) 
Increased accuracy Cumbersome 
Increased procedure 
time 
Needs ileal 
intubation 
Caecal 
videotaping 
- Reliable 
Consistently 
convincing 
Impractical 
Storage problems 
Cannot be accessed 
immediately 
Scope guide   New technology 
Not yet available 
readily 
No proven results 
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Quadrant 
coverage 
histogram 
  New technology 
Not yet available 
readily 
No proven results 
 
1.2.1.3 Use of endoscopic clips and follow-up abdominal x-ray for 
documentation of caecal intubation/ completion of colonoscopy 
Tabibian et al
32
 described the technique of applying endoscopic clips with follow on 
abdominal x-ray for objective documentation of completion. This study 
demonstrated that endoscopists were inaccurate in 34% of cases in terms of 
confirmation of caecal intubation. However, this technique has not been 
subsequently used or assessed further.  As part of this technique, the endoscopists 
performing colonoscopy apply an endoscopic clip on the most proximal part of 
colon reached. This should ideally be the caecum in colonoscopy or the descending 
colon in flexible sigmoidoscopy. The endoscopist then documents his assessment of 
position in the colon. Subsequently, all patients undergo an x-ray of the abdomen 
whilst there is still air in the colon. A review of such an x-ray would reveal the exact 
location of the clip and hence the most proximal part of the colon reached with the 
endoscope. This can confirm completion in either flexible sigmoidoscopy or 
colonoscopy.  
Endoscopic clips are commonly available, easy to use and are cheap. They tend to 
fall off in 2 weeks, and their safety record is excellent
43
. Currently, endoscopic clips 
have a number of uses and indications (table1.5).  
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Table 1.5 Indications for endoscopic clip therapy in GI disorders
44
 
 
 
A) Arrest of GI bleeding from various lesionsa 
i.   Peptic ulcer 
ii.  Dieulafoy’s lesion 
iii. Mallory-Weiss tear 
iv. Diverticular bleeding from duodenum 
v.  Diverticular bleeding from colon 
vi.  Post-polypectomy bleeding 
vii. Focal bleeding in ulcerative colitis 
 
B) Secure tubes, catheters, and stents to the GI wall 
i.   Jejunal feeding tube 
ii.  Colon manometry catheter 
iii. Oesophageal metal stent 
 
C) Close perforations and fistulas of the GI tract 
i.   Oesophagus, stomach, duodenum, and colon after 
     endoscopic therapy 
ii.  Seal anastomotic leaks and fistulas after 
     surgery 
 
D) Cut the blood supply of a polyp 
i.  Diminish the size of polyp to relieve gastric 
    outlet obstruction 
ii. Before polypectomy of a giant polyp 
                Clip-assisted biliary cannulation 
 
E) Direct therapy or identify an anatomic landmark 
i.  Assist interventional radiologists in embolisation 
    of a bleeding vessel 
ii. Aid radiation oncologists in focusing radiotherapy 
     of cancer 
iii  Help surgeons in deciding the extent of resection 
iv. Facilitate physiologists to identify oesophageal landmarks 
     during the evaluation of oesophageal function 
 
The current thesis aims to assess the feasibility of using this simple technique to 
objectively document completion. Further description of our modification of 
technique appears in chapter 4.   
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1.2.2 Pathology Miss Rates in colonoscopy 
The fundamental goal of colonoscopy in most instances is the detection of neoplastic 
lesions. However, there continues to be a disparity between different endoscopists in 
terms of pathology detection. Data from two U.S. practice groups
45,29
,  have 
indicated large disparities between gastroenterologists in their rates of detection of 
both small and large adenomas. With regard to cancer detection, one study 
demonstrated miss rates of 3% for gastroenterologists versus 13% for non-
gastroenterologists
28
. However, miss rates for cancer were 5% for one group of 
gastroenterologists compared with 1% for all other gastroenterologists studied
28, 46
. 
Currently, regular calculation of the polyp detection rate is considered to be the 
standard technique used to assess pathology miss/ detection rates and this is accepted 
by the Joint Advisory Group for Gastrointestinal endoscopy (JAG). However, this 
technique is not entirely flawless. It is based on an assumption that the procedure 
was complete. If the endoscopist is inaccurate in assessment of completion, 
obviously pathology may be missed in segments of bowel, which have not been 
visualised.  
Is there any other method of assessing pathology miss rates? The use of endoscopic 
clips with follow-up x-ray has been described above for detection of completion of 
colonoscopy. However, when these patients are audited at around 2 years, delayed 
pathology miss rates can be detected. We have also looked at the role of the 
technique of endomucosal clipping and follow up x-ray with audit at 2 years to 
objectively document completion as well as pathology miss rates. 
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1.2.3 Technical quality of flexible sigmoidoscopy 
Flexible sigmoidoscopy (FS) is a useful test to assess the left colon. Incomplete 
examination is an unfortunate drawback of FS, commonly occurring as the internal 
landmarks are not constant and clear. Furthermore, there is variability in defining 
completion of FS. The JAG has defined completion of FS as insertion of the 
endoscope to descending colon, and this should be achieved in 90% of examinations. 
However, generally endoscopists aim to examine as much of the distal colon as 
possible based on the limits of FS endoscope length or to the limits of patient 
tolerance. Studies
47
 have shown that anatomical factors, preparation quality or 
variations in patient tolerance and gender all may limit insertion depth of insertion or 
completion of FS.  Olynyk found that FS were incomplete in up to one-third of 
patients
48
. Painter et al
49
 found that in up to a quarter of patients the descending 
colon was not intubated. Stewart at al
50
 suggested a 25% incomplete examination 
rate and technical difficulty in up to a third of cases. Unlike colonoscopy, there are 
no constant landmarks in the left colon. Hence, documentation of completion of FS 
is difficult and unreliable. Furthermore, localising the depth of FS insertion by 
anatomical segment is also unreliable. The rectum is usually traversed by the distal 
10-20 cm of the FS endoscope. Adam et al
33
 have used a novel electromagnetic 
imaging (EMI) device to assess the position of the scope in the left colon. They 
showed that the endoscopists’ assessment of position was correct in only 47 cases 
(50%), with over-estimation of length in 25% and underestimation in the remainder. 
EMI also showed that the splenic flexure was not reached in around 60% of cases. 
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However, the use of such an EMI device has not become popular, due to the lack of 
availability and time involved in using the same. 
Lehman et al
51
 used radio-opaque clips in the left colon and subsequent barium 
enema to document completion. This technique is very similar to the one described 
previously in the section under colonoscopy completion, with the exception of 
barium enema instead of plain abdominal x-ray. They showed that a 60cm 
examination reached the splenic flexure in only 33% of patients; 50-55 cm 
examination reached the sigmoid colon in most instances
51
.  
The technique of endomucosal clipping with follow up x-ray is a relatively simple 
and effective technique and can be adopted in all hospitals without the need for 
additional complex equipment or expertise.  
1.2.4 Patient satisfaction with LGE 
1.2.4.1 Introduction and definition of patient satisfaction 
Patient satisfaction is an important aspect of quality assessment programmes in 
LGE. Interest in measuring satisfaction with healthcare has grown considerably in 
recent years and there is a large, diverse and expanding literature on the field. The 
term satisfaction itself comes from the Latin word “satis” meaning enough. 
However, it is generally agreed that patient satisfaction represents “a patients’ 
cognitive or emotional evaluation of a health care providers’ performance and is 
based on relevant aspects of the health care experience”52, 53.  
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1.2.4.2 Why measure patient satisfaction? 
Patient satisfaction is being increasingly measured for assessment of quality of 
healthcare. But is it important and if so, why? 
It is obvious that satisfied patients are more likely to participate in their own 
treatment regime, and follow their schedules. Conversely, dissatisfied patients do not 
respond well and do not comply with interventions. Studies have shown that regular 
patient satisfaction assessments promote a useful mechanism of identifying areas 
that need improvement. It is therefore important to identify levels of satisfaction and 
factors affecting patient satisfaction, so that we could potentially work on them.  
In countries like the United Kingdom, where the healthcare is delivered by the 
Government, the available resources remain finite, making it ever so important to 
identify patient perspectives and requirements, ensuring that the finances are utilised 
correctly. On the other hand, in countries like the USA, it is clear that customer 
satisfaction is the key to financial success and in having a bigger practice size and 
lesser litigation.  
1.2.4.3 Problems with measuring patient satisfaction 
Several problems arise when attempts are made to measure satisfaction. Broadly, 
this is either related to the inherent patient bias or problems with the actual 
instruments used in the measurement of satisfaction. Patients’ marking of the 
satisfaction questionnaire can be tempered by their own expectations rather than the 
actual quality of care. Further, expressed satisfaction can actually be a reflection of 
patients’ health outcomes and not necessarily level of care provided. A patient who 
has had a good outcome tends to rate the health service or provider much higher.  
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1.2.4.4 Methods of measuring patient satisfaction 
There are many different methods of measuring and assessing patient’s satisfaction 
with healthcare and several surveys have been published. Several factors affect the 
measurement method chosen and these include available resources and time, reasons 
for the study and the setting.  
Previous studies
53
 have demonstrated that there are broadly two different techniques 
of measuring patient satisfaction- survey methods and qualitative methods. Survey 
methods include either questionnaire administration or interviews. Questionnaires 
may be distributed by hand or at a computer terminal or be mailed. Personal 
interviews may be face to face, or by telephone. The advantages of questionnaires 
are that patients tend to be uninhibited in their responses, they are cheaper and there 
is no interviewer bias. However, the response rate can be low, and this in itself can 
introduce bias and it also disadvantages people with poor literacy skills.  
A good satisfaction study should aim to minimise these biases and problems, thus 
making it more relevant and robust. 
1.2.4.5 Need for measuring satisfaction with LGE 
The satisfaction of patients with endoscopy is currently considered to be a key 
indicator of the quality of service provided and this is reflected in the fact that the 
Global rating scale (GRS) includes quality of patient experience or satisfaction as 
one of the important dimensions. GRS is currently the standard of practice in the UK 
endoscopy practice for the assessment of quality of endoscopy services.  
Patient satisfaction will continue to remain an important outcome measure for GI 
endoscopy as screening initiatives intensify. With regard to colorectal cancer 
screening, to ensure that a substantial proportion of the eligible population is 
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compliant it will be necessary to focus on providing a satisfactory endoscopic 
experience. Moreover, in today’s world, it has become increasingly important to 
establish the cost-effectiveness of various procedures. The patient’s opinion is 
important in this process because expert views about procedures can be quite 
significantly different from those of the patients. Therefore, awareness of patients’ 
opinion is crucial to improve endoscopy services.  
Lin et al
54
 have shown that a well-designed and implemented patient satisfaction 
system can help establish performance standards, improve risk management, 
increase accountability of endoscopy staff and ultimately improve quality of care. 
Satisfied patients are more likely to continue use endoscopy services and as we 
mentioned before, it is expected to increase compliance with both screening 
programmes and follow-up programmes for cancers and polyps. 
Currently, there is no information on the factors associated with patient satisfaction, 
though various studies have concluded that waiting times, adequacy of explanation, 
sex of the patient and previous pelvic surgery are important factors
52
.   
Moreover, due to shortage of endoscopists, there has been an introduction of non-
medical endoscopists (both nurse and non-medical non-nurse endoscopists). 
However, there has been no study to assess if patient satisfaction with the three 
different types of endoscopists (doctors, nurses and non-medical) is different. Non-
medical endoscopy is discussed in detail in section 1.4. 
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1.3 Availability of LGE 
1.3.1 Increasing demand for LGE 
Limited availability of LGE has been considered as one of the biggest impediments 
for the successful introduction of 18-week pathway for colorectal diseases, primarily 
due to long waiting lists
55
. The National Bowel Cancer Screening programme in 
United Kingdom has further increased demand for LGE, putting enormous pressure 
on the provision of endoscopy services. It is estimated that around 60000 more 
colonoscopies 
56
 or one session per week (1 session=6 colonoscopies) for each 
district
 
general hospital serving a population of 250 000 need to be performed 
annually to meet the demand arising from the screening programme. Price et al have 
shown that demand for colonoscopy activity increased by 31 per cent in Scotland 
and 21 per cent in England due to the investigation of faecal occult blood testing 
(FOBt) positive subjects 
57
. There was a simultaneous increase in demand for non-
screening colonoscopy as well. It was also predicted that a follow-up of patients with 
adenomas diagnosed due to screening programmes will result in a further increase of 
28 per cent in the number of colonoscopies generated (over and above colonoscopy 
for FOBt-positive subjects), adding substantially to overall workload
57
.  
1.3.2 Potential solutions 
What are the potential solutions for this increasing demand?  We discuss three 
possible solutions in this work- increasing the number of endoscopists, decreasing 
demand for LGE and increasing turnover of colonoscopy by improving sedation.  
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At the outset, the simplest solution to the problem would be to increase the number 
of available endoscopists. However, it takes at least 15-16 years to train an 
individual to become a doctor and subsequently capable of performing colonoscopy. 
Hence, the Department of Health introduced the concept of nurse endoscopists, and, 
as a consequence, an increasing number of nurse endoscopists are being recruited in 
different hospitals across the United Kingdom. Despite this plan, there continues to 
be a high demand for endoscopists across the United Kingdom. Subsequently, the 
Department of Health then initiated a pilot project to train non-healthcare 
professionals to perform LGE
58
. These endoscopists will be called Non-Medical 
Endoscopists (NME) for the purposes of this thesis, though the term can generically 
be applied to all non-physician endoscopists. Further discussion follows in the next 
section. 
Furthermore, studies in high-volume European endoscopy centres have shown that 
around 21% to 39% of LGE were inappropriate
59
 or unnecessary. In other words, 
there is a potential to reduce the number of unnecessary LGEs, in which case the 
burden on colonoscopy services would be greatly decreased. However, the current 
clinical assessment techniques are not good enough to prevent these unnecessary or 
unhelpful procedures. In this thesis, we have, therefore, looked at the use of artificial 
neural networks to determine the presence of pathology in patients with colorectal 
symptoms, and the same has been discussed in section 1.6. 
Currently, intravenous sedation using Midazolam with either Fentanyl or Pethidine 
is most commonly used for providing sedation for colonoscopy. However, NME are 
unable to prescribe and give intravenous sedation, and require a doctor or a nurse to 
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administer the same. This defeats the very purpose for which the NME are being 
introduced. Hence, we need to identify a sedative regimen that can be administered 
safely by NME, and at the same time should be effective and have a quick onset and 
recovery profile.  
1.4 Non-Medical Endoscopy 
1.4.1 Introduction 
Lower gastrointestinal endoscopy (LGE), including both flexible sigmoidoscopy and 
colonoscopy is routinely provided by doctors. However, in 1977, Spencer and 
Ready
60
 published first descriptions of endoscopy by non-medically qualified 
personnel (nurses) and since then there has been an increase in interest in this 
concept. Duthie et al first described the concept of nurse endoscopy in 1998 in 
United Kingdom 
61
 and since then the concept has become accepted practice in many 
hospitals across England. 
The primary reason for these changes is the increasing demand for LGE and long 
waiting lists. A pilot study was undertaken in 2003 to evaluate the potential of 
training non-medical individuals to undertake flexible sigmoidoscopy, and this 
included a science graduate and a non-clinical member of hospital staff. These 
endoscopists are now defined as non-medical endoscopists (NME). For the purposes 
of this thesis, the term NME will be reserved for non-healthcare professionals 
undertaking endoscopy. 
This concept has now been taken further and one member (science graduate) of this 
pilot group has now successfully completed colonoscopy training, and is now a JAG 
(Joint Advisory Group) - accredited endoscopist. This non-medical endoscopist has 
participated in the current study, which is included in this thesis.  
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The reasoning behind the pilot was to provide a workforce capable of coping with 
the increasing demands of endoscopy. With time, the senior non medical 
endoscopists would probably progress to performing colonoscopy. At the moment, 
they are limited by an inability to prescribe medications and administer sedation. 
This necessitates the presence of a suitably trained nurse or doctor to provide 
sedation, when the NME performs colonoscopy. 
1.4.2 Training of non-medical endoscopists  
There are unique issues related to the training of non-medical endoscopists. Firstly, 
there are educational differences between non-medical endoscopists and doctors. 
Secondly, doctors have a broad knowledge base and culture of decision making, 
which is certainly not the case with non-medical endoscopists. Hence the British 
Society of Gastroenterology has emphasised that “the training of non-medical 
endoscopists should be sufficiently broad to ensure that their endoscopic and 
attendance skills are equal to that of doctors, and their cognitive, interpretive and 
decision making skills are also balanced” 62.  
This is reflected in the current training courses for the non-medical endoscopists. 
Based on the early experience with the pilot project of non-medical endoscopy, a 
three-year curriculum was developed at the University of Hull. During the first 
semester, students were trained and assessed in basic endoscopy skills which include 
cleaning of endoscopes, disinfection, and assisting at endoscopies. Themes include 
anatomy and physiology, endoscopy practice and theory, applied gastroenterology 
and professional practice. Hands-on practice was predominantly undertaken in the 
base NHS Trust under the supervision of a Joint Accreditation Group for GI 
Endoscopy (JAG) registered endoscopy trainer. 
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Table 1.6  Elements of practice and estimated timeframe for completion(from
63
) 
 
A basic overview of this course is that during the initial part of the course the 
participants are taught and encouraged to acquire basic knowledge of anatomy, 
physiology and pathology relevant to the training. As a continuum from year one, 
anatomy and physiology then take a more discipline specific approach, focusing on 
the GI tract in year two. Students extend basic understanding of general anatomy and 
physiology and applied concepts to the GI tract, with assessment being via written 
examination. Gardiner et al
64
 have shown the range of methods applied to assess 
clinical practice elements in this course and this includes Observed Structural 
Clinical Examination and Direct Observation of Procedural Skills on real cases, 
patient stimulation and role play. 
Year of 
Programme 
Semester Related 
practice 
module 
Expected element 
of practice to be 
completed  
1 1 Basic 
Endoscopic 
skills 
Set-up & take 
down endoscopes 
Cleaning & 
disinfection  
1 2 An introduction 
to Basic FS 
Observation 
Simulated practice 
FS 
1 3 An introduction 
to Basic FS 
Simulated practice 
FS 
[Withdrawals] 
2 1 The Practice of 
Diagnostic FS 
Withdrawals  
[Full procedures] 
2 2 Same as above Full procedures 
[Std biopsy] 
2 3 Same as above Same as above 
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Simultaneously, hands-on training is carried out at the individuals’ base hospital and 
there are additional sessions at the bigger centre for acquiring advanced skills. In 
fact it is a prerequisite for trainees joining this degree course that they have support 
at their own hospital for basic endoscopy training. Initially, observation of flexible 
sigmoidoscopy is commenced, with students recording observations undertaken. 
Following procedural observation, students undertake simulated procedures 
followed by endoscope withdrawal under direct supervision. Progression to full 
procedures commences once the student is deemed competent by the supervisor.  
Table 1.7 Competency requirements for flexible sigmoidoscopy training
63, 64
 
 
COMPETENCY ELEMENT DESCRIPTION 
HANDLING & CARE OF 
ENDOSCOPES  
 
The trainee demonstrates appropriate 
care and handling of endoscopes, and 
can identify the anatomy of the 
endoscope 
SAFETY IN ENDOSCOPY 
 
The trainee works with the team to 
organise and maintain a safe 
environment for the patient in all 
aspects of endoscopy preparation and 
examination 
COMMUNCIATION 
WITHIN ENDOSCOPY 
The trainee demonstrates the ability to 
communicate with the patient, family 
and members of the endoscopy team 
CONSENTING FOR 
FLEXIBLE 
SIGMOIDOSCOPY 
The trainee demonstrates the ability to 
obtain and record consent for the FS 
examination 
PATIENT PREPARATION The trainee is able to safely prepare 
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The training of the non medical endoscopist who participated in the research in this 
thesis extended training beyond flexible sigmoidoscopy. The first 100 cases of 
flexible sigmoidoscopy were supervised and subsequent ones required the trainer to 
be present in the endoscopy unit. Once declared competent to perform flexible 
sigmoidoscopy, the NME went onto structured training for colonoscopy, based on 
the guidelines issued by the JAG.  
In summary, the standards for training NME are the same as those for the training of 
doctors and nurses. These guidelines are developed and maintained by the JAG. 
1.4.3 Results of NME with flexible sigmoidoscopy/ colonoscopy 
the patient for the FS examination 
OBSERVATION OF 
ENDOSCOPY 
The trainee, through observation, is 
able to describe the basic techniques 
and manoeuvres of FS and normal / 
abnormal anatomy of the colon and 
rectum 
ENDOSCOPY 
SIMULATION 
The trainee is able to perform FS 
examination on a patient simulator 
ENDOSCOPE 
WITHDRAWAL  
 
The trainee is able to withdraw the 
endoscope safely, identifying all 
anatomical landmarks and 
pathologies, following insertion by an 
experienced endoscopist 
PRACTICE OF FLEXIBLE 
SIGMOIDOSCOPY  
The trainee safely performs FS 
examination 
THERAPEUTIC 
FLEXIBLE 
SIGMOIDOSCOPY  
The trainee is able to demonstrate the 
safe removal of polyps, if appropriate, 
for histological assessment 
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Three hundred and twenty five patients, who underwent flexible sigmoidoscopy and 
colonoscopy by two non-medical endoscopists, were reviewed. The first 50 cases 
(total) were directly supervised by an endoscopy trainer and the next 50 required the 
trainer to be present in the endoscopy suite. The M: F ratio was 210:165 with a 
median age of 62 (range, 22-82) years. Indications for endoscopy included cases for 
symptomatic (220), follow-ups (80) and family history (25). Sedation with Fentanyl 
and Midazolam was given in 70 of the 75 colonoscopies and no sedation used for 
flexible sigmoidoscopies. 
The median time for flexible sigmoidoscopy was 18 minutes (range, 5-40).  The 
indications included symptomatic patients, family history clinic patients and follow 
up patients. The transverse colon was intubated in 85% of patients with flexible 
sigmoidoscopy and the caecum was intubated in 91% of patients undergoing 
colonoscopy. No sedation or procedure-related complications occurred. The findings 
included: normal (186 cases), polyps (97), malignancy (10), inflammatory bowel 
disease (26) and others (6). Six polyps and a malignancy were missed on initial 
endoscopy. These were picked up on repeat endoscopy, which were done because 
the first was deemed incomplete. Only 3 polyps were truly missed.  
1.4.4. Medicolegal issues  
Concern has been expressed about the legal implications of endoscopy practice and 
the need for full medico-legal cover in the event of complications. The common law 
of negligence requires “that at all times a reasonable standard of care is practiced. A 
person who holds himself/herself as possessing special skills will be judged by the 
standard of the specialist”58. 
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Currently, the non medical endoscopists are not affiliated to a professional body but 
the Department of Health confirms that they are, however, covered under their local 
Trust Governance Frameworks under vicarious liability 
65
, and are all held on a 
voluntary list which will lead to regulation in the future. The issue of regulation is 
crucial and demands accelerated progress, not only to provide some reassurance to 
the endoscopy community but also to the public and the trainees alike. 
1.5 Sedation for LGE 
1.5.1 Introduction 
Colonoscopy is generally performed in the United Kingdom as an outpatient 
procedure. However, it can be a difficult and painful procedure, sometimes resulting 
in acute pain. This necessitates the provision of analgesia and sedation during 
colonoscopy. Although colonoscopies can be performed without sedation, results of 
two studies showed that 16% to 56% of such procedures are terminated because of 
pain
66, 67
. As a result, the caecum is not reached in these patients and hence lesions 
can be missed.  
Sedation is, therefore, routinely provided to patients during colonoscopy and is 
considered the standard of practice in the UK. In a multicentre study 
30
 conducted on 
over 9,000 colonoscopies, moderate sedation was used in 94.6% of patients, general 
anaesthesia in 0.2% and the remainder without any sedation.  
Although there are many different techniques and medications to achieve sedation 
during colonoscopy, the ideal amount and type of sedation for a patient undergoing 
colonoscopy has not been established. Hence there is a wide variation in the 
provision of sedation and analgesia throughout the world. In France, about 90% of 
all colonoscopies are performed under general anaesthesia, usually supervised by an 
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anaesthetist
68, 69
, while in Germany
70
 and Finland
71
 a number of procedures are 
carried out without any sedation.  
The different types of sedation for colonoscopy include general anaesthesia, deep 
sedation and moderate sedation. However, there has been a general consensus that 
moderate sedation (formerly conscious sedation) as opposed to general anaesthesia, 
is adequate for the overwhelming majority of routine colonoscopies
72
. 
1.5.2 What is moderate/conscious sedation? 
It is now clear that sedation provided by medications is usually a continuum, 
extending from minimal sedation to general anaesthesia. The British Society of 
Gastroenterology (BSG) recommends that “the doses of sedation and analgesics for 
colonoscopy should be kept to a minimum”73. Conscious sedation is defined by 
BSG
73
 as “a technique in which the use of drug or drugs produces a state of 
depression of the central nervous system enabling treatment to be carried out, but 
during which verbal contact with the patient is maintained throughout the period of 
sedation.  The drug and techniques used to provide conscious sedation should carry a 
margin of safety wide enough to render loss of consciousness unlikely”.  
1.5.3. Drugs for sedation 
There are different types of sedation regimes available at the present moment, 
signifying the fact that none of them provide ideal sedation. The most commonly 
used regime is a combination of benzodiazepines with opioids
30
. Bowles et al have 
shown that 57.85% colonoscopies were performed with this combination in the 
UK
30
. The most commonly used regimens are midazolam with fentanyl and 
midazolam alone. The other sedative regimes include propofol, either on its own or 
in combination with opioids, and Entonox gas inhalation. 
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1.5.4. Safety, advantages and disadvantages of current sedation regimes for 
colonoscopy 
Properties and dosing regimens for the most commonly used drugs in moderate 
sedation are summarised in table 1.8
27
 below: 
Table 1.8 Properties of commonly used sedative drugs for colonoscopy
27
 
Drug Pharmacolo-
gical class 
Effect Onset of 
action 
Duration 
of action 
Adverse Effects 
Midazolam Benzodiazep
ine 
sedation 
amnesia 
1-5min 1-3hours Hypotension, 
hypoventilation, 
increased 
respiratory rate 
and airway 
resistance, 
apnoea 
Diazepam benzodiaze
pine 
sedation 
amnesia 
1-5 min 20-60 
min 
Hypotension, 
Hypoventilation 
Apnoea 
Mepiridine Opioid sedation 
analgesia 
5 min 2-4 h Same as above 
Fentanyl Opioid sedation 
analgesia 
<1 min 30-60 
min 
Respiratory 
depression, 
hypoventilation 
Propofol Sedative 
hypnotic 
sedation 
analgesia 
30-60 sec 3-10 
min 
Hypotension, 
hypoventialtion 
 
There are a number of potential problems with available sedative agents. These 
include cardiorespiratory events, such as hypoxia, hypoventilation, arrythmias, and 
vasovagal episodes. In a retrospective study, it was estimated that the serious cardio 
respiratory complications and death rates from endoscopic sedation are unacceptably 
high at 54 and 3 per 10, 000 cases respectively 
74, 75
. Moreover, benzodiazepines are 
lipid-soluble, and ,hence, repeat doses result in accumulation in adipose tissue which 
is subsequently released and leads to prolonged effects
27
. It is due to these persisting 
effects that the current recommendations in UK require the patient to be 
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accompanied home by a relative/ friend. Patients are advised not to drive for at least 
24 hours, and also not to use heavy machinery or sign important documents for the 
same duration.  
1.5.5. Properties of an ideal agent 
The ideal agent should have certain properties to provide safe and effective minimal-
to-moderate sedation. These include a consistent and predictable 
pharmacokinetic/pharmacodynamic profile, rapid onset of action, analgesic and 
anxiolytic effects. The agents should wear off immediately and leave no effects on 
mental and psychomotor function. The currently used combinations of 
benzodiazepines with opioids unfortunately do not meet these criteria. 
1.5.6. Entonox  
          1.5.6.1 Entonox for sedation 
Nitrous oxide (N2O) gas has been known to have analgesic and sedative properties 
for over two hundred years ever since it was discovered by a Yorkshire chemist 
named Joseph Priestley
76
. The scientist Humphrey Davy inhaled the gas and found it 
gave him rapid pain relief from an infected tooth; on one occasion he reported 
momentarily losing consciousness, waking up laughing about the pleasurable 
feelings he had experienced: hence the term 'laughing gas' 
76
. As a medicinal gas, it 
is available as a mixture containing equal parts of N2O and oxygen (O2). In many 
countries this is commercially available as Entonox, and in the UK it is also often 
known to patients and staff as 'gas and air'. Entonox is ideal in situations where pain 
is predictable and of a short duration. It can provide relief of pain during minor 
procedures such as wound dressing changes, debridement, removal of drains or 
sutures and even turning a patient with a fracture or a pressure ulcer
76
. The gas is 
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administered using a face mask or mouthpiece; gas flow is controlled by a sensitive 
demand-valve activated by the patient's inspired breath. This allows pressurised gas 
from the cylinder to flow through a pressure regulator into the lungs at a steady rate. 
Longer and deeper breaths allow greater volumes of gas to be taken into the lungs if 
necessary.  
The gas is rapidly absorbed on inhalation, providing analgesia within minutes. It is 
excreted, largely unchanged, by the lungs and its rapid elimination from the body on 
cessation of inhalation makes it ideal for controlling pain during short procedures. 
There are no major incompatibilities with other drugs. Entonox will cause an 
enclosed air-pocket in the body to expand rapidly in volume as the gas mixture is 
absorbed from the blood into the space, resulting in a build up of pressure. It must 
therefore never be used if the patient has any conditions where air is trapped in the 
body and expansion would be dangerous; for example, it will exacerbate the onset 
and development of a pneumothorax (air inside the chest cavity but outside of the 
lung) and can increase the pressure of intracranial air following head trauma. 
The following are general contraindications to the use of Entonox (from 
77
 and 
76
):   
 artificial, spontaneous or traumatic pneumothorax  
 air embolism  
 decompression sickness  
 suspected bowel obstruction  
 emphysema 
 maxillofacial injuries 
Repeated exposure to Entonox may result in megaloblastic anaemia owing to 
interference with the action of vitamin B12. 
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  1.5.6.2  Protocol for administration of Entonox 
The protocol for Entonox administration is summarised below: 
 Practical considerations: The first step is to obviously ensure the availability of 
the Entonox cylinders and mouthpieces. Also, it is important to ensure that the 
cylinder has sufficient gas in it to last the procedure.  
 Patient involvement: Patients are then explained what the gas is for and what is   
required of them. The mouth piece is then given to the patient and he/she is 
instructed on the use. Patients generally practice a couple of breaths to ensure they 
are doing it correctly.  
 Documentation: Nursing documentation will confirm that proper patient 
instruction took place, and record the time period in which the gas was used. 
 Procedure for administration: The protocol is to encourage the patient to breathe 
the gas for around two minutes before commencing the procedure. The patient 
generally breathes continuously throughout the procedure. At all times the patient 
should be able to obey commands, but if a momentary loss of consciousness does 
occur, the seal around the mouthpiece will be lost as it falls away and the demand 
valve will fail to operate causing the flow of gas to stop.  
1.5.6.3.Entonox for Colonoscopy 
Entonox as described above is an inhalational sedative agent with analgesic 
properties and has a short onset and duration of action. In previous studies of inhaled 
Entonox versus placebo/intravenous sedation for colonoscopy, it has been shown to 
be associated with similar pain scores. Four studies
78-81
 compared pain scores in 
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patients undergoing colonoscopy and sedated with either Entonox or conventional 
intravenous sedation (see table 1.8 below). Three studies have shown that Entonox is 
atleast as effective as either midazolam/fentanyl or midazolam/pethidine or 
Midazolam/ketobomidone or pethidine alone. The fourth study by Forbes and 
Collins
81
 showed that pain scores were significantly lower in patients with 
conventional intravenous sedation as compared to Entonox, although the study was 
unblinded, with the possibility of bias. Despite these encouraging results, Entonox 
has not received widespread acceptance in colonoscopic practice. The probable 
explanation for such response is a lack of single, clear outcome, and the perceived 
difficulty in the use of Entonox. 
Table 1.9 Comparison of different studies involving Entonox sedation for 
colonoscopy 
Studies N* Entonox(E) 
Versus 
VAS
§
 Discharge 
time 
Completion 
rates 
Satisfaction 
scores 
Lindblom et 
al
78
 
50 Ketobomidone 
+ midazolam 
(KM) 
NS
¥
 E faster 
than KM 
Equal E>KM 
Saunders
79
 89 Midazolam + 
pethidine 
(MP) 
NS Same Equal E>MP 
Notini 
Gudmarsson
80
 
40 Pethidine (P)  NS E faster 
than P 
Equal E>P 
Forbes
81
 102 Midazolam + 
meperidine 
(MM) 
E 
worse 
than 
MM 
E faster 
than MM 
Equal MM>E 
§VAS=visual analogue scale.*N=total number of patients in the study.¥ NS=no 
significant difference in both groups. 
         1.5.7 Propofol  
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1.5.7.1 Introduction 
Propofol (2, 6-diisopropylphenol) is a substituted alkyl phenol derivative that is 
believed to facilitate gamma-amino butyric acid activity in the brain
82
. It has an 
instantaneous onset of action, because of high lipid solubility. The recovery from 
propofol is rapid as it has a half-life of only 2 to 4minutes.These qualities make 
propofol an excellent sedative agent for use during short duration procedures. The 
major disadvantage of propofol is that the sedation produced can rapidly and easily 
convert inot general anaesthesia. This can be disastrous, especially in the setting of 
endoscopy if there is no anaesthetic support available immediately. Hence it is 
hugely important to titrate the doses of propofol.  Moreover, propofol tends to cause 
deep sedation, which results in fewer propofol-treated patients being able to assist 
with the procedure (e.g. changing position). It has been reported in earlier studies 
that the greater level of sedation achieved with propofol potentially puts the patients 
at risk for perforation 
83
, though the evidence is not convincing. Also, there is a lack 
of a reversal agent for propofol, and over-sedation quickly leads to cardio-
respiratory compromise. 
Furthermore, it has a short-recovery time that makes it suitable as an intravenous 
agent for day-case anaesthesia and sedation. In practical terms, no matter how long 
the infusion period, recovery will occur within 10-20 minutes once it is 
discontinued. This is because propofol is rapidly metabolized, principally by 
conjugation in the liver
84
. 
All the studies have evaluated the use of propofol for ERCP or colonoscopy, and 
there has been no comparison with Entonox or Midazolam/ Fentanyl. Moreover, 
there has been only one study in the United Kingdom on the use of propofol for 
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colonoscopy, which used target controlled infusion of propofol for only 20 patients 
and concluded that patient maintained propofol is possible for colonoscopy
85
.  
1.5.7.2. Review of propofol versus traditional sedative regimes for colonoscopy 
Among gastroenterologists, there is increasing interest in the use of propofol for 
endoscopic sedation, and the number of reports of endoscopist-administered 
propofol sedation for colonoscopy is growing
83, 86-91
. Currently, more than 25% of 
patients undergoing endoscopy in the United States receive propofol for moderate 
sedation. Several studies
92, 93
 have been published showing propofol to be superior to 
traditional sedative regimens because of shorter recovery profile. In addition, 
propofol use has been shown to be overall cost-effective, even though additional 
trained personnel were required 
93
. Despite these advantages, the use of propofol has 
been hampered by the understanding that it has a narrow therapeutic index and hence 
it is mandatory for an anaesthetist to administer it. 
Qadeer et al 
94
 recently published the results of a systematic review comparing 
propofol with traditional sedative agents for gastrointestinal endoscopy (including 
ERCP and colonoscopy). Out of 1161 patients, 634 received propofol and the 
remainder received conventional intravenous sedation. The pooled odds ratio with 
the use of propofol for colonoscopy for developing hypotension or hypoxia was 0.4 
(95%CI, 0.2, 0.79), as compared to traditional sedative agents. Qadeer et al
94
 
concluded that propofol sedation for colonoscopy is associated with lower odds of 
cardiopulmonary complications compared with traditional agents.  
1.5.7.3. Target controlled infusion and Patient controlled propofol 
New concepts in sedation for colonoscopy include enhanced mechanisms like target 
controlled infusion (TCI) and patient controlled systems for propofol.  
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Target controlled infusion systems for anaesthetic agents are computer –controlled 
infusion systems designed to deliver intravenous drugs according to the drugs 
pharmacokinetics
95
. Target controlled systems use complex mathematical models to 
compute the drug dosage, which account for various patient characteristics that alter 
the drug disposition. Because they frequently recalculate the appropriate dosage of 
drug to be infused, based on the computer’s pharmacokinetic simulation of the drug 
concentration and ensuring that the correct concentration is infused at all times, TCI 
pumps address the limitations associated with delivery of drugs directly into the 
circulation. Propofol is commonly infused via TCI pumps, ensuring a titrated dose of 
the drug to be given, and this is particularly important due to the narrow therapeutic 
index of propofol. Published studies
96
 have shown TCI propofol is associated with 
longer time to sedation, but is safer and results in higher patient satisfaction. 
In PCS, the medication is self-administered by the patient in response to pain; 
therefore, the patient has to be conscious enough to press the handheld button. 
Specialised pumps are used that deliver a preset dose of medication in response to a 
patient pressing a handheld button. A lockout time is programmed into the pump to 
prevent the delivery of additional doses until the previous dose has taken its full 
effect. When rapid-acting drugs such as propofol and alfentanil are used for PCS, 
over sedation is unlikely to occur.  
In order to minimise the possible side effects with propofol, there have been 
attempts to combine TCI pumps with PCS to deliver propofol. Campbell et al
85
 
experimentally modified a TCI pump to connect it to PCS, and used the system for 
colonoscopy. In this study, 20 patients undergoing colonoscopy were connected to 
the handset and modified TCI system. There was a significant drop in systolic blood 
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pressure and heart rate, and four patients became over sedated, and there was a delay 
in recovery time, indicating this modification is still not optimal for use. 
The above mentioned modification of the TCI pump is not commercially available. 
Additionally, the manufacturer and the National Health Service trust were unable to 
modify the pumps due to patent reasons. Hence, in the current thesis, two separate 
pumps- PCS and TCI – have been used to achieve the target of delivering TCI-PCA 
sedation during colonoscopy (chapter 6). 
1.6 Artificial neural networks (ANN) for patients with colorectal symptoms 
1.6.1 Introduction to ANN 
Artificial neural networks (ANN) are special intelligent software programmes. 
Inspired by the function of the human brain, they are able to learn and adapt 
themselves based on the available data. As a result, ANN are able to analyse 
complex relationships in databases. It is generally agreed that ANN are well suited 
for solving non-linear problems. Non-linear problems are those problems “where the 
relationship between the inputs and the outputs of the problem are not clearly 
distinguishable”97.  
Structurally, ANN are networks of interconnected nodes or processing elements. The 
most basic ANN has an input, processing and output node. So, the information or 
data flows from the input node to the ouput node via the processing node. A 
prespecified function or algorithm sits in the processing node and this analysis or 
modifies the data and the result is fed to the output node. The connections between 
the nodes are also important. These connections are constantly weighted and altered 
in accordance with the learning of the programme. It is obvious that more compolex 
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networks will have hundreds of these nodes and the weights are constantly adapted 
to ensure accurate learning and output.  
Figure 1.1 Example of MLP
98
 
Artificial neural networks
In
p
u
ts
Output
An artificial neural network is composed of many artificial 
neurons that are linked together according to a specific 
network architecture. The objective of the neural network 
is to transform the inputs into meaningful outputs.
 
(modified from “Artficial neural networks- an introduction”98) 
ANN can be classified into feed-forward or feed-back networks. A different method 
of classification depends on the type of learning. This could be supervised learning 
or unsupervised learning networks.  The feed-forward ANN is one in which the 
input signal is coming from the units of the previous layer and forwarded to the 
following; & the feed-back ANN which are characterised by retroactive connections 
carrying the output of a unit back as input of a unit of same or previous layer.  
On the other hand, in the supervised learning networks, the ANN are trained by 
providing a data set which contains both inputs and outputs. The ANN learns from 
the outputs and designs itself by changing the connection to predict accurately. With 
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unsupervised learning, there is not a real training procedure since no target results 
for the input data are provided to the ANN. The input signals are treated like random 
variables and the network learns to find patterns in the data to produce outputs.  
ANN were pioneered by Rosenblatt, Widrow and Hoff and Widrow and Stearns 
99
. 
However, Werbos in 1974 extended the network models beyond the elementary 
concept of perceptron 
100
(a single trainable layer of weights), to include models with 
two layers of weights that were trainable in a general fashion, and that accomplished 
nonlinear discrimination and nonlinear function approximation
101
. This 
computational method is called back-error propagation.  
Among the different types of ANN, the most commonly used ones in medicine are 
the multilayered perceptron networks (MLP). The popularity of MLP comes from 
the fact that they are easy to use and can be trained by back-error propagation or 
other training methods. The MLP consists of multiple layers of artificial neurons, 
which are all connected to each other densely. As shown in figure 1.2, each input 
neuron is connected to all the neurons in the middle/ processing layer. The middle 
layer neurons have an activation function, which they apply to the input received 
from all the input neurons. The resultant output is then delivered to the output 
neurons, which further process this information to deliver the final outcome. The 
majority of clinical studies utilise such three layer networks in which the layers are 
fully interconnected
100, 102-105
. The interesting features of successful ANN models 
include the ability to perform accurately in the presence of heterogenous data (with 
some irregularities or measurement errors or unreliability), and the ability to detect 
and recognise complex non-linear relationships between the variables
100
. Thus, ANN 
 68 
offer promise for improving the predictive value of traditional statistical data 
analysis. 
1.6.2. Special features of ANN 
The mathematical structure of ANN makes it capable of simultaneously handling an 
exceptionally high number of variables characterising the data such as that collected 
in a clinical field. This is an enormous advantage as compared to the classical 
statistical models. ANN are not limited by certain fixed assumptions regarding the 
type and number of variables in the data. This is a distinct advantage as compared to 
traditional statistical approaches. The important component of ANN is that during 
the training of a network, 3 overlapping sets of data are used. Typically, a data set is 
divided into three subsets, usually randomly: the training, testing and validation sets. 
The training set is used to adjust weights during training. The testing set is used to 
determine when to stop training. A different subset is used to report the performance 
of the network, and this is called the validation set. 
On the other hand, disadvantages of ANN include: (a) difficulty in understanding 
how the relationships are being developed, (b) many methodological issues remain 
to be solved, (c) models prone to over-fitting, but this can be prevented by careful 
adjustment and establishment of stopping rules, and (d) there is conflicting evidence 
as to whether or not they are better than traditional regression statistical models for 
either data classification, or for predicting outcome. 
1.6.3 Training of ANN 
The majority of biomedical studies utilise three-layer networks, in which layers are 
fully connected. Each layer has a pre-defined set of nodes. There are additional 
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hidden nodes as well. The training of ANN broadly involves two activities :1. 
adjustment of weights and 2. activation of hidden nodes. 
Any ANN has a random weight assigned to each of the connections. As part of 
training, when the data is presented to the network, weights are adjusted on a 
constant basis. This is done once again on the basis of pre-determined algorithms 
like gradient descent etc. The knowledge gained from this process is then passed 
onto the next set of nodes until it reaches the output nodes. The results are then 
checked with the actual result and error rate is calculated. The process continues 
forwards and backwards until the error rate is minimized and generally below the 
preset acceptable level.   
However, it is important to realise that there should be patterns in the data for the 
ANN for identify and learn and hence successfully predict in the future. 
The time taken for a network to learn and adapt depends on the number of nodes and 
inputs and examples provided. For instance, a network with 200 inputs trained on a 
few hundred examples needs around 4 hours to train on an average computer.  
1.6.4 Measurements of performance and reliability 
There exist many different performance measurements for neural networks. Simple 
performance measure can be employed to demonstrate how well the neural network 
output matches data with known outcomes. Performance metrics include the Mean 
squared error (MSE) and root mean squared errors (RMS). Occasionally percent-
correct is used as a performance measurement. The area under the receiver operating 
characteristic (ROC) plot (AUC) is a more comprehensive performance measure to 
use with classification neural networks than either MSE or RMS. The area under the 
ROC [in which sensitivity is plotted as a function of (1 - specificity)] is an 
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acceptable performance measure to use with a single output classification neural 
network
106
. AUC gives a definitive measure of the classifier's discrimination ability 
that is not dependent upon the choice of the decision threshold
101
. It is essentially the 
ability of the network to differentiate a positive case from a negative case when both 
are presented to it.  
Other measures of the network's performance include the kappa value and the 
information given
101
. Unlike the AUC, these measures require an output threshold to 
be chosen. Kappa is the actual improvement in classification rate over the chance 
rate divided by the maximum possible improvement over the chance rate
101
. A value 
of 1 indicates perfect classification, and a value of 0 indicates classification at the 
chance rate. 
A comparison with experts can be conducted to measure performance- does the 
network predict an outcome as often as a trained expert does? 
1.6.5. Literature review of use of ANN in medicine 
Medical decision support with neural networks is an area of medicine which is 
increasing exponentially in the last two decades. Table 1.9 shows the different 
published applications of neural network in medicine. 
Table 1.10 Applications of neural networks in medicine
100
 
Diagnosis 
 Appendicitis 
 Dementia 
 Myocardial infarction 
 Prostate cancer 
 Sexually transmitted diseases (STD) 
Histology 
 Pap smear 
 Imaging 
 Nuclear Medicine scans 
 Perfusion scans  
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 Positron Emission Tomography (PET) scans 
 X-rays 
Outcome predictions 
 Cancer 
 Cardiopulmonary resuscitation (CPR) 
 Surgery 
Waveforms 
Arrythmias 
 Electroencephalograms (EEG) 
 Electrocardiograms (ECG) 
 
ANN have been used in the clinical diagnosis, image analysis in radiology and 
histopathology, and data interpretation in intensive care setting.  
Stamey et al 
107
 developed a neural network derived classification algorithm called 
ProsAsure Index, which can classify prostates as benign or malignant. This model 
was subsequently validated in prospective studies and had diagnostic accuracy of 
90%. PAPNET, a computerised automated screening system based on neural 
networks, has been developed to assist the cytologist in cervical screening and is one 
of the ANN models which is promoted commercially
108
. Prognostication is a vital 
area of medicine. Accurate identification of high risk patients and early targeted 
treatment is essential. ANN have also been shown to perform better than expert 
colorectal surgeons in predicting outcome in patients with colorectal cancer 
102
.  
1.6.6 ANN as a clinical decision tool to determine the need for LGE 
As discussed above, clinicians are not particularly accurate in determining if patients 
presenting for the first time in the clinic have significant lower gastrointestinal 
pathology. Hence, it is currently difficult to assess accurately which patients need a 
LGE. ANN have the ability to resolve complex relationships in data and have proven 
to be useful in various other clinical scenarios. Hence we decided to explore the 
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feasibility of using ANN for clinical decision making in colorectal/gastroenterology 
clinics.  
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Chapter 2 Aims and Materials/methods of the study 
2.1 Aims of the study: 
This study has been performed with the following aims: 
1. To assess patient satisfaction of LGE, and determine factors associated with 
patient satisfaction. 
2. To assess the feasibility of using the technique of endoscopic clipping with 
follow- up x-ray as an objective measure of completion and miss rates in LGE. 
3. To identify and assess methods of improving availability of LGE in the NHS by 
A. developing and assessing the feasibility of using artificial neural networks in 
accurately identifying patients presenting in colorectal clinics who need LGE 
B. Assessing the safety and efficacy of non-medical endoscopists (NME) in 
providing LGE services thereby enabling an increase in the number of endoscopists 
C. determining the best method of providing sedation for colonoscopy in order to 
reduce the time to discharge, and enabling NME to perform LGE independently 
(Entonox versus Midazolam/Fentanyl and Entonox versus Propofol). 
2.2 Materials and Methods 
           The materials and methods used in this thesis have been described in detail in the    
 individual chapters. 
2.3 Ethics and trust approvals 
 74 
    Ethical and trust approvals were obtained prior to commencement of recruitment. 
 (South Humber Research Ethics Committee: 04/Q1105/41: Randomised Controlled 
 Trial of Sedation for Colonoscopy: Entonox versus Midazolam/Fentanyl 
 (23/01/2006) and 05/Q1105/8: Assessment of lower gastrointestinal endoscopy 
 (07/02/2005). York Research Ethics Committee: Randomised controlled trial of 
 patient controlled sedation for colonoscopy: Entonox versus target-controlled 
 patient maintained propofol (31/08/2007)). Approval was also sought from the 
 Clinical Trials Department, Medicines and Health Regulatory Authority, London 
 for both the Randomised Controlled Trials. All studies were monitored by the 
 Clinical Trials Monitor, R&D, Hull and East Yorkshire NHS Trust, in accordance 
 with the ICH_GCP guidelines. 
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Chapter 3 Patient satisfaction with lower gastrointestinal endoscopy 
3.1 Introduction 
Patient satisfaction is a crucial measure of performance standards and accountability of the 
endoscopists. Monitoring satisfaction is essential for quality assurance, evaluation of 
treatments and also possibly as it affects health outcomes. The American Society of 
Gastrointestinal Endoscopy has included patient satisfaction as an important indicator in 
all quality assurance programmes for endoscopy 
109
. It is a valuable tool in assessing 
endoscopists’ performance, identifying areas of concern and planning optimal health care 
delivery
53
. For example, if we identify areas of concern and act upon them, it should 
theoretically lead to enhanced patient care and satisfaction. Previous patient satisfaction 
surveys
52, 110
 in endoscopy have attempted to analyse predictors of patient satisfaction and 
these have included endoscopists’ technical skills, adequacy of sedation and patient 
anxiety. However, there is still insufficient information related to both patient satisfaction 
with endoscopy as well as factors determining patient satisfaction. 
Moreover,  as mentioned in the previous chapters, the Department of Health, United 
Kingdom introduced a pilot programme to train non-healthcare professionals to perform 
endoscopy
111
. These non-healthcare professionals performing LGE are termed non-
medical endoscopists (NME). Though they have been shown to perform LGE safely, there 
are no studies comparing patient satisfaction between doctors, nurses and non-medical 
endoscopists.  
The aim of our study, therefore, was to determine patients’ satisfaction in our endoscopy 
unit, and identify factors related to patient satisfaction. A second objective was to compare 
doctors, nurses and non-medical endoscopists in terms of patient satisfaction. 
 
 76 
3.2 Methods: 
3.2.1 Study participants and data collection 
This study was performed in the endoscopy unit at Castle Hill Hospital, Cottingham, 
United Kingdom from August, 2004 to December, 2005. The study was approved by the 
South Humber Research Ethics Committee, United Kingdom. All patients undergoing 
LGE were included in the study, except patients undergoing both lower and upper 
gastrointestinal endoscopies in the same session and patients not willing to participate.  
Patients were sent invitation letters 3 weeks prior to the procedure, and this included a 
patient information leaflet (approved by the Ethics committee) outlining the aims of the 
study and what it entailed. The principal investigator was present to answer patient 
questions.  
Once patients agreed to participate in the study, they signed a consent form. The research 
co-ordinator handed two questionnaires to the patients- one before the procedure (pre-
procedure questionnaire) and the second one after the procedure (patient satisfaction 
questionnaire).  
Subsequently, all patients had their LGE and were allowed to recover as per the existing 
protocols in the unit.  The participants then completed the specifically designed 
satisfaction questionnaire at the point of discharge, but before they were informed the 
results of their endoscopy (to prevent any bias).  These anonymous questionnaires were 
deposited in a dedicated collection box.  
Participants were also given a second satisfaction questionnaire similar to the previous 
patient satisfaction questionnaire, and this was meant to be completed 24 hours after the 
procedure and sent back to the endoscopy unit. Phone calls were made approximately 2 
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weeks after the procedure to all the non-respondents. These calls were repeated at 4 weeks 
in case of further non-responders. No further telephone calls were made to these patients. 
3.2.2 Pre-procedure Questionnaire 
This questionnaire consisted of demographic questions as well as the Hospital Anxiety and 
Depression scale (HAD). The HAD scale was used for the assessment of pre-procedure 
anxiety, and it has been previously validated for use in this setting. This is a self screening 
test for depression and anxiety
112
. It consisted of 14 questions, seven for anxiety and seven 
for depression. Although it was designed for hospital general outpatient assessment, it has 
been extensively used in primary care
113
, and now in endoscopy research
114
.  
3.2.3 Patient Satisfaction Questionnaire (PSQ) 
The American Society for Gastrointestinal Endoscopy (ASGE) modified the GHAA-9 
satisfaction questionnaire to produce the instrument (m-GHAA 9) for measuring patient 
satisfaction with endoscopy
109
. The original Group Health Association of America 
(GHAA) satisfaction instrument
115
 is a commonly used patient satisfaction questionnaire 
and has been in existence for nearly 20 years. This questionnaire has been validated in 
other patient groups over the years. This mGHAA-9 is based on 6 aspects of patient care, 
and the remaining 3 questions in the questionnaire include an overall rating of the visit and 
inquiries into whether the patient would have the same procedure at the same hospital.  
We modified this questionnaire further to reflect the endoscopy process in the National 
Health Service in the United Kingdom. The development and validation of the new 
questionnaire for this study was done in stages: literature review and item generation, pilot 
study & initial validation, and concurrent validation in the main study. 
With regards to item generation, all the questions from the mGHAA-9 were included. A 
detailed review of literature was carried out to identify instruments for measuring patient 
 78 
satisfaction for endoscopy. An expert panel consisting of colorectal surgeons, nurses, 
surgical trainees and other endoscopists assessed the items and developed a final 
questionnaire. The questions included in the questionnaire were constructed to encompass 
issues of high priority for endoscopists and relevant to the current problems with 
endoscopy and National Health Service. Sedation is a key factor associated with patient 
experiences in endoscopy, as sufficient sedation-analgesia can minimise the pain/ 
discomfort and, hence, probably optimise satisfaction
52, 110
. This is reflected in several 
questions regarding satisfaction with sedation (measured on a 100 mm visual analogue 
scale (VAS)). Patient satisfaction with endoscopic procedure in general was also assessed 
by a 100mm VAS.  
A pilot study was then undertaken wherein the questionnaire was administered to patients 
undergoing LGE in the unit. Patients were asked to suggest any further questions of 
relevance and also those which were difficult and ambiguous. Patients were also asked to 
rank the 21 items on the questionnaire in decreasing order of importance to them. The aim 
was to determine which of the 21 questions were most relevant to patients with regard to a 
good experience of endoscopy.  
The content validity and the items’ face validity were tested by the above mentioned core 
group of experts and endoscopy staff. Items that were not answered by at least 10% of 
patients were deleted. Acceptability was assessed by the response rate. All patients 
reported that the questionnaire included all relevant items, proving the questionnaires’ face 
validity.  
Three questions were deleted from the final questionnaire, based on the analysis of the 100 
respondents. These patients were not included in the study. Internal consistency was 
assessed with Cronbach’s alpha. Factor analysis of 21 items revealed high consistency: 
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skills and hospital factors (α=0.81), pain reported after LGE (α=0.86), attitudes and 
information given (α=0.70).  
3.2.4 Endoscopists 
All the LGE in the study was carried out by three different types of endoscopists- medical 
endoscopists (ME), nurse endoscopist (NE) and non-medical endoscopists (NME). The 
doctors included in the study were consultants or senior colorectal trainees (JAG certified). 
The NE was a fully trained, JAG certified endoscopist, who is also a trainer on different 
endoscopy courses. The NME was the first fully trained non medical non nurse 
endoscopist. The individual was a science graduate, and was trained to perform lower 
gastrointestinal endoscopy, under the pilot programme started in 2003 by the Department 
of Health. The details of non-medical endoscopist training have been published 
elsewhere
116
. 
The patient satisfaction questionnaire was also administrated to the endoscopists, who 
were asked to rank the items in terms of how important they felt each question from a 
patient satisfaction perspective.  
In addition to above, demographic and clinical features recorded from all patients included 
age, gender, weight, height, clinical indications, past and family history, results and 
procedural findings.  
3.2.5 Statistical Analysis 
All the data was analysed using SPSS (v14.0) software. Patient satisfaction and 
satisfaction with sedation was compared between the three groups using the Mann 
Whitney U test. Demographic and baseline characteristics were compared with the use of 
Mann Whitney U test for continuous data and Chi Squared test for categorical data. All 
other factors were compared between the groups using Independent samples T-test, with 
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p<0.05 being significant. The weighted kappa test was used to correlate the answer 
provided immediately after endoscopy with those provided in the mail questionnaires. 
Descriptive statistics like frequency, medians and inter-quartile ranges were performed. 
Univariate analysis was performed to test the relation between different variables and the 
primary outcome (patient satisfaction and pain scores). In order to determine factors 
determining patient satisfaction with endoscopy, multivariate regression analysis was 
performed and p<0.05 was considered significant. 
3.3 RESULTS 
A total of 561 patients undergoing lower gastrointestinal endoscopy were invited to 
participate in the study. However, only 503 patients were included. Out of the 58 excluded 
patients, 36 marked the questionnaire incompletely, and the remainder gave multiple 
responses to the same question. 
3.3.1 General results 
Out of 503 procedures, 332 were colonoscopies and 171 were flexible sigmoidoscopies. 
Doctors performed 151 colonoscopies and 44 flexible sigmoidoscopies, whereas NC 
performed 110 colonoscopies and 51 flexible sigmoidoscopies. NME performed 76 
flexible sigmoidoscopies and 71 colonoscopies in the study period. General patient 
characteristics, including demographic features across all groups, are shown in table 9.1. 
In the colonoscopy group, 90 patients received Entonox and 242 patients received 
intravenous sedation (midazolam with fentanyl). Only 3 patients in the flexible 
sigmoidoscopy group received sedation.  
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Table 3.1 Baseline characteristics in the three groups 
 
  Doctors Nurses NME P* 
Age (median) in years 62 60 63.5 - 
Gender (Male:Female) 104:87 87:68 88:67 - 
Intravenous  
-  Midazolam 
-  Fentanyl 
Entonox  
 
2.5mg 
75mcg 
prn
§
 
 
2.0mg 
75mcg 
prn
§
 
 
3.0mg 
100mcg 
prn
§
 
 
0.96 
0.88 
- 
Endoscopy type 
Flexible 
sigmoidoscopy 
Colonoscopy 
 
 
44 
151 
 
 
51 
110 
 
 
76 
71 
 
 
0.091 
0.142 
Pre-procedure Anxiety 
scores
¥
 
5 6.5 5.4 0.925 
* Mann-Whitney U test. 
§ 
= as required. 
¥  
=measured on Hospital Anxiety and Depression 
scale (as described in text) 
 
The indications for colonoscopy were rectal bleeding (33%), change in bowel habit (25%), 
polyp follow up (22%), colorectal cancer follow-up (12%) and abdominal pain (8%). 
The pre-procedure anxiety scores in the flexible sigmoidoscopy and colonoscopy group as 
well in all groups are shown in the table 3.1. 
3.3.2 Correlation between direct and postal questionnaires  
Out of 503 questionnaires, only 412 patients returned the questionnaires at 24 hours. The 
inter-rater agreement (weighted kappa) between the question on overall satisfaction for the 
direct and postal questionnaires was 0.82. This signifies strong agreement between the two 
scores. The weighted kappa between the question on pain score when asked immediately 
post-endoscopy, and at the 24-hour follow up, was 0.72.  
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3.3.3 Patient satisfaction questionnaire results 
The overall satisfaction with lower gastrointestinal endoscopy was a median 94 (range, 38, 
100). However, it is difficult to assess an isolated single satisfaction score, though a score 
above 90 is usually indicative of very good performance
52
. The median satisfaction score 
in the colonoscopy group was 96 (range, 88-100) and the median score for the flexible 
sigmoidoscopy group was 91 (range, 82, 98). These differences were not statistically 
significant (p=0.4).   
We defined adverse endoscopic experience as a satisfaction score of less than 50mm on 
the VAS, a pain score more than 50mm on the VAS, or a lack of willingness to repeat the 
endoscopy again. This definition was adopted for the study and is not based on any 
previous studies. Among 503 patients, only 41 patients (8%) had an adverse endoscopic 
experience. 12 such patients had endoscopy under a doctor, whereas 15 and 14 patients 
respectively had the procedure under a nurse and a non-medical endoscopist. Once again, 
these differences were not statistically significant (p=0.3). The majority of patients, 84%, 
rated the endoscopists’ manner as excellent, followed by 8% very good, 7% good and 1% 
fair. Similarly, 88% of the patients rated the endoscopists’ technical skill as excellent, 2% 
very good, 8% good, 1.5% fair and 0.5 % poor. Only 18% of patients rated the bowel 
preparation experience excellent, whereas 22% rated very good, 38% good, 10% fair and 
12% poor (table 3.2). 
98% of the patients agreed to undergo the procedure in the same hospital (endoscopy 
suite) and 2% did not agree to the same. 99% of patients agreed to undergo the procedure 
again if necessary under the same endoscopist, and 4% did not agree. The median pain 
score was 20.6 (range, 0-60), on a scale of 0-100. 
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Table 3.2 Summary of patient satisfaction questionnaire results 
Wait for the procedure 
       -Excellent 
       -Very good 
       -Fair 
       -Poor 
 
75 
18 
5 
2 
Convenience of appointment time 
       -Excellent 
       -Very good 
       -Fair 
       -Poor 
 
68 
23 
7 
2 
Length of time at endoscopy suite 
       -Excellent 
       -Very good 
       -Fair 
       -Poor 
 
85 
10 
4 
1 
Instructions for the bowel prep 
       -Excellent 
       -Very good 
       -Fair 
       -Poor 
 
78 
12 
4 
6 
Bowel prep experience 
       -Excellent 
       -Very good 
       -Good 
       -Fair 
       -Poor 
 
18 
22 
38 
10 
12 
Personal manner  
       -Excellent 
       -Very good 
       -Good 
       -Fair 
 
84 
8 
7 
1 
Technical skills 
      -Excellent 
       -Very good 
       -Fair 
       -Good 
       -Poor 
 
88 
2 
8 
1.8 
0.15 
Time spent 
      -Excellent 
       -Very good 
       -Good 
       -Fair 
       -Poor 
 
81 
13 
4 
1 
1 
 84 
Explanation of procedure 
       -Excellent 
       -Very good 
       -Fair 
       -Good        
 
77 
15 
7 
1 
Personal manner of nurses 
      -Excellent 
       -Very good 
       -Good 
       -Fair        
 
72 
16 
10 
2 
Pain score*
§
 20.6 (0-60) 
Overall satisfaction*
§
 94 (40-100) 
Overall rating of visit 
       -Excellent 
       -Very good 
       -Fair 
       -Poor 
 
71 
18 
10 
1 
Will revisit same endoscopy suite 
       -Yes 
       -No 
 
98 
2 
Will undergo endoscopy by same endoscopist? 
      -Yes 
      - No 
 
99 
01 
Results quoted are in percentages except *where the result is quoted in median and range 
in brackets. 
§recorded on 100 
mm visual analogues scales where 0=worst and 100=best or 
0=no pain and 100=worst imaginable pain 
 
3.3.4 Comparison between doctors, NE and NME 
There was no difference in colonoscopy completion rates (table 3.3) between the three 
groups (p=0.3). The time to caecum was slightly higher in the NME group, as compared to 
the nurse and doctor groups, but the differences did not reach statistical significance 
(0.09). No differences were detected between the endoscopists in patient rating (table 3.3) 
for overall satisfaction (p = 0.6), technical skills of the endoscopist (p = 0.58), 
communication skills (p = 0.61) or interpersonal skills of the endoscopist (0.59). The 
median satisfaction scores for the three different types of endoscopists were 96, 95 and 97 
respectively for doctors, nurses and non-medical personnel. Furthermore, a total of 416 
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patients responded to the repeat questionnaire at 24 hours, and we lost 87 patients to 
follow up despite telephonic reminders. Importantly, there were still no differences in 
patient satisfaction between the three groups when marked at 24 hours post-procedure. 
Table 3.3 Outcomes in the three different endoscopist groups 
 Doctors  
(n=195) 
Nurses 
(n=161) 
NMC 
(n=147) 
P* 
Overall patient 
satisfaction 
96 (40-100) 95 (55-100) 97 (48-100) 0.1 
Patient 
satisfaction at 24 
hours 
95 (45-100) 95 (50-100) 98(55-100) 0.1 
Median pain 
scores 
    -at discharge 
    -at 24 hours 
 
21(0-60) 
22 (0-50) 
 
18 (10-60) 
20 (10-45) 
 
23 (10-60) 
21 (5-60) 
 
0.3 
0.1 
Median pain 
scores in 
different sedation 
groups: 
 - Entonox group 
 - IV
¥
 sedation 
group 
 
 
 
 
12 (0-40) 
34 (0-50) 
 
 
 
 
18 (10-45) 
28 (10-60) 
 
 
 
 
16 (10-40) 
32 (10-60) 
 
 
 
 
0.9 
0.8 
Adverse 
experience† 
12 17 14 0.3 
Caecal 
intubation
§ 
 
142 (94.5 %) 105 (96%) 66 (93.5%) 0.30 
Completion of 
FS 
§,†
 
40 (90.9%) 47 (92%) 70 (92.2%) 0.10 
Median time to 
caecum (min) 
14 (10-21) 12 (8-20) 16.8 (12-29) 0.09 
Median 
completion time 
(min) 
21 (18-45) 19 (13-38) 21 (19-40) 0.1 
Median time to 
discharge (min) 
36 (20-70) 43 (15-60) 38 (15-90) 0.09 
Technical skills
$
 1.72 1.66 1.72 058 
Communication 
skills
$
 
1.5 1.44 1.52 0.6 
Interpersonal 
skills
$
 
1.54 1.49 1.55 0.59 
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Values in parentheses are ranges, except 
§ 
where
 values are in percentages.  †=completion 
defined as insertion up-to descending colon. *Mann-Whitney U test. 
$ 
where 1=excellent, 
2=very good, 3=fair and 4= poor. 
 
3.3.5 Multivariate analysis to determine factors affecting patient satisfaction and pain 
perception 
Among all the variables tested in the univariate analysis, pre-procedure anxiety, age, sex 
of the patient, history of pelvic surgery/ hysterectomy, higher pain scores, pre-existing 
pain and type of endoscopy were associated with poor satisfaction scores. However, on 
multivariate analysis, higher pre-procedure anxiety, history of pelvic surgery/hysterectomy 
and higher pain scores were associated with adverse patient satisfaction (table 3.4). 
Table 3.4 Multivariate regression analysis of factors affecting patient satisfaction 
 Hazards Ratio (95% 
Confidence Interval) 
p-value 
Age 1.95 [0.64,2.96] 0.3 
Female sex 0.92  [0.67, 1.96] 0.1 
H/o pelvic procedures 0.60 [0.31, 0.82] 0.04 
Type of procedure 4.5 [2.56,6.65] 0.9 
Pre-test anxiety scores 2.1 [1.4, 4.94] 0.042 
Procedural pain 1.19 [1.1,2.89] 0.03 
Colon resection 3.4 [0.8, 5.6] 0.95 
Endoscopist type 1.6 [0.62,3.1] 0.913 
 
 
In the case of pain scores, pre-procedure anxiety, history of pelvic surgery/ hysterectomy 
and female sex were associated with higher pain scores on multivariate analysis. 
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3.3.6 Patient and endoscopists’ preferences 
Patients scored pain control as the most crucial factor affecting their satisfaction with 
lower gastrointestinal endoscopy. The next two critical facets for the patients were the 
technical skills of the endoscopists and the waiting time for the appointment. The 
endoscopists, on the other hand, marked the personal manner of the endoscopists, followed 
by the attitude of the endoscopists as the two most important markers of possible patient 
satisfaction. Notably, endoscopists ranked the pain/ discomfort levels as the third priority, 
and the personal manner of the nurses and supporting staff as subsequent component 
influencing patient satisfaction. 
3.4 Discussion 
Patient satisfaction has gained increasing importance and is at the forefront of healthcare 
outcomes measurements in recent years
52
. Monitoring patient satisfaction is an integral 
part of quality assurance of healthcare. It is already known that patient satisfaction can 
affect health outcomes 
117
. Fitzpatrick has shown that satisfied patients are more optimistic 
about their situation and are more compliant with their treatment regimens 
118
. Screening 
programmes for colorectal cancer have been introduced in different countries, including 
the United Kingdom in 2006. It is essential for patients to have a satisfactory experience of 
colonoscopy or flexible sigmoidoscopy, if they are to be compliant with screening 
programmes 
119
. With increasing demand for lower gastrointestinal endoscopy, monitoring 
of patient satisfaction and integration of feedback plays a pivotal role in providing quality 
assurance.      
In this study, we have found that patient satisfaction with LGE was high. There are 2 key 
findings from the study: identification of factors that influence satisfaction with LGE, and 
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that there was no difference between doctors, NME or nurses in terms of patient 
satisfaction. 
Identification of factors that determine satisfaction is critical, because it provides a 
theoretical opportunity to modify these factors to ensure a better clinical outcome. Several 
factors have been proposed as predictors of decreased endoscopic satisfaction. These 
factors can be further categorised as either procedure related or patient related
54
. Raymond 
et al found that prior use of benzodiazepines and females were independently associated 
with low satisfaction rates
120
. However, the majority of these endoscopies were upper 
gastrointestinal endoscopies and were performed without sedation. Ko et al
121
 have shown 
that procedural pain, bedside manners, technical skills, physical environment and 
communication with the patient are factors that affect patient satisfaction. In our 
multivariate analysis, we found that higher pre-procedure anxiety scores, pain during the 
procedure and a history of pelvic surgery/hysterectomy were associated with the lowest 
patient satisfaction scores. Higher pain scores were associated with poor patient 
satisfaction. It is interesting to note that patients receiving intravenous sedation 
experienced greater pain, as compared to those receiving Entonox gas. Consequently, 
satisfaction scores were lower in the IV group as compared to the Entonox group. These 
findings are similar to our previous randomised controlled trial comparing Entonox with 
Midazolam/Fentanyl for sedation for colonoscopy
122
. Other studies have shown that bowel 
preparation process has been associated with poor satisfaction
123
. However, we found no 
correlation between bowel preparation and satisfaction scores. Though other studies have 
shown baseline patient anxiety
124
, female patients
125
 and higher socioeconomic status
125
 to 
be associated with poor satisfaction, we found no such correlations. The other items 
looked at included instructions for bowel preparation, waiting time for endoscopy and the 
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attitude of the reception staff. Del Rio et al
126
 also found that waiting time for endoscopy 
is an important component of patient satisfaction. However, these factors did not reach any 
significance in our study; this is possibly because the number of unsatisfied patients was 
remarkably low, and the number of patients rating waiting times poor was also low. 
Furthermore, we noted differences in patient and endoscopists’ perception of factors 
associated with satisfaction. Adequacy of pain control was the number one relevant factor 
for the patients, followed by the technical skills of the endoscopists and waiting time for 
appointment. Endoscopists, however, prioritised the personal manner of the endoscopists 
followed by the attitude of the endoscopists as the most important markers of possible 
patient satisfaction. Surprisingly, pain/discomfort associated with the procedure was the 
third most important factor for the healthcare professional. In a previous study 
127
, patients 
marked friendliness of the endoscopists as  the most important factor. However, Yacavone 
et al found that 16% of all patients in their study ranked adequacy of pain control as the 
number one factor influencing their satisfaction, and this item was ranked overall number 
two 
52
. It is, therefore, important to address these issues in any quality assurance 
programmes on endoscopy.  
Having identified the key factors that affect patient satisfaction, the obvious next step is to 
enhance the patient’s experience. Currently, there are long term efforts to improve the 
quality of LGE by the Department of Health, United Kingdom and other speciality 
organisations. The development of the Global Rating Scale (GRS) to monitor the 
performances of endoscopists and endoscopy units, and improve patient experiences is 
expected to produce rich dividends in the form of increased satisfaction. The GRS 
provides a simple, web based, unified opportunity to continuously quality assure 
endoscopy services. It is a tool that enables endoscopy units to determine how well a 
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patient centred endoscopy service they are providing. The various domains of the GRS 
include clinical quality, quality of patient experience, training and workforce domains. 
These domains are completed twice a year in April and October. The patient satisfaction 
domains include equality of access and privacy, timeliness (eg. waiting times etc), booking 
and choice, privacy & dignity, aftercare and ability to provide feedback. These seem to 
encompass all the previously discussed factors that affect patient satisfaction.  
Patient satisfaction is usually assessed by questionnaires, but there are numerous pitfalls 
with respect to validity and reliability of questionnaires
54
. We therefore tested our 
questionnaire for both internal validity (content and face validity) and reliability 
(Cronbach’s alpha), and found the questionnaire performed well on both the tests. 
Criterion validity cannot be assessed because there is no universal standard to measure it 
against
54
. The most commonly used questionnaire for assessment of patient satisfaction in 
endoscopy is the m-GHAA-9 questionnaire which we modified in our study. This 
questionnaire on its own suffers from the fact that it does not ask about procedural pain or 
bowel preparation process. Moreover, scores on the questionnaires can be affected by the 
method and timing of administration
54
. In order to overcome this potential bias, patients in 
our study completed the questionnaires anonymously, deposited it in a box and filled out 
another anonymous questionnaire 24 hours later.   
The second important finding of the study is that we found no difference between NME 
and doctors and nurses in terms of patient satisfaction.  Moreover, patients did not find any 
significant difference between the 3 groups in terms of technical skills, time spent and 
explanation given by the endoscopists, endoscopists’ attitudes and other aspects of the 
endoscopy service. Patients were asked if they would undergo the procedure again (if they 
had to) under the same endoscopists. It is interesting to see that once again the number of 
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patients agreeing was similar in the three groups. We believe that these findings are 
extremely important. The current study is the first study of this size to evaluate patient 
findings comparing medical, nurse and non-medical endoscopists. Though this study is not 
a randomised controlled trial, the findings are reassuring in terms of patient satisfaction. 
Notably, there were no complications, either endoscopy-related or sedation-related in any 
of the groups.  
The current study was carried out in a single institution and, hence, reflects the views of a 
particular cross-section of population. We believe that assessment of satisfaction should be 
carried out in multiple centres, and indeed this forms part of the United Kingdom 
Government initiative in using the Global Rating Scale 
128
.  
In conclusion, we have identified several factors affecting patient satisfaction including 
procedural pain, pre-procedure anxiety and history of pelvic surgery. This study has also 
shown that there are no differences between medical, nurse and non-medical endoscopists 
in terms of patient satisfaction with lower gastrointestinal endoscopy. 
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Chapter 4 Technical quality assurance in colonoscopy: role of endoscopic clips 
4.1 Introduction:  
As discussed before, for colonoscopy to remain an effective diagnostic tool, it is necessary 
to perform a complete procedure with meticulous visualisation of mucosa, ensuring that no 
significant lesions are missed. However, it remains a technically difficult and lengthy 
procedure, which results in differing quality at different centres. Significant complications 
of colonoscopy are thankfully uncommon and thus difficult to use for assessment of 
quality. Documented completion rates and low long-term pathology miss rates could 
therefore be recognised as key indicators of technical quality.  
A complete colonoscopy is usually defined as the passage of the endoscope to the caecum 
or terminal ileum. The current recommendations are that the caecum should be intubated 
in at least 90% of cases
129
. A recent review of endoscopic practices indicated that the 
average caecal intubation rate was only around 57%
130
, which was far less than that 
recommended. Furthermore, it is not just enough to do a complete colonoscopy. It is 
equally important to visualise the mucosa of the entire colon adequately, ensuring that all 
pathologies are identified. These TWO key principles should, therefore, underpin any 
quality assurance programmes in colonoscopy.  
There have been recent multifaceted efforts to improve the quality of LGE by the 
gastroenterology societies and royal colleges as well as the Department of Health, United 
Kingdom. A result of such quality assurance programmes is the creation of the Joint 
Advisory Group for endoscopy (JAG) and the Global Rating Scale (GRS). The JAG 
(www.thejag.org.uk) is responsible for the training of endoscopists and for setting up of 
standards for endoscopy. The GRS (www.grs.nhs.uk), on the other hand, is a web-based 
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tool that enables endoscopy units assess regularly how well they are offering a patient 
centred endoscopy service. The GRS consists of different dimensions and one of them is 
the technical completion rates of colonoscopy. Though the current requirements are for a 
colonoscopy completion rate of 90% and above, there is no stipulation regarding how this 
should be objectively recorded. The American Society of Gastrointestinal Endoscopy 
(ASGE) Taskforce on Quality in Endoscopy
46
 still recommends photo-documentation for 
the confirmation of caecal intubation, despite recognized limitations with this method
131
 
(see chapter 1). The documentation of completion in the GRS is based on the 
endoscopists’ own assessment of completion, and there is no objective method of 
identification of caecal landmarks. It is recognized that the 3 caecal landmarks (ileocaecal 
valve, appendicular orifice and the tri-radiate fold) are relatively constant and the best 
method of identification of caecum. However, as discussed in chapter 1, there is still no 
single consistent method of objectively documenting caecal intubation. 
The technique of applying endoscopic clips followed by abdominal x-ray to confirm 
completion is a relatively easy to use method of documenting completion. The technique 
has previously been used in a small study to check if endoscopists have reached the 
caecum or not
32
. We aimed to evaluate this technique to objectively document both 
completion of colonoscopy and determination of pathology miss rates. 
 4.2 Methods 
All patients undergoing colonoscopy by a single trained endoscopy team (consultant and 
nurse endoscopist) at a tertiary referral hospital between January 1998 and December 1999 
were included in the study. The exclusion criteria included emergency colonoscopies, 
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pregnant females, post-surgical resection, patients not willing to participate and patients on 
endoscopy lists when the consultant was not available. 
The study was approved by the Local Research Ethics Committee and the hospital 
research and development department. All patients undergoing colonoscopy were sent 
letters inviting them to participate in the study two weeks before the procedure. The study 
was explained to patients on their arrival to the endoscopy suite. Participating patients 
subsequently signed an approved consent form. Both the participating endoscopists were 
fully trained and independent endoscopists.  
Colonoscopy was then performed in a routine manner using Pentax 160cm video-
colonoscopes with a 3.6mm biopsy channel. Intravenous sedation with Midazolam and 
Fentanyl was given to all patients. During the procedure, patients were monitored in 
accordance with the British Society of Gastroenterology guidelines
132
. When the 
endoscopist was convinced that the caecum was reached (with positive recognition of 2 of 
the 3 above mentioned caecal landmarks), a clip was applied on the most proximal mucosa 
using an Olympus Titanium Endoclip applicator. Clips were attached to the mucosa at 
maximum endoscope insertion as near to the instrument tip as possible. The working 
length of the clip applicator was 1650mm (Olympus HX-200L-135) with a standard clip 
length and a clip angle of 135 degrees. The clip applicator was inserted into the biopsy 
channel of the colonoscope and advanced until the tip appeared within the endoscopic 
field of view. The jaws of the clip were opened and the clip was pushed at the target 
mucosa. The slider was then pulled firmly to close the clip. The slider was then pulled up 
to the thumb ring to detach the closed clip from the coil sheath. The endoscopist identified 
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where the clip had been placed in the colon, and the same was recorded by the attending 
nurse. 
All the patients were allowed to recover and were discharged as per the existing protocols 
in the unit (table 3.1). However, at the time of discharge, all the participants had an 
abdominal x-ray to determine the position of the clip. No excess air was left behind to 
facilitate the identification of clips. Only one patient required a repeat abdominal x-ray 
because the first film had limited exposure (not for inability to identify clip). A consultant 
radiologist reported the x-rays blinded to the procedure and the clip position. The 
colonoscopy completion rate was determined using this and then compared with the 
endoscopist findings. All incomplete endoscopies were repeated over as soon as possible.  
Patients were then followed for a median of 6 (range 4-7) years. Subsequently, the 
endoscopy database was reviewed to identify participants who underwent repeat 
colonoscopies in the follow up period. The hospital pathology database was also reviewed 
for any other positive histological results for all the participants over the five year period. 
All patients’ case notes were reviewed and those who did not have a repeat colonoscopy 
were contacted to check whether they had a repeat procedure elsewhere or had persisting 
colorectal symptoms. The aim was to look for missed pathology. 
For the purposes of this study, missed lesions were defined as all those lesions identified in 
repeat colonoscopies within a median interval of six years.  
Data was entered into SPSS v14.0 for statistical analysis. Differences in proportion were 
tested using the Pearson chi-squared test, with p<0.05 considered significant. 
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4.3 Results 
Eighty two patients underwent colonoscopy with endoscopic clipping and follow-up 
abdominal x-ray during this study from January to December 1999. The patient 
characteristics are detailed in table 4.1. 
Table 4.1 Patient and procedure characteristics  
Number of patients 82 
Median age (range in brackets) 58 (21-92) years 
Sex (male:female) 50:32 
The indications for colonoscopy included symptomatic cases (n= 39), polyps (n=13), 
cancers (n=4), colitis assessment (n=15) and others (n=11). All patients received 
intravenous conscious sedation with median doses of Midazolam of 4mg and Fentanyl of 
75mcg. There were no procedure or sedation related complications. There were no 30-day 
procedure-related mortality (determined by medical records- no patient died in the median 
6 year period) or documented procedure-related re-admissions within this period. 
4.3.1 Position of the clips and completion rates 
The position of the endoclip as reported on abdominal x-ray is shown in table 4.2. Thus, 
the colonoscopy was complete in 76 (93%) of patients. In the remaining 6 patients, the 
clips were found to be at varying places including ascending colon (n=3), hepatic flexure 
(n=1) and splenic flexure (n=2). The caecal intubation rate was 100% as judged by the 
endoscopists, but 93% as judged by the radiologists. The adenoma detection rate was 22%. 
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Table 4.2 Position of the endoscopic clip on abdominal x-ray 
Position of the clip Number of patients (percentage) 
Caecum 76 (93%) 
Ascending Colon 3 (3.6%) 
Hepatic flexure 1 (1.2%) 
Splenic flexure 2 (2.4%) 
4.3.2 Endoscopist assessment versus imaging 
The endoscopists’ assessment was then compared with the x-ray findings. The endoscopist 
opinion was inaccurate in 6 (7%) procedures, despite using at at-least two out of three 
endoscopic landmarks to identify the caecum (table 4.2 and figure 4.1). All these patients 
subsequently underwent repeat colonoscopies as soon as possible thereafter. 
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Figure 4.1 X-ray abdomen showing a clip in the caecum (correctly identified by 
endoscopist) 
 
4.3.3 Follow up results and pathology miss rates 
3 adenomas and 1 cancer were missed in the group of patients who were originally 
deemed to have a complete colonoscopy (table 4.3 and 4.4). The endoscopist considered 
the procedure complete in all these cases, but the use of the endoscopic clip and abdominal 
x-ray revealed an incomplete colonoscopy and subsequently these patients underwent 
Clip in the 
caecum 
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repeat colonoscopy. All the lesions were proximal to the site of clip application. Therefore, 
these are technically missed lesions; most likely missed because the procedures were 
incomplete. The missed cancer was located in the proximal ascending colon. It was 
subsequently identified on a repeat colonoscopy done in 10 days time. The patient 
underwent a right colonic resection and is currently free from recurrence.  
Table 4.3 Missed pathology in complete and incomplete colonoscopies 
  Incomplete 
Colonoscopy (n=06) 
Complete 
Colonoscopy (n=76) 
Adenoma missed 3(50%) 1(1.3%) 
Cancer missed 1(16%) 0(0%) 
Furthermore, at median 6 years-follow up, 33 patients had undergone repeat colonoscopies 
for various indications. The procedure was normal in 23 patients, and the diagnosis of 
inflammatory bowel disease/ diverticular disease was confirmed in further 9 patients. 1 
adenoma was found in a patient who had undergone colonoscopy previously within 
median duration of 6 years. This lesion was missed during the first colonoscopy and 
subsequently detected on repeat procedures. Thus, 1 lesion was missed in complete 
colonoscopies at a median follow up of 6 years (1/76 complete colonoscopies). 
Therefore, it is clear from table 4.3 that significant lesions are missed in nearly 66% (4/6) 
of incomplete colonoscopies, as compared to only 1.3% (1/76) of complete colonoscopies. 
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Table 4.4 Incomplete Colonoscopies and Outcomes 
 
No. Actual 
Level 
reached 
Endoscopist 
Opinion 
Lesion 
missed 
Site of missed 
1 Distal 
ascending 
colon 
Complete Adenoma Caecum 
2 Transverse 
colon 
Complete Cancer Ascending colon 
3 Hepatic 
flexure 
Complete Adenoma Caecum/Ascending 
colon 
4 Splenic 
flexure 
Complete Adenoma Caecum 
5 Ascending 
colon 
Complete None N/A 
6 Hepatic 
flexure 
Complete None N/A 
 
4.4 Discussion: 
Technical success is a crucial feature of quality of colonoscopy and has enormous 
significance for the patient. The two fundamental components of procedural success 
include completion to caecum and successful identification of all pathology. This is 
particularly pertinent as incomplete endoscopies are associated with extremely high 
pathology miss rates, as demonstrated in our study (67% in incomplete procedures v/s 
1.3% in complete colonoscopies) and others
133
. There are 3 findings from our study: 
experienced endoscopists can over estimate the proximal extent of colonoscopy which can 
lead to serious pathology being missed, and the technique of endoscopic clips with x-ray 
can help in objective documentation of completion, in some cases.  
If we have to provide stringent quality assurance of colonoscopy, then indisputable 
evidence of caecal intubation will need to be provided
54
. Currently accepted identification 
markers of caecal intubation are a combination of images of the tri-radiate fold, 
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appendicular orifice and the ileocaecal valve. The JAG and the ASGE recommend caecal 
photography (to capture images of atleast 2 of the above 3 landmarks) for objective 
documentation of caecal intubation. It is easy to obtain and store images of the caecum 
showing the above mentioned landmarks, especially with the advent of the modern 
reporting systems. However, Thuraisingam et al
42
 have recently shown that the sensitivity 
(51.4%) and specificity (89.2%) of caecal photography is too low to be used for reliably 
documenting colonoscopy completion. The difficulty lies in recording a moving image. 
Several studies have also shown similar results
134, 135
. The current study has shown that 
even experienced endoscopists can over estimate the position of the endoscope during 
colonoscopy, despite using the reliable caecal landmarks. The colonoscopists were 
inaccurate in around 7% of cases and 66% of these cases had significant pathology 
proximal to the tip of the endoscope. This emphasises the need to use accurate methods of 
identifying and objectively documenting caecal intubation in colonoscopy. If photography 
of caecal landmarks is not enough, then what are the other options? 
There are several other methods of documenting completion of colonoscopy, which have 
been discussed earlier in chapter 1. Ileal intubation with ileal biopsy is considered to be the 
gold standard for confirmation of completion of colonoscopy. However, without clinical 
indication, ileal biopsy is not cost-effective as there is only 2-3% yield of significant 
pathology. Additionally, there is a potential risk of vCJD transmission. Therefore, the 
Royal College of Pathologists actively discourage ileal biopsy and suggest ileal 
photography instead. However, Baraza et al
40
 have shown that ileal photography, either on 
its own or with additional enhancement by a pool of water or indigo-carmine dye, is an 
unreliable method of confirming ileal intubation. In our study, we have assessed the 
technique of application of endoscopic clip (with a follow-up abdominal x-ray) to assess 
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completion. The results confirm that the technique is useful and easy to practice. There are 
potential uses for the clip technique- endoscopic clips with abdominal x-ray could be used 
in a random number of procedures for every endoscopist each year and their completion 
rates determined. Additionally, all such procedures could be audited at an interval of 2 
years to determine the true miss rates for each endoscopist. Furthermore, there are 3 
possible scenarios with the identification of caecum on colonoscopy in terms of quality 
assurance and outcomes. First, the endoscopist is confident about completion and has 
identified two of the above landmarks and he is correct. Second scenario is where the 
endoscopist has a doubt regarding the completion and, therefore, performs a repeat 
colonoscopy. The third is where the endoscopist is confident about completion, but he/she 
is incorrect. It is the third scenario which is crucial for quality assurance as it could easily 
result in missed lesions. We emphasise the role of endoscopic clips with follow-on 
abdominal x-rays for resolving these scenarios. In this study, six patients were found to 
have incomplete colonoscopies, based on the results of endoscopic clipping and follow on 
x-ray. Based on these findings, the patients had a repeat procedure and missed lesions 
were detected in 4 out of 6 patients (67%). Three adenomas and one cancer were missed in 
these procedures. However, as they were deemed incomplete at the end of the procedure, 
and hence underwent repeat scoping, they cannot be classified as true misses. On the other 
hand, only one adenoma was missed in the remaining patients and this happened despite 
the procedure being complete. The pathology miss rate for this series of colonoscopies 
would have been 5/82 (around 6%). However, as patients underwent endoscopic clipping 
with x-ray, incomplete procedures were immediately identified and repeated, leading to a 
reduction in final miss rate to 1.3% (1/76) only. This technique aids in objective 
determination of completion, and, at the same time, is safe and easy to use. Moreover, 
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when this is combined with an audit of the procedures in two years, missed lesions thus 
determined reflect the true miss rates, once again emphasizing the usefulness of the 
technique.  
The salient feature pertinent to quality assurance is that the technique of endoscopic 
clipping and follow on x-ray enables the determination of the accuracy of the intra-
procedural opinion of the endoscopists, with regards to the identification of caecum and 
hence completion of colonoscopy. In other words, it quantifies the accuracy level of each 
endoscopist’s assessment of completion. The implication is that if an endoscopist is of a 
high quality as demonstrated by the use of endoscopic clips, it follows that there is a high 
degree of accuracy in his assessment of completion of colonoscopy.  
However, though the technique of endoscopic clipping with x-ray is useful, it has not yet 
been validated against the current criterion standard which is ileal intubation and biopsy. 
Moreover, identification of the exact position of the clip on an abdominal x-ray could be 
difficult in some cases though we did not find the same in our study. This could be 
possibly due to the small number of patients in our study. We believe that future studies 
are required to validate this useful technique against the technique of ileal biopsy, and also 
to validate the accuracy of abdominal x-rays (in locating the clip) against reliable 
radiological imaging methods, for instance, computerised tomography of the abdomen.  
The adenoma miss rate for this series was 4/82 (4.8%). Out of 4 adenomas missed 
complete colonoscopies, 2 were lesser than 1cm in size and the other two were greater 
than 1cm. A systematic review
136
 has shown that the pooled miss rate for polyps of any 
size was 22% (95% CI: 19–26%; 370/1,650 polyps) after colonoscopy. Adenoma miss rate 
by size was, respectively, 2.1% (95% CI: 0.3–7.3%; 2/96 adenomas ≥10 mm), 13% (95% 
CI: 8.0–18%; 16/124 adenomas 5–10 mm), and 26% (95% CI: 27–35%; 151/587 
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adenomas 1–5 mm). For non adenomatous polyps, the miss rate was: zero of eight non-
adenomatous polyps ≥10 mm were missed (0%; 95% CI: 0–36.9%), and 83 of 384 non-
adenomatous polyps <10 mm were missed (22%; 95% CI: 18–26%). Pabby et al137 in the 
Polyp Prevention Trial showed that 13 patients (n=2079) had cancer detected during 
follow-up at 1-4 years after a clearing colonoscopy and that 3 cancers were missed at 
baseline colonoscopy. 
Once technical quality is quantified using this technique and subsequent areas of 
deficiency identified, the only direction for endoscopists (and units) is to improve the 
quality by achieving higher completion rates and removing all polyps on index 
colonoscopy. Obviously, other aspects of quality of colonoscopy including adenoma 
detection rates, patient satisfaction and rate of complications need to be assured on a 
regular basis. It is, therefore, evident that any quality assurance in colonoscopy based on 
technical aspects should form part of a bigger programme to evaluate colonoscopy 
globally and include other criteria such as patient satisfaction, and adenoma hit rates.  
4.5 Conclusions:  
We have shown in this study that even experienced endoscopists over estimate the 
proximal extent of colonoscopy despite the use of standard caecal landmarks, and that 
there is a higher chance of missing lesions if the colonoscopy is incomplete. The study has 
also shown that the technique of endoscopic clipping with follow-on abdominal x-ray is a 
feasible method of objectively documenting colonoscopy completion, but there is a need 
for further validation before it can be routinely applied in clinical practice.  
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Chapter 5 Technical quality assurance in flexible sigmoidoscopy: role of endoscopic 
clips 
5.1 Introduction 
Flexible sigmoidoscopy (FS) is a straightforward and relatively safe procedure, which is 
generally well tolerated without any sedation. Previous studies
138, 139
 have shown that the 
use of FS results in a 59-80% reduction in mortality from cancers arising in the distal 
colon and rectum. It is widely used a first line investigation for assessment of rectal 
bleeding
140
, colitis and is now being advocated for screening for colorectal cancer
141
.  
The limitation of FS is that the depth of insertion and hence the completion rate is 
variable. The internal landmarks are not constant and distinct in the left colon, and there is 
no reliable marker of completion, as compared to colonoscopy. Some believe that the 
splenic flexure is a reliable landmark. However, visualisation of the splenic flexure is 
possible in only around 50% of examination and if the examination stops short of the 
splenic flexure, it cannot be used as a reliable landmark
51
. The Joint Advisory Group 
(JAG) in Endoscopy has defined completion of flexible sigmoidoscopy as insertion of the 
endoscope to the descending colon, and this should be achieved in 90% of examinations. 
A previous study has shown that the examination of the entire sigmoid colon was not 
achieved in 25% of cases and the descending colon was intubated in a minority of cases
142
. 
Currently, there is no universally established method of objectively validating completion 
in FS. The technique of applying endoscopic clips with a follow- up abdominal x-ray was 
previously shown to be an objective marker of completion in colonoscopy
51, 143
 (as shown 
in the previous chapter). This method has not been previously applied to FS. 
Further, in view of increasing demand for endoscopy and the introduction of screening 
programmes, the Department of Health in the United Kingdom has begun to train non-
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healthcare professionals to perform endoscopy
58
. However, there have been no studies to 
establish their accuracy and completion rates in FS. 
We, therefore, performed this study with the following aims: to determine the accuracy of 
the endoscopists’ clinical impression regarding the actual position of the endoscope in the 
colon during FS, to compare ME and NME in terms of such clinical accuracy and to 
determine the role of endoscopic clips with follow-up x-rays in objectively documenting 
completion.  
5.2 Methods 
This was a prospective study performed in the Endoscopy unit at Castle Hill Hospital, 
Cottingham, United Kingdom from June 2006 to January 2008, and was approved by the 
South Humber Research Ethics Committee, United Kingdom. It was undertaken according 
to International Conference on Harmonisation Good Clinical Practice standards (ICH-
GCP), including on-site monitoring and source data verification. 
All patients undergoing elective FS were invited to participate in the study. They were also 
given detailed information leaflets (approved by the Ethics committee) about the trial two 
weeks before the procedure and then had an opportunity to discuss the trial with the co-
coordinator, throughout the 2-week period as well as before the FS. The exclusion criteria 
included emergency FS, pregnancy, post-surgical resection, patients not willing to 
participate, patients on endoscopy lists when the consultant was not available and patients 
having an immediate barium enema as part of one- stop assessment. 
All patients had the study explained in detail upon their arrival in the endoscopy suite and 
then participating patients signed a consent form. FS was subsequently performed in a 
routine manner using Pentax 160cm video-colonoscopes incorporating a 3.6mm biopsy 
channel. Only one patient requested sedation (midazolam-2.5 mg) and the remaining 
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procedures were done without any sedation. During the procedure, the patients were 
monitored in accordance with the British Society of Gastroenterology guidelines
132
.  
The endoscopists were asked to insert the flexible sigmoidoscope at least up to the 
descending colon for completion, except when they had to abandon the procedure or it was 
technically not feasible. Once the most proximal part of the colon was reached, the 
endoscopist clipped the colonic mucosa, using an Olympus Titanium Endoclip applicator. 
The endoscopist identified where the clip had been placed in the colon and the same was 
recorded by the attending nurse.  
Post-procedure patients were allowed to recover as per existing protocols (chapter 5). Prior 
to discharge, participants underwent an abdominal x-ray to determine the position of the 
clip. A consultant radiologist reported the x-rays and the clip position. The completion rate 
was determined using the radiology findings and then compared with the endoscopist 
findings. All incomplete endoscopies were repeated subsequently.  
The two endoscopists taking part in the study were a surgical registrar and a non-medical 
non-nurse endoscopist (called as non-medical endoscopists-NME, for the purpose of this 
study). Both endoscopists had performed more than 100 FS prior to the study and 
regularly perform FS.  The NME was a non-healthcare professional who was currently 
working in the capacity of an Assistant Endoscopy Practitioner. This NME, who was also 
pursuing a degree (B.Sc.) in Coloproctology from the University of Hull, was part of the 
Pilot project initiated by the Department of Health to train non-healthcare professionals to 
perform endoscopy. Further details of non-medical endoscopist training are described 
elsewhere
58
. For the purposes of this study, we defined the procedure complete when the 
flexible sigmoidoscope reached the descending colon. All procedures were included in the 
study even if the descending colon was not reached, because the aim of the study was to 
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determine the accuracy of the endoscopists’ assessment of the position of the endoscope in 
the colon. 
Data was entered into SPSS v14.0 for statistical analysis. Differences in proportion were 
tested using the Pearson chi-squared test, with p<0.05 considered significant. 
5.3 Results 
Fifty one patients underwent endoscopic clipping during FS in this study from June, 2006 
to January, 2008. The patient characteristics, indications and findings of FS performed in 
this study are detailed in table 5.1. There were no procedure or sedation related 
complications. There was neither any 30-day procedure-related mortality nor any 
documented procedure-related re-admissions within this period. 
The medical endoscopist performed 25 procedures and the NME performed the remainder 
(26). We found no correlation between the length of the endoscope inserted and the 
position of the endoscope in the colon (p=0.14). 
 
 
 
 
 
 
 109 
Table 5.1 Demographic details  
 Overall  ME NME 
Number of patients 51 
 
25 26 
Sex (Males: Females) 28:23 
 
10:15 14:12 
Median age *  in years 55 (37, 69)  
 
53 (33, 71.5)  57.5 (40, 65) 
Median time for 
completion*   
12 (10,16)  11 (10,14) 13 (12,16) 
Overall Accuracy  74.5% (38/51) 80 % (20/25) 70 % (18/26) 
Findings on FS 
- Normal 
- Cancer 
- Polyp 
- Colitis 
- Diverticular disease 
 
34 (66.7%) 
01 (2%) 
05 (9.8%) 
07 (13.7%) 
04 (7.8%) 
 
15 
01 
02 
04 
03 
 
19 
00 
03 
03 
01 
Indications  
- Rectal bleeding 
- Polyp on barium 
enema 
- Change of bowel 
habits 
- Diarrhoea (with 
bleeding) 
- Colitis assessment 
 
 
34 (66.7%) 
 
4 (7.8%) 
 
8 (15.7%) 
 
3 (5.9%) 
2 (3.9%) 
 
 
16 
 
01 
 
06 
 
01 
01 
 
18 
 
03 
 
02 
 
02 
01 
*  range in brackets 
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Figure 5.1 X-ray abdomen showing a clip at the splenic flexure (incorrectly identified by 
endoscopist) 
 
5.3.1 Accuracy of endoscopists’ assessment and completion rates 
Of 51 patients included in the study, the descending colon was reached in 18 patients and 
splenic flexure or beyond in a further 20 patients. The scope reached upto the sigmoid 
colon in the remaining 13 patients (26%). However, in 6 out of these 13 incomplete 
flexible sigmoidoscopies, the procedure was terminated in sigmoid colon because of pain 
(2) or poor bowel preparation (3) or severe proctitis (1). This gives a crude completion rate 
of 74% and a corrected completion rate of 84%. 
The endoscopists’ assessment of the position of the scope in the colon was accurate in 
38/51 cases, giving an overall accuracy of 75%. This compares favourably with previous 
studies where the accuracy rates were around 50%
33
. The ME was inaccurate in 4 
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procedures. There was over estimation of the position of the endoscope in 2 out of 4 
procedures and under estimation in the remainder. The NME was inaccurate in 8 
procedures, over estimating the position in 4 cases and under estimating in the remainder. 
All patients who had incomplete FS subsequently underwent repeat procedures and no 
significant pathology was found.  
Table 5.2 Analysis of inaccurate predictions of position 
 Endoscopist 
opinion regarding 
position of the 
endoscope in colon 
Actual position of the 
endoscope in left colon 
Medical 
endoscopist  
  
1 Distal Descending 
colon 
Sigmoid colon 
2 Splenic flexure Sigmoid colon 
3 Sigmoid colon Proximal descending colon 
4 Distal Descending 
colon 
Transverse colon 
5 Sigmoid colon Proximal descending colon 
Non-
medical 
endoscopist 
opinion 
  
1 Splenic flexure Proximal Descending colon 
2 Splenic flexure Sigmoid colon 
3 Sigmoid colon Distal Descending colon 
4 Distal Descending 
colon 
Splenic flexure 
5 Proximal 
Descending colon 
Sigmoid colon 
6 Transverse colon Descending colon 
7 Sigmoid colon Proximal Descending colon 
8 Descending colon Transverse colon 
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5.3.2 Medical versus non-medical endoscopists 
The demographic features were similar in both groups (table 5.1). There was no difference 
between the two groups in terms of ability to reach the transverse colon flexure, 
completion rates, total procedure time and depth of insertion. The medical endoscopists’ 
impression regarding the position of the scope in the colon was accurate in 20 out of 25 
procedures (80% accuracy) as compared to the non-medical endoscopist’s impression (18 
accurate out of 26; 70%). These differences did not reach any statistical significance 
(Fisher’s exact test, P=0.09).  The medical endoscopist’s opinion was inaccurate in 5 
examinations. Table 4.2 gives details of sites of inaccuracies with both medical and non-
medical endoscopists. The ME over-estimated the position in 2 examinations and under-
estimated the position in further 3 patients. On the other hand, the NME over-estimated the 
position in 3 patients and under-estimated in 5 procedures. The median procedure time and 
depth of insertion were similar in both groups (table 5.3). 
Table 5.3 Medical versus non medical endoscopists: outcomes 
 Medical endoscopist Non-medical 
endoscopist 
P value 
Numbers to descending 
colon 
8 10 - 
Numbers to splenic 
flexure  
9 4 - 
Numbers to transverse 
colon 
4 3 - 
Sigmoid colon only 4 9 - 
Completion rate 22/25 (88%) 21/26 (85%) 0.54 
Overall accuracy 80% (20/25cases) 70%(18/26cases) 0.09 
Mean procedure time ( 
range) in minutes 
12 (8,14) 14 (10,18)  0.9 
Mean insertion depth in 
cm 
75 (67.5, 82)  67.5 (55,71 0.34 
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5.4 Discussion 
We have shown in this study that the endoscopists’ impression regarding the position of 
the scope in the left colon during flexible sigmoidoscopy is accurate in only 75% 
procedures. The technique of endoscopic clip application and follow-up x-ray is a feasible 
method of assessing completion. Furthermore, the study has shown that were no 
differences between the medical and non medical endoscopists with regards to accuracy 
and FS completion rates. 
The JAG defines a complete FS as intubation of the descending colon. However, 
technically incomplete examination is an unfortunate drawback of FS. Using radio opaque 
clips, Lehman et al
51
 noted that the splenic flexure was reached in only 33% of flexible 
sigmoidoscopies. The implications of incomplete examination are enormous in that this 
may result in missed polyps and cancers
47
. Additionally, both the patient and the 
endoscopist may be falsely reassured regarding the findings on the background of a 
potentially incomplete FS. 
Anatomical factors, preparation quality, variations in patient tolerance and female gender 
all play a role in limiting depth of insertion and are hence more likely to be associated with 
incomplete FS
144
. Inaccurate assessments of the anatomical segment of the colon reached 
by the endoscopist can also potentially lead to incomplete FS. However, there is a serious 
problem with this failure- if the endoscopist does not recognise that a procedure is 
incomplete and assumes he/she has identified sufficient left colon, not only do lesions tend 
to be missed, but patients might be falsely reassured as well. This makes quality assurance 
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of endoscopists performing flexible sigmoidoscopy with regards to the accuracy of their 
assessment of position in colon particularly important. 
How do we objectively assess an endoscopist’s accuracy in determining completion in 
flexible sigmoidoscopy? Due to the lack of consistent anatomical landmarks in the left 
colon, there is no universally agreed technique of objectively documenting completion in 
flexible sigmoidoscopy. There are a couple of previous studies that attempt to address this 
question. Adam et al
33
 used an electromagnetic imaging device (EMI) to identify the 
position of the endoscope in the left colon and compared with the endoscopists own 
assessment of the position. The study showed that the endoscopists’ assessment of position 
in the left colon was accurate in around 50% of cases. The splenic flexure was not reached 
in 60% of cases.  However, the EMI device is cumbersome to use and impractical. This 
technique cannot be used on a routine basis and has also not been validated. A second 
study
145
 used a video assessment scoring method to determine the accuracy of endoscopist 
performance at flexible sigmoidoscopy. The aim of this study was to develop a valid and 
reliable objective scoring method using video footage of screening flexible 
sigmoidoscopies
145
. The final parameters used for scoring included time spent viewing the 
mucosa, re-examination of poorly viewed areas, suctioning of fluid pools, distension of the 
lumen, lower rectal examination, and overall quality of the examination. Though the 
technique was used to assess overall quality of FS, there is no specific focus on completion 
itself. Moreover, this technique necessitates video recording of the procedure making it 
impractical and cumbersome. We, on the other hand, have shown that the technique of 
applying endoscopic clips with follow-on abdominal x-ray to determine the accuracy of 
the endoscopists’ assessment of the position of the endoscope is feasible and safe. The 
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application of an endoscopic clip does not add significantly to the procedure time. 
Endoscopic clips with abdominal x-ray could probably be used in a random number of 
procedures every two years for each endoscopist to determine their completion rates as 
well as their accuracy of assessment of position in the colon. These results could be re-
audited in two years to determine if any lesions have been missed. This technique can also 
be used when the endoscopist performing the flexible sigmoidoscopy is not sure about 
his/her position in the left colon. The limitation of this technique is that it has not been 
validated. However, there is no criterion standard against which the technique can be 
validated. A second limitation is that the ability of the abdominal x-ray to accurately 
identify the position of the clip has not been validated against a standard radiological 
imaging technique like computerized tomography of the abdomen (CT). The future plan is 
to validate this technique against CT abdomen and also video footage of the procedure. 
This study has also shown that localization of the segment of colon reached by depth of 
insertion of the endoscope is not as accurate as the endoscopists’ impression. When the 
endoscope was inserted up to 60cm, the splenic flexure was reached in only 25% of cases, 
and the descending colon was reached in 60% of cases. However, it was not possible to 
exactly correlate the depth of insertion with the anatomical segment of the left colon, 
though we could probably estimate that when the endoscope is inserted for 60cm, there is 
a 60% probability that the descending colon will be reached.  
We also compared the accuracy of the medical and the non-medical endoscopist. While 
the medical endoscopist was accurate in 20/25 cases, the non-medical endoscopist was 
accurate in 18/26 cases. These differences were not statistically significant. There were no 
differences between the two endoscopists in terms of mean insertion depth (75cms versus 
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67.5 cms; p=0.34) and completion rates to descending colon (22/25 versus 21/26 cases; 
p=0.54). It is important to note that this is not a randomised controlled trial and was not 
powered to detect any differences. However, the findings are reassuring regarding both the 
medical and the non-medical endoscopists.  
In conclusion, this study has shown that the clinical impression of endoscopists is accurate 
in only around 75% of cases, implying the need for quality assurance. The technique of 
endoscopic clipping with follow up abdominal x-ray is a feasible method of objectively 
documenting completion. However, there is a need for further validation of the technique 
before it can be routinely applied. Finally, this study has shown that non-medical 
endoscopists can perform FS with similar accuracy, completion rates and depth of 
insertion, as compared to medical endoscopists. 
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Chapter 6 Randomised controlled trial of sedation for colonoscopy: Entonox versus 
Midazolam/Fentanyl 
6.1 Introduction 
With screening programmes shown to reduce mortality from colorectal cancer, and their 
subsequent introduction in the United States and recently in the United Kingdom, it is 
obvious that referrals for colonoscopy have increased. A prerequisite for successful 
colonoscopy is good analgesia and sedation during the procedure. Colonoscopy is usually 
performed with the patient sedated using a combination of benzodiazepines and an 
opioid
74, 146-149
, mostly midazolam and fentanyl or pethidine (mepiridine), which is the 
standard practice in most countries. Although such intravenous sedation provides varying 
degrees of pain relief, it is associated with a small but definite risk of cardiopulmonary 
complications of 0.1% to 0.54%
75
, and mortality of 0.03%
74
. Oxygen desaturation seems 
in part to be due to medication, even when an attempt is made to titrate the dose
74, 150-152
.  
Patient controlled Nitrous oxide mixed with oxygen (50:50; Entonox
®
, BOC gases, 
Guildford, UK) has been shown to be safe and effective, even under adverse cardiac 
conditions. This weak inhalation agent has anaesthetic, sedative and anxiolytic properties. 
Entonox
®
 has a low blood/gas solubility ratio and, therefore, has a rapid onset and 
clearance time. It is used to alleviate pain in dental treatment, in ambulatory care including 
ischaemic heart disease, and during prolonged labour. 
The aim of this randomised controlled trial was to evaluate the role of Entonox
® 
as a 
sedative-analgesic in colonoscopy compared with intravenous midazolam-fentanyl, in 
terms of analgesic efficacy, depth of sedation, rate of complications, recovery of 
psychomotor function and time to discharge. 
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6.2 METHODS: 
6.2.1 Study Design 
This trial was performed in the endoscopy unit at Castle Hill Hospital, Cottingham, United 
Kingdom between April, 2005 and March, 2006. The study was approved by the South 
Humber Research Ethics Committee, and the Clinical Trials Unit, Medicines and Health 
Regulatory Authority, and preregistered with the European Clinical Trials Database 
(EudraCT number 2004-004890-26) and the International Standard Randomised 
Controlled Trial Number Register (ISRCTN 81142957). It was undertaken according to 
International Conference on Harmonisation good clinical practice standards, including on-
site monitoring and source data verification. 
6.2.2 Inclusion and Exclusion Criteria 
All patients undergoing elective colonoscopy were invited to participate in the trial. They 
received detailed information leaflets (approved by the Ethics committee) about the trial 
two weeks before the procedure and also had an opportunity to discuss the trial with the 
co-ordinator. Informed written consent was obtained from all patients before they were 
randomised. Patients with a history of pneumothorax or severe bronchial asthma, previous 
colonic resection, intolerance to any of the drugs, those undergoing upper gastrointestinal 
endoscopy and colonoscopy simultaneously, and those taking opiates were excluded from 
the study. 
6.2.3 Randomisation and allocation concealment 
Block randomisation was used, with stratification based on the types of colonoscopist: 
doctors, nurse colonoscopists and non-medical non-nurse colonoscopists (also known as 
non-medical colonoscopists). A block size of six was used to help concealment of 
allocation. The assignments were held in sequentially numbered, opaque sealed envelopes. 
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The envelopes were opened sequentially and only after the participant's name, address, 
date of birth and other details were written on the appropriate envelope at a central 
location, by a person unrelated to the trial. Neither the patients nor the colonoscopists were 
blinded to the treatment modality. 
6.2.4 Interventions  
Patients were randomly assigned to receive either intravenous Midazolam  (2mg/ml; 
Hypnovel
®
, Roche, UK) and Fentanyl (50mcg/ml; Sublimaze
®
, Janssen-Cilag, High 
Wycombe, UK) or inhaled Entonox
®
. They were informed about the relevant procedure, 
the reasons for sedation and the technique. 
Patients randomised to intravenous sedation 0.75-1mg Fentanyl, followed by 1-mg 
incremental doses of midazolam (2mg/ml) up to a maximum of 10 mg. All patients 
received supplemental oxygen at the rate of 2-3 l/minute during the procedure. 
Colonoscopy was performed 5 minutes after the last dose of Midazolam. The 
colonoscopist was allowed to administer further doses of midazolam, if warranted 
throughout the procedure. 
Those randomised to Entonox
® 
inhaled the gas through a mouthpiece for a full 120 
seconds initially, for a further period until the caecum was reached, and as required 
thereafter. If the patient found the procedure too uncomfortable or the colonoscopist 
judged that the patient was in discomfort, intravenous sedation was given, but only after a 
washout of 4-5 minutes.   
All patients were assessed continuously throughout the procedure, in accordance with the 
guidelines of the British Society of Gastroenterology
130
 (see table 6.1). The aim of 
conscious sedation was that the patient should be able to obey commands at all times. 
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Patients were allowed to recover after the procedure and discharged by recovery room 
nursing staff according to pre-existing discharge criteria (table 6.1).  
Table 6.1 Monitoring of patients and discharge criteria 
Monitoring 
1. 2-3L oxygen given to all patients 
2. Intravenous cannulae in situ before the procedure in all patients 
3. Pulse oximetry  
4. Clinical monitoring- including heart rate, blood pressure. This was continued into 
recovery area, and it was the responsibility of both the endoscopists as well as the 
nurses to monitor these physiological variables. 
5. Full resuscitation equipment available within easy reach in the endoscopy suite. 
Discharge Criteria 
1. Patient responded appropriately to questions and was able to communicate clearly. 
2. Patient was able to sit upright for at least 5 minutes and was able to tolerate 
liquids/solids. Patient was able to dress independently and use the toilet. 
Modified Observer’s Assessment and Alertness/Sedation Scale (MOAAS) 
SCORE RESPONSIVENESS 
5 Responds readily to the name spoken in 
normal tone 
4 Lethargic response to the name spoken in 
normal tone 
3 Responds only after the name is called 
loudly and/or repeatedly 
2 Responds only after mild prodding or 
shaking 
1 Responds only after painful trapezius 
squeeze 
0 No response after painful trapezius squeeze 
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6.2.5 Colonoscopy 
All colonoscopies were performed according to a standard operating procedure with the 
Pentax video colonoscopes (Pentax, Hamburg, Germany). Colonoscopy was carried out by 
three different types of colonoscopists: doctors (colorectal consultants), senior nurses with 
experience of more than 5000 colonoscopies, and non-medical colonoscopists. Completion 
to the caecum was documented based on two of three landmarks- ileocaecal valve, 
appendiceal orifice and/or the tri-radiate fold. 
6.2.6 Data collection and outcomes 
Demographic and clinical features recorded for all patients included age, sex, weight, 
height, clinical indications, past and family history, results and procedural findings. 
All participants completed a Hospital Anxiety and Depression questionnaire, baseline 
letter cancellation test and scored pain on a 100-mm visual analogue scale before 
randomisation, but after giving consent to be included in the trial. Patients who refused to 
participate were asked their reasons for doing so, such as experience with any of the drugs 
or frightened by the idea of deciding own sedation. These patients also completed 
questionnaires before and after the procedure. 
The primary end-point was the degree of pain experienced by the patient during the 
procedure assessed on a 100-mmvisual analogue scale (VAS). Measurements were taken 
immediately, and at15-min intervals after the procedure until discharge (table 6.2). 
Patients also marked a VAS at 24 hours after colonoscopy after allowing recovery from 
sedation. 
The secondary end-points included degree of sedation, patient, nurse and endoscopist 
satisfaction, complication rate, time taken to reach caecum and total colonoscopy time, 
completion rate, degree of psychomotor recovery and time to discharge (table 6.2). 
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The degree of sedation was measured on the Modified Observer’s Assessment of 
Alertness/Sedation scale (MOAAS; table 6.1), at 1-min intervals throughout the procedure 
and 5-min intervals during recovery.  
Patient satisfaction was measured at discharge and 24 hours after colonoscopy by means 
of a 100-mm VAS, which was incorporated into a previously validated patient satisfaction 
questionnaire for colonoscopy
109
. Nurse and Endoscopist satisfaction was measured using 
a similar 100-mm VAS, as part of a different questionnaire. 
Psychometric tests were administered immediately upon arrival of the patient to the 
recovery area and then at 15-min intervals until discharge. Inability of the patient to 
perform the tests immediately on return to the recovery room was noted. Psychomotor 
recovery was assessed using the Letter cancellation test
153
, which measures concentration 
and perception. The patient was presented with a sheet of paper containing a printed 
paragraph of 20 rows of 40 randomly arranged letters, and then asked to read from left to 
right and top to bottom, simultaneously marking through all occurrences of a pre-
designated letter. The number of lines completed in 120 seconds and the number of times 
the pre-designated letter was correctly identified were recorded. Post-procedure scores 
were compared with baseline values and results presented as percentage recovery of 
psychomotor function. This test has previously been shown to be an accurate means of 
measuring psychomotor recovery in the post-endoscopy setting
153, 154
. 
The efficacy of sedation was evaluated by colonoscopists in terms of the rate of caecal 
intubation, time taken to reach the caecum, total colonoscopy time and complication rate. 
The colonoscopists also completed a questionnaire concerning the degree of sedation, 
difficulty of colonoscopy and difficulty in manoeuvring the patient. After the procedure 
the attending nurses completed a questionnaire for each colonoscopy concerning the 
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perceived adequacy of sedation, ability of the patient to assist with moving during the 
procedure, and maximum depth of sedation. 
Table 6.2  Administration of questionnaires to participants 
A. Pre-colonoscopy (after consent and before randomisation) 
1. Hospital Anxiety and Depression Scale 
2. Letter Cancellation Test  
3. 100 mm Visual Analogue Scale  
  B.  Post colonoscopy 
        1. Visual Analogue Scale- immediately after the procedure and at 15-minute     
            intervals up to and including at discharge; repeated at 24-hours post  
            colonoscopy 
        2. Letter Cancellation Test – immediately after the procedure and at 15-minute  
            intervals up to and including at discharge 
   3. Patient satisfaction questionnaire- at discharge and at 24 hours post  
colonoscopy 
6.2.7 Statistical Analysis and sample size calculation 
The required sample size was estimated from the results of a pilot study in which the 
degree of pain experienced by 20 patients undergoing colonoscopy under Entonox
®   
 
or intravenous midazolam-fentanyl sedation (10 patients in each group) was measured on a 
100-mm VAS. Using a power of 80 percent and a 2-sided level of significance of 0.05 
(based on Wilcoxon-Mann-Whitney statistic appropriate for a two-group comparison), it 
was calculated that a total sample size of 120 would be required to determine a difference 
of 15 points on a 100-mm VAS between groups. The 20 patients in the pilot study were 
not included in the final analyses for the randomised controlled trial. 
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All analyses followed the intention to treat principle. No interim analyses were performed 
before analysis of the primary endpoint. Demographic and baseline characteristics were 
compared by two-way ANOVA for continuous data and Fishers exact test for categorical 
data. Differences in proportion were tested using the chi-squared test, or Fisher’s exact test 
for smaller samples. VAS scores, sedation scores, postoperative time to discharge and 
results of the letter cancellation test were evaluated using the Mann-Whitney U test. All P 
values are two tailed. 
6.3 Results  
6.3.1 General characteristics  
Of a total of 176 patients assessed for eligibility, 45 were excluded (Fig.6.1):13 were 
ineligible (seven had undergone surgical resection, two had a combined upper 
and lower gastrointestinal endoscopy, and four had severe asthma) and 32 patients refused 
to participate (20 patients did not want to participate in any trial as they were too 
anxious, and the remainder had inhaled Entonox
®
 in the past and were not happy to 
participate). The remaining 131 patients were included in the trial, of which 65 were 
randomized to receive Entonox
®
 and 66 intravenous sedation with midazolam–fentanyl. 
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Figure 6.1  Flowchart of patients in the randomised controlled trial  
 
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
176 patients were assessed for 
eligibility 
  45 patients were excluded   
 1. Not meeting inclusion     
criteria (n= 15) 
 2. Refused to participate (n=30) 
   
    65 patients completed trial 
 
         Randomly assigned to  
Entonox
®
 group 
       N=65 
    66 patients completed trial 
             Randomly assigned to  
 Intravenous sedation 
              N=66 
 
             Randomised  
     N=131 
           Analysed n=65 
           No exclusions 
          Analysed n=66 
           No exclusions 
 126 
The two groups had similar demographic characteristics and American Society of 
Anesthesiologists (ASA) grades, and there was no difference in pre-procedure anxiety 
scores (7·5 (range 3–10) versus 6.0 (range 2–12); P = 0.143) (Table 6.3). 
Table 6.3 Baseline characteristics   
 ENTONOX
® 
(N=65) 
Midazolam-fentanyl 
(N=66) 
Gender (M:F) 29:36 34:32 
Median age (years)(range) 56.1 (39-70) 60.4 (41-69) 
ASA class      1 
                      2 
53 
12 
55 
11 
Pre-procedure  
Anxiety (median) 
 
7.5 (3-10) 
 
6 (2-12) 
Doses  
    Midazolam 
    Fentanyl 
 
 
- 
- 
 
4 mg 
100 mcg 
 
Indications for colonoscopy included symptoms (79 patients), family history (28) and 
follow-up (24). Colonoscopy findings included colorectal cancer (five), polyps (26), 
normal (53) and other pathology (47). Median doses of midazolam and fentanyl were 4 
(range 3–5) mg and 0·1 (range 0·05–0·1) mg respectively. There were no complications in 
either group, although one patient in the intravenous group complained of nausea which 
settled spontaneously. None of patients in the Entonox
®
 group required additional sedation 
or conversion to intravenous sedation. Twenty-one patients had undergone colonoscopy 
previously, and another 11 had had flexible sigmoidoscopy. Of the former 21 patients, 19 
had received midazolam with fentanyl or pethidine, whereas two had received pethidine 
only. Nine of these patients were randomized to Entonox
® 
in the present trial and found 
the current sedation better. The remaining 12 patients received intravenous sedation during 
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this study, of whom six found the current regimen better, two described no difference and 
the remaining four thought the current regimen was worse. 
6.3.2 Primary outcome - Pain 
Patients in the Entonox
®
 group recalled significantly less pain during colonoscopy than 
those receiving midazolam–fentanyl (mean VAS score 16·7 versus 40. 1; P = 0·001; 95 
per cent confidence interval (c.i.) of the difference 21·5 to 29·1). These differences 
persisted at different points after the procedure and also after 24 h (Table 6.4). 
Table 6.4 Pain scores on visual analogue scores 
Pain scores on 
VAS 
Entonox
®
 IV Significance 
(p-value) 
At discharge  
 
16.7 (0-24) 40.1(18-91) 0.001 
15 min 16.5 (0-24) 39.6 (18-91) 0.001 
30 mins 16.6 (0-25) 40 (18-92) 0.001 
At 24- hours post 
procedure 
15.0 (0-25) 38 (15-94) 0.001 
 
6.3.3 Depth of sedation 
The median depth of sedation measured using the MOAAS was 4 (range 4–5) and 3 (range 
3–4) in patients receiving Entonox® and midazolam–fentanyl respectively (P = 0·163). 
6.3.4 Intubation rates and completion time 
Caecal intubation rates were 94 and 92 per cent respectively (P = 0·513). Two patients in 
the Entonox
®
 group had an impassable stricture/cancer and one patient had poor bowel 
preparation. In another patient, it was not technically possible to complete the colonoscopy 
beyond the hepatic flexure. In the intravenous sedation group, three patients had poor 
bowel preparation, one patient had a technically difficult colon and one patient had a 
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distally obstructing cancer. There was no difference between the groups in time to reach 
the caecum or total completion time (Table 6.6). 
6.3.5 Psychomotor recovery and time to discharge 
Patients in the Entonox
®
 group had recovered 92·2 (range 89·5–96·0) per cent of their 
baseline psychomotor function immediately upon return to the recovery area, whereas 
recovery in the intravenous sedation group could not be calculated as most patients were 
unable to answer the letter cancellation test due to the effects of sedation. Values at 15 min 
after the procedure were 94 (range 92·5–100) and 68 (range 60·8–71·1) per cent 
respectively. At the time of discharge, significant differences remained and psychomotor 
function had fully recovered only in the Entonox
®
 group (Table 6.5). Patients undergoing 
colonoscopy under intravenous sedation had a longer time to discharge. 
Table 6.5  Recovery of psychomotor function and time to discharge 
Variables 
 
Entonox
®
 
(95%confidence 
intervals) 
Midazolam-
fentanyl 
(95%confidence 
intervals) 
Significance 
p-value 
(Mann 
Whitney U 
test) 
Recovery of 
function  
  Immediate 
  15 min 
  Discharge 
 
 
92% (89.5,96) 
94% (92.5,100) 
100% 
 
  
- 
68% (60.8,71.1) 
87% (82,94.6) 
 
  
  - 
p=0.001  
p=0.003  
 
Time to 
discharge 
(Mean) 
 
28 min 
 
51 min 
 
p=0.001 
 
6.3.6 Patients’ assessment 
All patients completed the satisfaction questionnaire before being given their results so 
that the colonoscopy findings did not affect the satisfaction scores. The median 
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satisfaction score was significantly higher in patients who received Entonox
®
 (96 versus 
89; P = 0·024; 95 per cent c.i. of the difference 4 to 12) (Table 6.6). These differences 
persisted when patient satisfaction was assessed 24 h after the procedure. More patients in 
the Entonox
®
 group would agree to a repeat colonoscopy under the same sedation (89 
versus 73 per cent; P = 0·011. Sixty per cent of patients who received Entonox
® 
reported 
requiring additional sleep compared with 95 per cent of those who had intravenous 
sedation (P = 0·032). Median time to return to normal activities after the procedure was 
1·5 (1–4) h and 9·5 (8–12) h respectively (P = 0·011) in Entonox® and intravenous groups. 
Table 6.6  Patients’, endoscopists’ and nurses’ assessment 
 Patient 
assessment 
Entonox
® 
(n=65) 
Midazolam-
fentanyl (n=66) 
Significance 
(p-value)§ 
Median 
Satisfaction score† 
96.4 (90-100) 89 (20-95) 0.001 
Agree to repeat use 
of same sedation* 
58 (89) 48 (73) 0.011¥ 
Endoscopists’ 
assessment  
   
Caecal intubation*  61 (94) 61 (91.7%) 0.513¥ 
Median time to 
caecum (min) 
18 (6-24) 20 (5-23) 0.812 
Median completion 
time (min) 
26.5 (18-47.5) 31.9 (20.4-51.8) 0.761 
Median difficulty of 
colonoscopy‡ 
17 (10-31) 14 (12-30) 0.714 
Median 
Satisfaction Score† 
 
95 (90-100) 90 (70-100) 0.061 
 Nurses’ 
assessment 
   
Median satisfaction 
score† 
95 (30-100) 90 (20-100) 0.168 
Adequate sedation-
analgesia* 
56 (86) 50 (76) 0.013 
Difficulty in 
manoeuvring* 
3 (5) 14 (21) 0.001 
Values in parentheses are ranges, except *Values are percentages. †On a 100-mm visual 
analogue scale. ‡On a 100-mm visual analogue scale, where O is the easiest, and 100 is 
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the most difficult ever seen- 50 is very difficult. §Mann-Whitney U test, except ¥chi-
squared test. 
6.3.7 Endoscopists’ assessment 
The endoscopists assessed the technical difficulty of procedures carried out with the two 
types of sedative. Median scores for difficulty were similar, as were satisfaction scores for 
sedation (Table 6.6). Analysis of the endoscopists’ perception of difficulty in manoeuvring 
patients during colonoscopy showed that more patients sedated with midazolam–fentanyl 
were difficult to move as compared to the patients receiving Entonox
®
. 
6.3.8 Nurses’ assessment 
There was no difference in nurses’ assessment of satisfaction with either type of sedation 
(Table 6.6). Only three patients in the Entonox
®
 group were difficult to manoeuvre during 
the procedure compared with 14 patients in the intravenous sedation group. 
6.3.9 Effect of type of colonoscopist 
The baseline characteristics were similar for the three types of colonoscopists.  
Table 6.7 Baseline characteristics in the 3 groups 
  Doctors 
N=44 
Nurses 
N=44 
Non-Medical 
N=43 
Age (median) in 
years 
62 60 63.5 
Gender (M:F) 26:18 29:15 25:18 
Intravenous  
  -Midazolam 
  -Fentanyl 
 
 
2.5mg
$
 
75mcg* 
 
 
2.0mg
$
 
75mcg* 
 
 
3mg
$
 
100mcg* 
ASA grade 
Grade 1 
Grade 2 
 
32 
12 
 
31 
13 
 
32 
11 
*= microgrammes. 
$ 
= milligrammes. 
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Subgroup analysis revealed no differences between the three types of colonoscopist in 
terms of pain scores, patient and nurse satisfaction. 
Table 6.8 Patient and attending nurse assessments 
  Doctors 
N=44 
Nurses 
N=44 
Non-Medical 
N=43 
Significance 
P 
Pain Scores 
    -discharge 
    -24 hours 
 
21 
22 
 
24 
24 
 
18 
19 
 
0.9 
0.9 
Patient 
satisfaction  
 
96 
 
95 
 
95 
 
- 
Nurse 
Satisfaction 
 
4.1/5 
 
4.3/5 
 
4/5 
 
0.76 
There were no differences in the groups in terms of time to reach the caecum, completion 
and complications rates, sedation or pain scores and recovery times (table 6.9). 
Table 6.9 Primary and secondary outcomes for all the groups 
  Doctors 
N=44 
Nurses 
N=44 
Non-Medical 
N=43 
Significance 
(p-value) 
Completion Rates 95% 97.5% 92.5% 0.3 
Time to Caecum 14 min 16 min 16.5 min 0.2 
Total time 18 min 19 min 21 min 0.09 
Time to  discharge 38 min 43 min 36 min 0.08 
 
6.4 Discussion 
This randomised controlled trial has shown that sedation with Entonox
®
 effective for 
colonoscopy. Both diagnostic and therapeutic procedures were performed efficiently, with 
a high completion rate with no complications. Patients experienced less discomfort and 
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pain, recovered earlier from sedation and are discharged home faster than those given 
intravenous sedation. Use of Entonox was also associated with higher patient, endoscopist 
and nurse satisfaction scores. 
Colonoscopy can be uncomfortable, necessitating the administration of analgesics and 
sedatives. The commonly used benzodiazepine -opioid combination can cause cardio-
respiratory depression and occasionally death, especially in elderly patients. An important 
reason for this is the lack of a clear dosing regimen and difficulty in dose titration. As 
intravenous sedation causes cardio-respiratory depression, the alternative would be to use 
brief analgesia (with sedation) that offers fast recovery without risk of complications. 
Entonox
®
 clearly seems to fit the bill. It is effective and easy to administer; the patient 
inhales through a special mouthpiece attached to a cylinder and this obviates the need to 
administer additional oxygen through a different nasal cannula. The onset of action is 
rapid, and the effect is apparent within 1-2 minutes. Patients tend to become slightly 
drowsy, but remarkably more relaxed in the initial 2 minutes, which contributes to pain 
relief. 
The primary outcome measured in this study was pain perceived by the patient, which was 
measured at different times after the procedure. Measurement of pain after 24 hours is 
important as the effects of sedation are minimised by then. Pain perception at 24 hours 
also influences patient’s decision to attend for repeat colonoscopy if necessary. 
There were no complications in either group. There is virtually no risk of overdose with 
Entonox
®
 as the patient’s level of consciousness governs his/her ability to maintain the 
flow of gas. There is no risk of inhalation of the gas by colonoscopy staff, as it flows 
through a one-way valve and does not leak into the environment.  
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The total procedure time was similar in both groups. However, psychomotor function 
recovered more rapidly in patients sedated with Entonox
®
, owing to rapid elimination of 
the gas from the body, usually within 30-45 seconds after stopping inhalation. These 
patients were discharged earlier and were able to return to routine activities more quickly 
than those receiving intravenous sedation. With 100% recovery of psychomotor function 
after the use of Entonox
®
 , as also noted previously
155
, there is no apparent reason to stop 
patients from driving home immediately after discharge. The manufacturer has now issued 
guidelines indicating that patients can drive immediately after discharge from the 
endoscopy unit after undergoing any procedure under Entonox
®
.  
Patient satisfaction is another area where current practice is suboptimal and the use of 
Entonox
®
 also addresses this issue. Higher patient satisfaction with Entonox
®
 was related 
to the reduced pain and faster recovery. Entonox
®
 sedation is essentially patient controlled, 
and this probably contributed to greater patient satisfaction as well. Inhalation of the gas as 
necessary, with longer and deeper breaths allowing greater volumes in the lungs, not only 
helps in relieving discomfort and pain, but alleviates anxiety as the patient is in control of 
their own pain relief. The latter contributes to the often discussed and possible placebo 
effect with Entonox
®
.  
Currently,  there is a low uptake of colorectal cancer screening by patients in the USA
156
. 
It is, therefore, essential to optimise the experience of colonoscopy, by minimising 
discomfort and allowing early resumption of normal activities. This will lead to an 
increase in the number of patients willing to undergo the procedure for screening. 
The present results differed from previous studies
78, 81, 157
 on the use of Entonox
®
 for 
colonoscopy in that Entonox
®
 was shown to be superior to intravenous agents. The dose of 
midazolam used in this trial (median 4mg) was comparable to that used in previous 
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studies. Forbes and Collins
81
 used a median of 4.7 mg midazolam, but still concluded that 
intravenous sedation was better than Entonox
®
. Importantly, the doses of midazolam in the 
participant and non-participant groups in our study were similar, hence confirming the 
absence of any bias.  
A limitation of this study is that patients and colonoscopists were not blinded to the type of 
sedation. Even though it has been shown previously that the noise made by Entonox
®
 
cylinders can be masked
78, 157
, the pilot study demonstrated that this is difficult to achieve. 
However, even without blinding, it was possible to address the issues of whether Entonox
®
 
is able to provide sufficient sedation-analgesia and whether it could be adopted in a busy 
endoscopic unit. None of the colonoscopists had previously used Entonox
®
 for sedation, 
and this should reduce any bias. Furthermore, the person collecting the data was blinded to 
the treatment offered.  Another limitation of the trial is that the primary outcome was 
measured using a VAS, as no absolute pain scoring systems are available for colonoscopy. 
However, it was possible to compare VAS scores between the two groups and to establish 
that Entonox
®
 was associated with less pain. Baseline scores were also collected to 
determine whether patients were already in pain before the procedure. Furthermore, there 
are contraindications to the use of Entonox
®
 in patients with history of pneumothorax or 
severe emphysema, limiting the use of Entonox
®
. However, only a small proportion of 
patients fall into this category- 7% in our series. Routine intravenous sedation or propofol 
sedation can be offered to these patients. 
In the current global financial scenario, hospitals look for cost-effectiveness in the 
products they choose, as well as safety, efficacy, ease of use and efficiency. The cost of a 
single cylinder of Entonox is around £110. Each cylinder can be used for around 65 
patients, as seen in our study. This works out to around £1.60 per patient per colonoscopy. 
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On the other hand, the cost of intravenous sedation is around £1 per patient for every 
colonoscopy (Midazolam- £0.73 and Fentanyl £0.23). However, we have shown that 
patients undergoing sedation with Entonox recover faster and can be discharged earlier, 
thereby saving time and bed stay costs. Patients can drive home 30 minutes after Entonox
® 
sedation. These are potential economic benefits for the patients because they no longer 
require taking additional time off work, and do not need an escort to go home after the 
procedure. Entonox
® 
is easy to use and can be administered by nurses or healthcare 
assistants. This potentially lowers treatment costs by avoiding more resource-demanding 
options.  
An agent with shorter duration of action would be desirable for providing sedation in 
colonoscopy; one that permits more rapid recovery of function, while providing good 
patient comfort during the procedure and with a safety profile equivalent to that of 
medications currently in use. We conclude that the use of Entonox
®
 for colonoscopy 
sedation is associated with better sedation-analgesia and faster recovery and discharge 
than intravenous sedation. Furthermore, non-medical endoscopists would be able to 
perform independent colonoscopy (when fully trained) without depending on either nurses 
or doctors for sedation, realising their full potential. We believe that Entonox
® 
can 
potentially be used routinely for providing sedation for colonoscopies, except in patients 
with contraindications to the use of Entonox
®
. 
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Chapter 7 Randomised controlled trial of patient controlled sedation for 
colonoscopy: Target controlled patient-maintained propofol versus Entonox 
7.1 Introduction 
Colonoscopy is characterised by short intervals of discomfort, mostly related to stretching 
of colonic mesentery
158
. Patient controlled analgesia/sedation (PCA) is ideally suited to 
manage this type of pain. PCA is accomplished with a specific pump that delivers a preset 
dose of the medication in response to either the press of a button or, in case of inhaled 
gases, a deep breath through the face mask. There is a growing interest in patient 
controlled sedation for colonoscopy. Several studies
159-161
 have shown that patients 
receiving PCA experience procedure-related satisfaction that is comparable with and in 
some cases, better than, conventional sedation. This satisfaction is partly because it allows 
patients to be in control of their pain relief. The total dosage of drug used tends to be lower 
than that used in conventional sedation, and, thus recovery is reported to be faster.  
For a drug to be effective in a PCA system, it should have rapid-on and rapid-off 
pharmacokinetic properties
158
. In the previous randomised controlled trial (chapter 6), we 
have shown that Entonox
® 
is superior to midazolam/fentanyl for providing analgesia 
during colonoscopy. Entonox
® 
is now the standard of
 
practice in our unit for sedation 
during colonoscopy, and is normally delivered as a patient controlled analgesia. 
Propofol is another drug that has been used most frequently either as a PCA, or target 
controlled infusion (TCI), especially in the endoscopy setting. This sedative agent has 
been shown to be superior to benzodiazepines and narcotics with regard to rapid induction 
of sedation
162
, faster recovery
163, 164
 and equivalent levels of amnesia
165, 166
.  However, as 
discussed previously, Propofol has a narrow therapeutic index and can produce deep 
sedation, resulting in respiratory depression and even apnoea. Because the depth of 
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sedation is a continuum, the doses required for conscious sedation as used in colonoscopy 
is markedly lower than those used for induction of anaesthesia
167
. Deeper sedation can also 
make patient manoeuvring difficult during colonoscopy. Propofol is typically delivered as 
a target controlled infusion (TCI) for various indications. TCI of Propofol enables an exact 
amount of the drug to be delivered, maintaining a preset concentration of Propofol in the 
blood or brain. This technique has previously been used in colonoscopy and Campbell
85
 et 
al modified a TCI pump to achieve patient maintained sedation. However, this 
modification is experimental and its efficacy is not proven in large studies.   
We devised a new protocol for delivering propofol for colonoscopy in our unit, combining 
a target controlled infusion with patient controlled sedation (TCI-PCA). Under this 
protocol, Propofol sedation was initiated with a TCI pump to achieve a preset effect site 
concentration, and subsequently sedation was maintained by the patients using a simple 
patient controlled analgesia pump (PCA) delivering Propofol on demand.   
Though there have been studies
167-169
 comparing Propofol with conventional intravenous 
sedation, there are none comparing it with Entonox
®
. Further to out previous study on 
Entonox
®
, we currently use Entonox
®
 for all colonoscopies. Around 25% of all 
colonoscopies in the United States are now performed using propofol. Therefore, the aim 
of this randomised controlled trial was to evaluate the role of TCI-PCA propofol as a 
sedative-analgesic in colonoscopy compared with Entonox
®
, in terms of analgesic 
efficacy, depth of sedation, manoeuvrability, rate of complications, rate of psychomotor 
recovery and time to discharge.  
7.2 METHODS: 
7.2.1 Study Design 
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This trial was performed in the endoscopy unit at Castle Hill Hospital, Cottingham, United 
Kingdom between January, 2005 and June 2006. The study was approved by the South 
Humber Research Ethics Committee, UK, and the Clinical Trials Unit, Medicines and 
Health Regulatory Authority, and preregistered with the European Clinical Trials 
Database, as well as the International Standardised Randomised Controlled Trials 
Database. It was undertaken according to International Conference on Harmonisation good 
clinical practice standards, including independent on-site monitoring and source data 
verification. 
7.2.2 Inclusion and Exclusion Criteria 
All patients undergoing elective colonoscopy were invited to participate in the trial. They 
received information leaflets (approved by Ethics Committee) two weeks before the 
intended procedure, and also had the opportunity to discuss the trial with the co-ordinator. 
Patients with chronic pulmonary disease, history of colonic resection, intolerance to any of 
the drugs, ASA class IV, those with an allergy to soyabeans/eggs, those with history of 
seizure disorder, sleep apnoea, or difficult intubation, short thick neck or inability to open 
mouth widely, and those unwilling to enter the trial, were excluded from the study 
7.2.3 Randomisation and allocation concealment 
Participants were randomised using the technique of block randomisation. A block size of 
five was used to conceal allocation. The assignments were held in sequentially numbered, 
opaque sealed envelopes. These envelopes were opened sequentially and only after the 
participant's name, address, date of birth and other details were written on the appropriate 
envelope. The colonoscopists were not aware of the location of the envelopes. Neither the 
patients nor the colonoscopists were blinded to the treatment modality after the allocation. 
7.2.4 Interventions  
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After informed written consent was obtained, patients were randomly assigned to receive 
either inhaled Entonox
® 
or TCI-PCA propofol. They were informed about the relevant 
procedure, the reasons for sedation and the technique.  
Patients randomised to TCI-PCA propofol were administered propofol through an 
intravenous cannula using our modified system. The system consisted of a Graseby
®
 
(Watford, Herts, UK) 3400 TCI pump, controlled by a microprocessor system. The 
microprocessor in this pump is pre-programmed with the pharmacokinetic data describing 
the distribution and elimination of Propofol
170
. The anaesthetist entered the patient’s age 
and weight into the microprocessor, and the system displayed the target blood 
concentration and calculated effect site (brain) concentration. The anaesthetist was able to 
manually override the system to alter the concentration in the event of over sedation. 
Patients were given Propofol through the pump to achieve a target concentration of 1.2 
μg/ml/hr. Simultaneously, patients were connected via a Y-connector to another PCA 
(patient controlled analgesia-Graseby, Watford, Herts, UK) pump containing Propofol. 
Patients were given a handset connected to this PCA pump. The press of this handset 
delivered a bolus of 200mcg/kg/ml, with a lockout period of 2 minutes. Patients were 
encouraged to press the button during the procedure, if they wanted to feel sleepier.  
Those randomised to Entonox
® 
were administered the gas through a mouthpiece connected 
to an Entonox
® 
cylinder. This mouthpiece has a one-way demand valve system, which is 
operated by the act of inhalation of the patient and closes down when the patient ceases to 
inhale
77
. Details of delivery of Entonox
® 
are described in chapter 6. 
In both groups, colonoscopy was started once a sedation score (Modified Observer’s 
Assessment of Alertness and Sedation Scale- MOAAS) of 4 was reached. This policy was 
adopted to ensure comparability of both groups. The aim of conscious sedation was that at 
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all times the patient should be able to obey commands, and hence an MOAAS score of 4 
was the target. The anaesthetist was allowed to give intravenous Fentanyl, if patients were 
too uncomfortable during the procedure. 
All patients were assessed continuously during the procedure, as per the guidelines of the 
British Society of Gastroenterology
130
. Patients were allowed to recover normally after the 
procedure and discharged by the recovery room staff in accordance with the existing 
protocols (table7.1).  
Table 7.1 Discharge criteria, sedation and manoeuvrability scoring  
Discharge Criteria 
1. Patient responds appropriately to questions and is able to communicate clearly.  
2. Patient is able to sit upright for at least 5 minutes and is able to tolerate 
liquids/solids. 
3. Patient is able to dress independently and use the toilet. 
Sedation Scoring (ASA/MOAAS) 
     5- responds readily to name spoken in a normal tone 
     4- lethargic response to name spoken in a normal tone 
     3- responds only after name is called loudly and/or repeatedly 
     2- responds only after mild prodding or shaking 
     1- responds only after painful trapezius squeeze 
     0- no response after painful trapezius squeeze 
Degree of manoeuvrability (Manoeuvrability scoring) 
1. Patient was awake and responded to all verbal commands 
2. Drowsy and responded to most of the commands to move (>50%) 
3. Patient was able to move to some commands (<50%) 
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4. Quite difficult to manoeuvre and/or no response to verbal commands to move 
(<10%) 
7.2.5 Colonoscopy 
All colonoscopies were performed according to a standard operating procedure with the 
Pentax video colonoscopes (Pentax, Hamburg, Germany). Colonoscopy was carried out by 
three different types of colonoscopists: doctors (colorectal consultants), senior nurses with 
experience of more than 5000 colonoscopies, and non-medical colonoscopists. Completion 
to the caecum was documented based on two of three landmarks- ileocaecal valve, 
appendiceal orifice and the tri-radiate fold. 
7.2.6 Data collection and measurements 
Demographic and clinical features recorded for all patients included age, sex, weight, 
height, clinical indications, past and family history, results and procedural findings. 
All participants completed a Hospital Anxiety and Depression questionnaire, baseline 
letter cancellation test and scored pain on a 100-mm visual analogue scale before 
randomisation, but after giving consent to be included in the trial. Patients who refused to 
participate were asked their reasons for doing so, such as past experience with any of the 
drugs or frightened by the idea of deciding own sedation. These patients also completed 
questionnaires before and after the procedure. 
The primary end-point was the degree of pain experienced by the patient during the 
procedure assessed on a 100-mmvisual analogue scale (VAS). Measurements were taken 
immediately, and at15-min intervals after the procedure until discharge (table 6.2). 
Patients also marked a VAS at 24 hours after colonoscopy after allowing recovery from 
sedation. 
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The secondary end-points included degree of sedation, patient, nurse and endoscopist 
satisfaction, complication rate, time taken to reach caecum and total colonoscopy time, 
completion rate, degree of psychomotor recovery and time to discharge (table 6.2). 
The degree of sedation was measured by the anaesthetist on the Modified Observer’s 
Assessment of Alertness/Sedation scale (MOAAS; table 7.1), at 1-min intervals 
throughout the procedure and 5-min intervals during recovery (by the research co-
ordinator). 
Patient satisfaction was measured at discharge and 24 hours after colonoscopy by means 
of a 100-mm VAS, which was incorporated into a previously validated patient satisfaction 
questionnaire for colonoscopy
109
. Nurse and Endoscopist satisfaction was measured using 
a similar 100-mm VAS, as part of a different questionnaire. 
Psychometric tests were administered immediately upon arrival of the patient to the 
recovery area and then at 15-min intervals until discharge. Inability of the patient to 
perform the tests immediately on return to the recovery room was noted. Psychomotor 
recovery was assessed using the Letter cancellation test
153
, which measures concentration 
and perception. The patient was presented with a sheet of paper containing a printed 
paragraph of 20 rows of 40 randomly arranged letters, and then asked to read from left to 
right and top to bottom, simultaneously marking through all the occurrences of a 
predesignated letter. The number of lines completed in 120 seconds and the number of 
times the pre-designated letter was correctly identified were recorded. Post-procedure 
scores were compared with baseline values and results presented as percentage recovery of 
psychomotor function. This test has previously been shown to be an accurate means of 
measuring psychomotor recovery in the postendoscopy setting
153, 154
. 
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The efficacy of sedation was evaluated by colonoscopists in terms of the rate of caecal 
intubation, time taken to reach the caecum, total colonoscopy time and complication rate. 
The colonoscopists also completed a questionnaire concerning the degree of sedation, 
difficulty of colonoscopy and difficulty in manoeuvring the patient. The difficulty in 
manoeuvring was measured using a manoeuvrability scoring system (table 7.1). 
After the procedure the attending nurses completed a questionnaire for each colonoscopy 
concerning the perceived adequacy of sedation, ability of the patient to assist with moving 
during the procedure, and maximum depth of sedation. 
Sedation complications were defined as a prolonged drop in oxygen saturation below 85%, 
with the need for positive pressure ventilation using a bag-valve system. Other 
complications recorded include prolonged drop in blood pressure and heart rate. 
7.2.7 Statistical Analysis and sample size calculation 
This was an equivalence study. The estimates of sample size were based on the primary 
outcome measure, which was the degree of pain experienced by the patient and measured 
using the 100-mm VAS. The variance was assumed to be similar in both groups to be 
around 30 points, as determined by previous studies
87
 as well as our own randomised 
controlled trial
171
. The hypothesis was that the two drugs could be considered equivalent if 
the 95% two-sided confidence interval for the treatment difference fell wholly within the 
interval +/- 15mm. If the difference between Propofol and Entonox groups is less
 
than this 
predetermined equivalence margin (-15 mm to +15 mm), then the treatments would
 
be 
considered equally equivalent.  
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Using a statistical power of 80% and a 2-sided level of significance of 0.05, it was 
calculated (based on formula from Jones and colleagues
172
) that a total sample size of 96 
patients would be required to test the hypothesis.  
All analyses followed the intention to treat principle. No interim analyses were performed 
before analysis of the primary endpoint. Demographic and baseline characteristics were 
compared by two-way ANOVA for continuous data and Fishers exact test for categorical 
data. Differences in proportion were tested using the chi-squared test, or Fisher’s exact test 
for smaller samples. VAS scores, sedation scores, postoperative time to discharge and 
results of the letter cancellation test were evaluated using the Mann-Whitney U test. All P 
values are two tailed. 
7.3 Results  
7.3.1 Patients 
During the study period, a total of 112 patients were assessed for eligibility (figure 7.1), 
out of which 12 patients were excluded after eligibility assessment: 8 were ineligible (7 
patients were post-surgical resection, 1 patient had severe chronic obstructive airways 
disease) and 4 patients refused to participate. Among those patients who refused to 
participate, 2 patients said that they did not want to participate in any trial as they were too 
anxious and the remainder said that they had inhaled Entonox
® 
in the past and were not 
happy to participate. The remaining 100 patients were included in the trial, of which 50 
each were randomised to receive either TCI-PCA propofol or Entonox
®
. 
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Figure 7.1. Participants in the study and randomisation 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The two groups had similar baseline characteristics, ASA grades, and there was no 
difference in pre-procedure anxiety scores (7.5 (range 4-11) versus 8.4 (range 3-10); 
P=0.214) (table 7.2). There were no complications in either group.  
7.3.2 Medication 
The median doses of TCI, PCA and total propofol were 37mg, 137mg and 174.8mg (range 
148,210). Patients pressed the PCA handset button for a median of 4 times (range: 1-7) 
during each procedure, and 96% of these attempts were successful. In the Entonox
® 
group, 
112 patients were assessed for 
eligibility 
12 patients were excluded   
 1. Not meeting inclusion     
criteria (n= 8) 
 2. Refused to participate 
(n=4) 
   
50 patients completed trial 
50 randomly assigned to  
Entonox  
50 patients completed trial 
         50 randomly assigned to  
Propofol sedation 
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patients inhaled the gas until the caecum was reached and thereafter only 30% (15/50) 
continued to inhale Entonox
®
. 
Table 7.2  Baseline characteristics of patients in both groups  
 Entonox
®
 TCI-PCA propofol 
Gender (M:/F) 29:21 24:26 
Median age in years 
(range) 
56.1 (42, 66) 60.4 (40,71) 
ASA class      1 
                      2 
                     3 
08 (16%) 
33 (66%) 
               09 (18%) 
10 (20%) 
29 (58%) 
11 (26%) 
Median Pre-procedure  
Anxiety score (median) 
7.5 (4-11) 8.4 (3-10) 
Diagnosis   
      Colorectal Cancer 6 4 
      Colorectal Polyp 12 16 
      Diverticulitis 8 12 
      Colitis 7 3 
      Others/normal  21 16 
 
7.3.3 Primary Outcome- Pain Scores 
The pain score at discharge was 15.38 (range:14-20) in the Entonox
® 
group versus 17.31 
(range:10-20) in the TCI-PCA propofol group (odds ratio, 1.03;
 
95 percent confidence 
interval, -0.89 to 5.02; P = 0.16). At 24 hours,
 
the pain scores were 16.14 (range 14, 21) 
with Entonox
® 
and 17.89 (range: 10,20) with TCI-PCA propofol. (P=0.16). The 95 percent 
confidence interval
 
for the absolute difference in pain scores was -0.89 to 5.02 (table 7.3). 
This difference was well within the preset limit of +/- 15.  The similarity in the overall 
pain scores remained
 
consistent across all points of measurement.  
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Table 7.3 Visual Analogue Scores  (Primary outcome measure) 
Pain scores on 
VAS 
Entonox Propofol  Significance 
(p-value) 
At discharge  
 
15.38 (IQR14,20) 17.31 (IQR 10,20) 0.16 (-0.89,5.02) 
15 minutes 15.78 (IQR 12,20) 16.54 (IQR 10,20) 0.16 (-0.93, 5.06) 
At 24- hours post 
procedure 
16.14 (IQR 14,21) 17.89 (IQR 10, 20) 0.16 (-0.88, 5.03) 
 
7.3.4 Secondary Outcomes 
7.3.4.1 Depth of sedation 
The median depth of sedation was 4 (IQR 5-4) and 3 (5-3) in the Entonox
® 
and TCI-PCA
 
propofol groups respectively (P=0.091).  
7.3.4.2 Manoeuvrability during the procedure 
The median manoeuvrability scores were 1 (range 1-2) and 2 (range 1-3) in the Entonox
®   
and TCI-PCA groups respectively (P=0.2).  
7.3.4.3 Completion Rates and procedure time 
Caecal intubation rates were 96 and 98 percent respectively in the Entonox
® 
and TCI-PCA 
propofol groups (P=0.551) (table 7.4). One patient in the Entonox
® 
group had an 
impassable stricture, and another had poor bowel preparation leading to incomplete 
colonoscopy. In the TCI-PCA propofol group, the single incomplete colonoscopy was due 
to an obstructing lesion in the hepatic flexure.  
There was no difference between the groups in time to reach the caecum or total 
completion time (table 7.4).  
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Table 7.4 Patient assessment 
 Endoscopist 
Assessment 
Entonox Propofol Significance 
(p-value) 
Caecal intubation 
(%) 
48/50 (96%)  49/50 (98%) 0.55 
Median time to 
caecum (min) 
13 (10,16.25) 14 (12, 23.25) 0.18 
Median completion 
time (min) 
22.6 (18,28) 20.4 (17,23) 0.09 
Median difficulty of 
colonoscopy 
24 22 0.79 
Satisfaction 
 
96 (95,98) 98 (96,100) 0.26 
Nurses assessment     
Median satisfaction 
score (out of 100) 
95 (93.4,98) 97 (95, 99) 0.34 
Adequate sedo-
analgesia 
56 54 0.2 
Maneouvrability 
Score 
1 2 0.2 
Patient 
Assessment 
   
Median 
Satisfaction score 
94  96 (94,98) 0.10 
Agree to repeat use 
of same sedation 
46 48 0.56 
Remember start of 
procedure 
39/50 42/50 0.39 
Remember end of 
procedure 
41/50 45/50 0.35 
*Interquartile range in brackets 
7.3.4.4 Psychomotor recovery and time to discharge 
Patients in both groups demonstrated rapid recovery of psychomotor function after the 
procedure (table 7.5). However, patients in the Entonox
® 
had complete recovery of 
psychomotor function at discharge compared to the TCI-PCA propofol group, where the 
median recovery was 96% (IQR, 94,100; P=0.04). The median time to discharge was 
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27.86 min (22, 30.5) and 28.08 (23,32) in the Entonox
® 
and TCI-PCA propofol groups 
respectively (P=0.86).   
Table 7.5 Recovery of psychomotor function and time to discharge 
 
Variables 
 
Entonox (IQR) Propofol (IQR) Significance 
Recovery of 
function  
  Immediate 
  15 min 
  Discharge 
 
 
92% (89.5,96) 
99% (98.5,100) 
100% 
 
  
90% (84,92) 
94% (91,99) 
96% (94,100) 
 
  
p=0.79 
p=0.08  
p=0.02 
 
Time to 
discharge 
(Mean) 
 
27.86 min (22,30.5)  
 
28.08 min (23,32) 
 
p=0.86 
 
7.3.4.5 Patient, Nurse and Endoscopist satisfaction 
All patients marked their satisfaction questionnaire before being given their colonoscopy 
results so that the findings of colonoscopy did not affect the satisfaction scores. The 
median satisfaction scores were 96 (range: 95-98) and 98 (96-100) in the Entonox
® 
and 
TCI-PCA propofol groups respectively (P=0.261) (table 7.4). The attending nurses and 
endoscopists found no differences in their assessment of satisfaction with either Entonox
® 
or TCI-PCA propofol sedation-analgesia (table 7.4).  
7.3.4.6 Amnesia and Additional sleep and return to normal activities 
All patients completed a satisfaction questionnaire at 24 hours after the colonoscopy. This 
questionnaire also included questions regarding the number of additional hours of sleep 
required and the time taken to get back to routine work. The resumption of normal 
activities was at a median of 2-4 hours and 6 hours respectively in the Entonox
®
 and TCI-
PCA propofol groups (P=0.021). 54 percent patients in the Entonox
®
 group reported 
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requiring additional sleep, as compared to 96 percent in the TCI-PCA propofol group 
(p=0.03). 
7.4 Discussion 
The chief finding of this trial is that TCI-PCA propofol is equivalent to Entonox
®
 in 
analgesic efficacy. Furthermore, in terms of depth of sedation, manoeuvrability, rate of 
completion, complication rates, satisfaction rates, completion rates and time to discharge, 
the results of TCI-PCA propofol are similar to Entonox
®
.  
Propofol is a rapidly acting sedative drug with a short duration of action and has attracted 
increasing attention as it is well tolerated by patients and dramatically reduces recovery 
time after successful sedation, in comparison to routine intravenous sedation
173, 174
. 
However, three primary concerns have been expressed and this has led to a relatively 
lesser uptake of propofol for sedation during colonoscopy in the United Kingdom. These 
relate to its narrow therapeutic range, lack of an antidote in cases of over-sedation and 
difficulty in manoeuvring patients during colonoscopy. In order to overcome these 
problems, we modified the technique of propofol administration to make it a TCI-PCA 
propofol regime. The aim was to ensure that a low dose of Propofol was used; 
simultaneously providing effective pain relief and ensuring that the patient was awake 
enough to move as required during the colonoscopy. The current protocol for propofol 
administration has enabled these goals to be achieved in this trial. There were no 
complications with the use of Propofol; verbal communication was not lost in any of the 
patients, and haemodynamic stability was maintained, even in the elderly patients. 
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Entonox
®
 provides effective sedation and analgesia for colonoscopy and is very safe. We 
chose to compare Propofol with Entonox because we have previously demonstrated that 
the latter is more effective than routine intravenous sedation, including opiates and 
benzodiazepines
171
.
 
We found in our study that recovery of psychomotor function was initially similar with 
both Entonox
® 
and modified TCI Propofol. However, at discharge, only Entonox
®
 patients 
had complete recovery of psychomotor function. Currently, the manufacturer recommends 
that patients having colonoscopy under Entonox
®
 can drive home after discharge. 
However, restrictions exist on patients having propofol for colonoscopy, in terms of 
requiring to be accompanied home and a need for an adult carer for 24 hours after the 
procedure. Though both Entonox
®
 and TCI-PCA propofol are equally efficacious and 
allow comfortable colonoscopy, Entonox
® 
is easy to administer, provides faster recovery 
(both immediate and subsequent 24 hour recovery) and permits patients to drive home 
after the procedure, as compared to propofol. Furthermore, the current guidelines require 
anaesthetist presence when patients are being sedated with propofol. This need for an 
additional doctor seems non-feasible in the current budgetary constraints of most hospitals 
in the United Kingdom. There is increasing data, especially from the United States, that 
nurses can safely monitor and administer propofol during colonoscopy. However, the 
evidence is not sufficient enough yet. We believe, based on these advantages, that 
Entonox
® 
should be used routinely for all colonoscopies (except patients with 
contraindications) whereas TCI-PCA propofol could be used for patients needing higher 
sedation.  
Both Entonox
® 
and propofol are associated with higher patient satisfaction and pain relief. 
There are suggestions that a placebo effect (due to patient control) could explain the better 
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outcomes. We do agree that a placebo effect contributes partly to the effects of both 
Entonox
® 
and propofol.  
A limitation of this study is that patients and colonoscopists were not blinded to the type of 
sedation. However, even without blinding, it was possible to address the issues of whether 
TCI-PCA propofol was as efficacious as Entonox
®
, and whether both sedation regimes 
could be adopted in a busy endoscopic unit. Secondly, we started colonoscopy when the 
MOAAS score of 4 was reached, rather than wait for the target concentration of Propofol 
to be achieved. We adopted this methodology to enable comparability in both groups and 
also because the aim of all sedation in colonoscopy is to provide conscious sedation.  
As discussed before, hospitals seek cost-effectiveness in the products chosen for patients. 
The cost of a single cylinder of Entonox
® 
is around £110. Each cylinder can be used for 
around 65 patients, resulting in a cost per patient of £1.60. On the other hand, the cost of 
each 20ml ampoule of propofol is around 4.18, which is the cost per patient per 
colonoscopy. There is a further expense with propofol in that an additional anaesthetist (or 
a suitably trained nurse) is required per colonoscopy, which is impossible to achieve in the 
current financial criteria.  
We chose to adopt the model of equivalence testing for this study. We have already 
demonstrated that Entonox
® 
is superior to conventional midazolam/fentanyl sedation for 
colonoscopy (refer chapter 5) and, hence, Entonox
®
 is the standard sedation practice in our 
unit. In this study, we, therefore, aimed to determine if propofol is as efficacious as 
Entonox
® 
and hence the equivalence protocol.  
In summary, both our novel method of administering Propofol as well as Entonox
®
 
inhalation provide effective sedation-analgesia, and are associated with a high degree of 
patient and endoscopist satisfaction. The depth of sedation seems appropriate, allowing 
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patients to be easily manoeuvred during the procedures. However, there is a need for 
further randomised controlled trials to compare different methods of delivering propofol, 
and a direct comparison with different agents for sedation. 
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Chapter 8 Artificial Neural Networks to predict the presence of significant pathology 
and subsequent need for lower gastrointestinal endoscopy in patients presenting to 
routine colorectal clinics 
8.1 Introduction 
 
The question most frequently asked in a clinic when seeing patients with colorectal 
symptoms is “Does this patient have any significant colorectal pathology and does he/she 
need a Lower Gastrointestinal Endoscopy (either colonoscopy or flexible sigmoidoscopy- 
LGE)?” Clinicians are currently unable to predict accurately which patients with colorectal 
symptoms will have polyps, cancer or colitis, and hence warrant referral for LGE. 
The current available methods for such prediction are clinical assessment and linear 
statistics. Clinical assessment suffers from a degree of inaccuracy leading to around 21%-
39% of unhelpful/unnecessary colonoscopies
59
, as shown in high-volume European 
centres. The two week criterion
175, 176
, which was developed in order to overcome this, has 
not been entirely successful. Chohan et al
177
 have shown in a review of fast track referrals 
under the two week criterion that overall only 14% of the fast-track patients were 
diagnosed with colorectal cancer. The majority, therefore, had no abnormal findings. 
Algorithms based on expert systems are cumbersome and have not been shown to be better 
than clinical decision making 
102, 178
. 
Artificial neural networks (ANN) have previously been used for a number of medical 
classification tasks
179-181
. These are computational methodologies that perform multi-
factorial analyses. One of the desirable aspects of these dynamic software programmes is 
the ability to determine complex relationships between variables in biological data, based 
on weighting of these variables when presented, while not requiring any background 
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knowledge of diagnostic rules
181
. Our own previous work has shown that ANN are capable 
of accurately predicting outcomes in patients treated for colorectal cancer
102
 and also in 
patients who underwent anal sphincter repair
103
. In both these studies, ANN were shown to 
be more accurate than clinicians and statistical programmes. However, ANN have 
previously not been applied for diagnostic triage of patients with colorectal symptoms.  
The aim of the present study was to develop, train and validate ANN algorithms capable of 
identifying accurately individual patients attending routine colorectal clinics likely to have 
a positive diagnosis (cancer, polyp, or colitis) necessitating a lower gastrointestinal 
endoscopy, to externally validate the networks in the primary care and to compare them 
with clinicians’ diagnostic accuracy.  
8.2 Methods  
This is a prospective study on the use of ANN to identify patients attending for lower 
gastrointestinal endoscopy (LGE) at high risk for colorectal cancer, polyps or colitis. The 
study was based at the Academic Colorectal Unit, Castle Hill Hospital, Cottingham, 
United Kingdom from April 2004 to March 2005. Research Ethics Committee approval 
was obtained. The study was monitored by and conducted according to the International 
Committee on Harmonisation -Good Clinical Practice (ICH-GCP) standards. 
8.2.1 Participants and study design 
300 consecutive patients undergoing lower gastrointestinal endoscopy (including 
colonoscopy and flexible sigmoidoscopy) were recruited for the study. All participants 
(aged 18 and over) were initially seen in a colorectal clinic with lower gastrointestinal 
symptoms. The Consultant team then made the clinical diagnosis and referred these 
patients for LGE. These patients were recruited for the study. Those patients from the 
clinic who were not referred for further investigations included patients who were deemed 
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to have anal canal type lesions (eg. fissures, haemorrhoids) and those who did not warrant 
any further investigations. 
The exclusion criteria included patients with previous colorectal cancer resection, past 
history of inflammatory bowel disease, colorectal polyps or diverticular disease and those 
refusing to participate in the study. Patients were sent an invitation letter with a detailed 
information leaflet two weeks before recruitment and had the option of discussing the 
study with the trial conductors before the procedure.   
All participants then signed an approved consent form and answered a symptom 
questionnaire specifically developed for this study. After the procedure, patients were 
discharged as per the existing protocols in the unit. The results of the LGE were then 
collated with the questionnaires. Demographic and clinical data was also collected for all 
participants on a separate data collection form. All such data including the responses from 
the questionnaire were then entered into a database. 
8.2.2 Development of the questionnaire 
The questionnaire used for this study was specifically developed and internally validated 
using peer review method. The peer review group included colorectal consultants, senior 
colorectal fellows, colorectal specialist nurse and non-medical colonoscopists, as well as 
nurses. Pilot studies were conducted with the first three versions of the questionnaire and 
modifications introduced based on both patient feedback as well as network performance. 
The fourth questionnaire incorporated all the changes from the previous versions and 
eventually was adopted for use in this study. 
The questionnaire was constructed on the basis of a typical clinical interview with the 
patient who presents for the first time in a colorectal clinic with lower gastrointestinal 
symptoms. It does not include advanced laboratory blood tests or imaging results or 
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endoscopy outcomes. Each questionnaire takes around 4-5 minutes to answer and contains 
typically 40 yes/no/not applicable type responses. 
8.2.3 Development and internal/external validation of the ANN 
The following figure provides an overview of the ANN training and validation: 
Figure 8.1 ANN training and validation 
1. Design
2. Train
3. Validate
4. Apply
Input
variables
Prediction of outcome
 
8.2.3.1 Design 
We used a fully connected multilayer feed forward network since the analytical power of 
this type of network has already been proven in different studies
102, 182
. A more 
comprehensive description of neural networks can be found elsewhere
183-185
. The networks 
were constructed by means of two general-purpose neural-network software programmes – 
Brainsheet
®
 and Neuro XL Predictor for Excel
®
 (version 1). The number of units in the 
input layer was determined by the number of input data values. The number of units in the 
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middle layer was chosen by experimentation. Several different networks were constructed 
containing varying numbers (two to 15) of units in the middle layer. The output was coded 
as either the presence (1) or absence (0) of any one the following three conditions: polyps, 
colorectal cancer or colitis. These three conditions are the most common yet significant 
findings in patients presenting to any colorectal clinic.  
8.2.3.2 Training 
Data from the first 100 patients during the initial study period were used to train the ANN. 
These were a separate set of 100 patients and were not included in the study. 
Subsequently, data from the next set of 100 patients was used to train and test the ANN. 
During training, the input variables were entered as either continuous or categorical data, 
whereas the output variables were entered as binary variables. The network was allowed to 
run and make a prediction; subsequently, the software correlated the network output with 
the actual outcome. If the network was incorrect, then a process of back propagation 
readjusted the hidden weights within the network until the correct prediction was 
achieved. This process was automatically repeated, and after thousands of such repetitions 
the network was trained (table 8.2). In order to decide when to terminate the training 
process to achieve optimum performance and to avoid overtraining, the training was 
terminated when the sum of squares error with respect to the validation data set was at a 
minimum.  
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Figure 8.2 ANN training by back-propagation 
 
 
 
 
 
 
 
 
 
8.2.3.3 Internal validation 
Data from the next set of 200 patients was then used for internal validation. Patients in this 
group were recruited after the end of first recruitment in order to achieve temporal 
staggeration. During validation, the actual outcome was concealed from the networks, and 
the predictive accuracy was compared with the actual outcome. 
8.2.3.4 External Validation 
Once the network was internally validated, it was presented to the community medical 
practice for external validation. A primary care practice (general practice) in Hedon, Hull 
was chosen because this practice offered independent LGE services. 50 consecutive 
patients presenting at this practice with colorectal symptoms, and subsequently posted for 
LGE were recruited for the study. These patients completed the validated questionnaire 
Mean Error: Given Results vs. Neural 
network prediction
0
0.1
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0.4
1 26 51 76 101 126 151 176 201 226 251
Cycles
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r
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before their LGE.  The data from these questionnaires were fed into the trained network 
and the predictions made by the trained network were then compared with actual results. 
8.2.4 Comparison with clinicians 
Four clinicians were then provided with the completed questionnaires, and asked to predict 
for each patient the presence/absence of a positive colorectal pathology, and if present, 
which one of the four diagnoses mentioned above was applicable. The clinicians’ 
predictions were then compared with the actual findings. These clinicians were either 
senior colorectal trainees or post-training fellows or consultant colorectal surgeons. 
Personal data and the results of the neural networks were not available to the clinicians. 
8.2.5 Statistical Analysis 
The results of comparison between the performance of the ANN and the actual findings, as 
well as that of the clinicians is expressed in terms of overall accuracy, sensitivity, 
specificity, positive and negative predictive values.  
Receiver operating characteristic (ROC) curves were computed for training, internal 
validation and external validation data. Their areas (area under ROC curve- AUC) were 
calculated using the ROC web-based calculator. Standard errors were calculated according 
to the method of Hanley and Mc Neill.   
Sensitivity was defined as true positives/(true positives + false negatives), specificity as 
true negatives/(true negatives + false positives), positive predictive value as true 
positives/(true positives + false positives), and negative predictive value as true 
negatives/(true negatives + false negatives). 
All statistical analyses will be done using SPSS
®
 14.0 for Windows. 
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8.3 Results 
The demographic characteristics including findings of LGE are shown in table 1. The data 
from the first group was used to train the ANN (April to September, 2004; n=100). Data 
from the second group was used for internal validation (September, 2004 to April 2005; 
n=200). The two groups were similar in terms of demographic features and distribution of 
diagnoses (table 8.1). 
Table 8.1 Demographic features in all the groups 
 
 
 
 
Group 1 (training) 
 
N= 100 
Group 2 
(prediction) 
N= 200 
External 
validation 
N= 50 
Age*  58.2 (38-84) 
 
60.4 (29-78) 54.6 (32-58) 
Males:Females 42:58 
 
106:94 22:28 
Diagnosis  
 
  
   -Normal 49 (49%) 
 
88 (44%) 25 (50%) 
   -Colitis 14 (14%) 
 
28 (14%) 06 (12)% 
   -Polyp 22 (22%) 
 
48 (24%) 11 (22%) 
   -Cancer 10 (10%) 
 
26 (13)% 05 (10%) 
   -Miscellaneous/ 
    Diverticular  
    disease       
05 (5%) 10 (5%) 
 
03 (6%) 
* in years and range in brackets. 
 
8.3.1 Internal Validation of the ANN 
The best ANN models selected for analysis achieved an accuracy of 90% in predicting the 
presence of significant pathology- polyps, colitis, or colorectal cancer at internal validation 
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(table 8.2). The ability of the ANN to determine accurately the absence of any significant 
pathology (NPV) was 95%. In other words, the network wrongly predicted in 5% patients 
that there was no significant pathology. All these patients had either colitis or polyps. All 
colorectal cancers were accurately diagnosed.  
Table 8.2 Results of Internal and External Validation 
 
 
                                 INTERNAL VALIDATION 
  Accuracy% 
(95% CI) 
Sensitivity% 
(95% CI) 
Specificity% 
(95% CI) 
PPV NPV 
Test 
N=100 
95% 94% 96% 95% 94% 
Predict 
N=200 
90% 
(180/200) 
87-94 
88.2% 
(85.3, 91.1) 
91.8% 96% 98% 
 
EXTERNAL VALIDATION 
GP-EV* 
n=50 
89.6% 
(45/50) 
(82-96) 
86.4% 
(84.3, 88.5) 
92.9% 90.4% 89.65% 
* External validation group at General practitioner’s clinic 
Table 8.3 compares the performance of the 40, 35, 25 and 20 factor models on the training 
and test data. It is clear that the performance of the models deteriorates significantly with 
reduction in the number of variables to less than 40. Hence, the 40-factor model was 
selected, in view of its good calibration and best fit.  
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Table 8.3 Performance of the ANN models on training data 
 
 
 
 
 
Measure 
Number of factors 
35 40 45 
Area under 
The ROC 
0.812 0.954 0.96 
Sensitivity 76.4 88.2 89.1 
Specificity 81.6 91.8 91.5 
 
The ANN model was reasonably well calibrated and accurate as shown in table 8.4. The 
table also shows the mean square error statistics, along with 95% confidence intervals, 
supporting the hypothesis that the fit is robust across the range of operation.  
Table 8.4 Comparison of ROC curves for all groups 
 
  ROC curve 
(Area under 
the curve) 
Standard 
Error 
95% Confidence 
intervals 
Internal  
validation 
0.954 0.0152 0.92, 0.98 
External 
validation 
0.932 0.017 0.90,0.962 
Clinician 0.836 0.026 0.8,0.868 
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The following ROC curves (figure 8.3) for the selected ANN model in internal validation  
and external validation show an area under curve consistently above 0.90, indicating a  
high degree of accuracy and reliability.  
 
Figure 8.3 –ROC curves for all data sets 
 
A. ROC curve for test and train data (area under the curve = 0.98) 
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B. ROC curve for internal validation data set  
     (Legend: 1. Middle line (blue) - ROC curve; 2. Top (yellow) & bottom (pink) lines- 
95% confidence interval of the ROC curve) 
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C. ROC curves for external validation (area under curve = 0.932)  
ROC curves for external 
validation
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8.3.2 ANN versus Clinicians 
 The overall accuracy of the clinicians was 75% (95% CI; 59, 87), which was significantly 
lower than the accuracy of the ANN (table 8.5). The AUC for ANN for prediction of the 
outcome variables were significantly superior to the Clinicians. Similarly, the ANN 
proved superior in terms of NPV, PPV, sensitivity and specificity.  
 
Table 8.5   Clinicians versus ANN 
 
 
  Accuracy 
(95%CI) 
Sensitivity Specificity PPV NPV 
ANN* 
(n=200) 
90% 
(87-94) 
88.2% 
(85.3, 91.1) 
91.8% 96% 98% 
Clinician* 
(n=200) 
75% 
(69-83) 
72.5% 76.5% 77% 73% 
* 95% confidence intervals in the brackets 
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8.3.3 External Validation 
The details of the demographic features and diagnosis in patients in the external validation 
group are shown in table 8.1. The predictive accuracy of the ANN model in the external 
validation group was similar to the internal validation group and so were the sensitivity, 
specificity, positive and negative predictive value (table 8.2). The individual accuracies for 
the ANN in the external validation group were 100%, 87% and 92% respectively for 
colorectal cancer, colitis and polyps. Figure 8.3 demonstrates the AUC for ANN in the 
external validation group. 
8.4 Discussion 
The current study has shown that ANN programmes can be trained to predict the presence 
of significant pathology in patients presenting with colorectal symptoms to routine clinics. 
The algorithm performed equally well in the external population and was clearly superior 
to Clinicians. 
There are two salient aspects of the current study- the development of the questionnaire 
and the training of the ANN. The questionnaire is an essential component of such artificial 
intelligence programmes and has to be clinically relevant as well. The questionnaire that 
was developed for this study was modelled on simple physician-patient clinical encounter 
scenario. It is based on the belief that any predictive instrument can only be useful if it 
uses exactly the same data that is available to the clinicians, as the possible future 
application of such a decision tool is either in primary/general practice or the first clinical 
consultation in tertiary care. Our ANN model used only data from clinical history and 
physical examination. Commercially available ANN software can be used in any standard 
laptop or desktop computer. We envisage that when patients first present to a family 
doctor (General Practitioner), the use of this tool after clinical assessment should support 
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the doctor in making a decision whether the patient needs to be urgently referred to the 
specialist colorectal / gastroenterology services. Likewise, a colorectal surgeon or 
gastroenterologist should be able to use this tool to aid his decision regarding further 
investigations for the patient. In patients who present with obvious sinister symptoms (for 
e.g. Change of bowel habits, weight loss and pr bleeding), it is generally easy to make a 
clinical decision. However, in patients with borderline symptoms (for e.g. a 45 year old 
man with fresh per rectal bleeding or change of bowel habits), it becomes difficult to 
decide whether the symptoms are sinister enough to warrant an urgent LGE. It is such 
scenarios where the presence of accurate decision tools will play an important role. The 
clinician could ask the patient to complete the questionnaire while waiting to be seen, and 
the same could be fed into the computer, aiding decisions to be made. 
The second crucial feature of the study was the development and training of the ANN. As 
shown in the results section, the final version of the ANN performed well in terms of 
ability to identify the presence of significant pathology. The network was highly accurate 
in diagnosing colorectal cancer, polyps and colitis. The models generated were well 
calibrated and performed well on data prospectively collected at a later date at the same 
institute as well as an external practice. For a diagnostic algorithm to be performing well 
and be useful, it should be robust enough to be used in different clinical settings. The ANN 
model developed in our study proved reasonably portable and performed well in the 
external data set derived from a primary care practice. The AUC as well as sensitivities 
and specificities were comparable in both groups of data. 
Mean negative predictive values were high for the ANN model in predicting the presence 
of significant pathology in both internal and external data. This implies that the ANN can 
be relied upon to identify patients who do not have sinister pathology and, hence, 
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conceivably such patients can either be discharged or arranged for more routine clinical 
follow up. This strategy can have a positive impact on health-care resources and lead to 
more efficient utilisation of endoscopy services, though the current study does not focus 
on this aspect.  
This is the first study of this kind to assess the role of ANN in reducing endoscopy 
workload. In this study, 162 patients had a procedure wherein the colon was normal. The 
ANN was able to accurately predict this in 158 patients. Hence, a large number of LGE 
were preventable with the use of ANN, though it is difficult to determine the exact 
number. Previous use of ANN in endoscopy have been for different aetiologies, like 
predicting outcomes after GI bleeds
104, 186
, classifying dyspepsia
187
, discriminant analysis 
of atrophic gastritis
188
 and others.  
Furthermore, with the introduction of screening programmes, there is a different set of 
patients (asymptomatic) presenting for endoscopies. In order to assess the role of ANN in 
this group, we are currently setting up a new trial involving different hospitals, and aim to 
include these patients as well.  
In retrospect, we agree that there are few limitations in our study. Firstly, the clinicians 
were supplied data in the form of completed questionnaires and were not able to interview 
and examine the patients themselves before making their own predictions. This denied 
them the full use of their diagnostic skills. The number of patients in the external 
validation group was low as compared to the internal validation group. We would prefer to 
increase the number of patients in the external validation group.  
Finally, only those patients with colorectal symptoms and subsequently referred for LGE 
were invited to participate, possibly introducing some selection bias. We deliberately 
chose this select group of patients because these are the patients most likely to harbour 
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serious pathology (on clinical assessment), and, yet most difficult to diagnose accurately 
enough to be able to triage into those needing LGE and those not needing LGE. The 
purpose of developing the ANN in this study was to be able to perform accurately this 
triage function. The remainder of patients presenting in the clinics and not included in the 
study would either be those seen as follow up or clinically diagnosed with conditions not 
requiring a LGE. These patients are not a diagnostic dilemma and, hence, do not need the 
help of the ANN. 
This paper does not contend that neural networks are the substitute for clinical judgment. 
We also do not claim that ANN should they be considered as an answer for all complex 
data analysis or all complex clinical decisions. In fact, careful clinical judgement is 
required to ensure that the information entered is correct and the ANN produces 
meaningful results.  We also do not imply that all the decisions should be based on ANN 
output only. It was not developed to diagnose all abdominal pathologies, but to focus 
specifically on the three conditions mentioned previously. 
 
8.4 Conclusion 
Artificial neural networks offer the possibility of personal prediction of outcome for 
individual patients presenting in clinics with colorectal symptoms, making it possible to 
make appropriate requests for lower gastrointestinal endoscopy. 
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CHAPTER 9 SUMMARY OF CONCLUSIONS 
The overall aims of this thesis were to determine methods of assessing the quality of LGE, 
and improving both the availability and technical quality of LGE in the National Health 
Service. Having reviewed the literature, we conducted six different studies to achieve 
these goals.  
Quality and availability of LGE are issues gaining unprecedented attention in recent years.   
The American Society of Gastroenterology
46
 and others
189
 have defined different aspects 
of quality of LGE. However, we chose to look only at the technical aspects of quality 
assurance in this thesis both because a review of all the quality indicators would be 
impossible in one work, and also because technical quality is an important part of LGE, as 
indicated by patients in most studies
52
 including the current one. The three principal 
aspects of technical quality assurance of lower gastrointestinal endoscopy (LGE) include 
completion rates, pathology miss rates and patient satisfaction. We developed and 
validated a patient satisfaction questionnaire to specifically assess patient satisfaction in 
our unit and to identify factors associated with the same. This study showed the levels of 
satisfaction in our unit in both non-medical and medical endoscopists to be high. A 
multivariate analysis of all questions from the patient satisfaction questionnaire, as well as 
demographics and clinical features, has shown that higher pre-procedure anxiety scores, 
pain during the procedure and a history of pelvic surgery/hysterectomy were associated 
with lowest patient satisfaction scores. Patients marked pain and technical skills as the 
most important factor affecting their satisfaction. These findings are important; a 
theoretical advantage is that modification of such patient and procedure-related factors 
should lead to better patient experience in the future. Armed with this knowledge of 
patient needs, we looked at methods of improving technical quality of LGE and patient 
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experience of colonoscopy in terms of pain/discomfort, and performed two randomised 
controlled trials on sedation for colonoscopy.  
We assessed the role of the technique of endoscopic clipping (with follow-up abdominal 
x-ray) in quality assuring both colonoscopy and flexible sigmoidoscopy. Both studies have 
shown this technique to be safe and feasible. The major advantage of this technique of 
objective validation is that it enables assessment of both completion and miss rates. The 
current method of validation of completion is the use of photographs of caecal landmarks, 
but studies have shown them to be difficult to interpret and equally susceptible to errors
134, 
135
. Does the technique of clipping perform better? We believe that it is a simple and 
feasible technique, but the current study should be interpreted as a pilot study. Further 
validation by comparing it with different modalities like caecal photography or ileal 
biopsies is mandatory. Another shortcoming of the study was the lack of validation of the 
accuracy of the abdominal x-ray in identifying the position of clips. A future study of this 
kind should include a comparison with current standards, and also a computerised 
tomography scan on a random number of patients should be performed.  
With regards to improving methods of pain relief, the first randomised controlled trial has 
shown that Entonox
®
 provides better relief than conventional intravenous sedation, and is 
associated with better patient satisfaction and faster discharge. The second study showed 
no difference between Entonox
®
 and propofol in terms of pain relief, time to 
discharge/recovery and patient satisfaction. These two studies provide evidence for the 
role of Entonox
®
 in routine sedation for colonoscopy. However, there is a possibility that 
the beneficial effect of Entonox
®
 arises from a placebo effect- the act of controlling 
sedation makes the patient feel empowered and in control. The second problem with 
Entonox
®
 sedation is that in around 7-10% of patients, it is contraindicated. The option 
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therefore is to use either intravenous sedation or propofol in this small group of patients. A 
multi-centre randomised controlled trail to evaluate all three types of sedation 
(conventional intravenous, propofol and Entonox
®
) with both patients and endoscopists 
blinded to the treatment modality would be an ideal method of answering the questions.  
The current NHS targets (two week wait, 62 days for urgent treatment, 31 days for all 
from the decision to treat to treatment and the 18-week pathway) are difficult to achieve 
and sustain for most NHS trusts, mainly because, in most places, the primary diagnostic 
test (LGE) is not directly accessible to GPs, and partly because of the long waiting time, 
and complex pre-treatment pathway for bowel cancer patients. In addition, the two week 
wait (TWW) criteria are not a particularly reliable predictor of the presence of bowel 
cancer. In most reported series, only about 10% of TWW patients were found to have 
bowel cancer and only a quarter of patients who turn out to have cancer come through the 
Two Week Wait pathway
190
. Furthermore, there is a prediction for further increase in 
demand due to the introduction of screening programmes and long-term surveillance 
schedules to prevent recurrence of benign and malignant tumours.  
In this thesis, we assessed two possible solutions to shortening the interval to LGE: 
introduction of non-medical endoscopists (NME) and the role of artificial neural networks 
(ANN). In order to increase the number of available endoscopists (and, hence, the 
availability of LGE), the Department of Health trained non-medical personnel to perform 
LGE. We have shown that NME can perform diagnostic LGE procedures, with similar 
completion rates and patient satisfaction to medical endoscopists. However, NME cannot 
provide intravenous sedation on their own, and are dependant on doctors or suitably 
trained nurses to prescribe sedation. The use of Entonox
®
 for routine sedation can obviate 
the need for a doctor or nurse to prescribe sedation. We have also shown that NME can 
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colonoscope with equal effectiveness using Entonox sedation, as compared to both doctors 
and nurses. This is a key finding for this study, as it enables NME to perform LGE 
independently. However, we need to remember that none of these studies were powered to 
directly determine differences between non medical endoscopists and nurses/doctors in 
terms of technical quality of LGE.  
Lastly, we used artificial neural networks to predict which patients with colorectal 
symptoms will have polyps, cancer or colitis. Clinicians are currently unable to accurately 
identify such patients in the outpatient setting and therefore a large number of unnecessary 
LGE are ordered for. Our study has shown that ANN programmes can be trained to predict 
the presence of significant pathology in patients presenting with colorectal symptoms to 
routine clinics. The algorithm performed equally well in the external population and was 
clearly superior to Clinicians. We envisage that either a general practitioner or a colorectal 
surgeon should likewise be able to use this tool to aid his decision regarding further 
investigations for the patient. This study was applied to symptomatic colorectal patients, 
who were already screened in a clinic. However, it would be interesting to assess the 
ability of ANN to predict in asymptomatic patients, particularly those being screened for 
colorectal cancer.  
9.1 FUTURE DIRECTIONS:  
Quality assurance of LGE will continue to be of paramount importance in the future. GRS 
could be the skeletal framework around which all quality improvements could be based. 
Within this framework, there is further opportunity for objective assessment of quality of 
LGE. Several interesting areas of work can be identified from this thesis to pursue in the 
future.  
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We plan to validate the technique of endoscopic clip application with follow-up abdominal 
x-ray in the assessment of both completion and pathology miss rates of LGE against 
current standards, like ileal photography and biopsy, and caecal photography. 
We have shown that patient satisfaction with LGE can be predicted by several factors. 
These include pre-procedural anxiety and intra-procedural pain. There is, therefore, scope 
for a randomized controlled trial of pre-emptive interventions aimed at improving the 
patients’ experience of colonoscopy. This thesis already includes 2 trials showing that 
Entonox
®
 is associated with lesser pain/discomfort during colonoscopy, leading to higher 
patient satisfaction. It would also be interesting to see if the findings in this thesis 
especially regarding Entonox
®
 can be replicated in other hospitals.  
We have shown that non-medical endoscopists can perform LGE with similar completion 
rates, and patient satisfaction, as compared to medical endoscopists. We anticipate a 
bigger role for non medical endoscopists in providing endoscopy services in the future, 
more so in the face of an increasing demand. The use of Entonox
®
 for sedation for 
colonoscopy could mean more trained NME providing independent LGE services than is 
feasible currently. Larger multicentre studies could be designed to compare doctors with 
non-medical endoscopists in different settings and hospitals, especially with a long follow-
up period.  
The results on the use of artificial neural networks to accurately predict outcomes in 
patients with colorectal symptoms are hugely encouraging and exciting. We are currently 
setting up a trial to assess their usefulness in asymptomatic patients who are undergoing 
screening for colorectal cancer. Multicentre studies could clarify more precisely how ANN 
can be applied to both symptomatic and asymptomatic patients. 
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Appendix 1:  Visual Analogue Scale 
 
Thank you very much for participating in this trial. We would like you to indicate on this 
scale how much pain you had during the procedure. This scale is marked from 0 to 100, 
where 0 represents no pain and 100 represents worst pain ever. Please mark the 
appropriate number and write the number in digits as well. 
 
Thanks once again. 
 
 
 
 
 
 
 
0(no pain)               100 (worst pain ever) 
 
 
 
 
Example only- not for use--- 
 
The above is an example of VAS used in the study. We used single VAS on single page 
each time they were assessed. 
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Appendix 2:  Visual Analogue Scale -24 hours post procedure 
 
 
Thank you very much for participating in this trial. It is now 24 hours since the 
colonoscopy. We would like you to indicate on this scale given below how much pain you 
had during the procedure. This scale is marked from 0 to 100, where 0 represents no pain 
and 100 represents intolerable pain. Please mark the appropriate number and write the 
number in digits as well. 
 
 
 
 
 
 
 
 
 
 
 
 
 
0         100 
 
 
 
 
We now request you to send us this scale in the prepaid envelope. This information is 
extremely important to us and enables proper conduct and analysis of the trial. 
Thank you once again. 
 
 
 
 
 
 
 
 
 
 
 189 
 
 
Appendix 3:  Letter cancellation test: 
 
 
Thanks for participating in the trial. Given below is a jumble of randomly arranged letters. 
We request you to identify and cross-out the letter C each time it appears. You have a 
maximum of 120 seconds to do so. At the end of 120 seconds, please stop the test and put 
your pen down. Thanks once again. 
 
B E I F H EH F E G I C H E I C B D A C H F B E D A C D A F C I H C F E 
B A F E  
D C F G H E C C A H E F A C D C F E H B F C A D E H A E I E G D E G 
H B C A E C 
G I C E H C I E F H I C D B C G F D E B A E B C A F C B E H F A E FE G 
C H G C 
D E H B A E G D A C H E B A E D G C D A F C B I F E A D C B E A C G 
C C D C A A 
G A C H E F B C A F E A B F C H D E F C G A C B E D C F A H E H E F 
D I C H A C 
 B I E B C A H C D E F B A C B C G B I E H A C A F C I C A B E G F B E 
F A E A E 
 B G C G F A C D B E B C H F E A D H C A I E F E G E D H B C A D G E 
A D F E F W 
B E I G A C G E D A C H G E D C A B A C F B C H D A C G B E H C D F 
E H A E I Q 
E D G C D A F C B I F E A D C B E A C G C C D G A C H E F B C A F E 
A B F C H A 
D E F C G A C B E D C F A H E H E F D I C H B I E B C A H C D E F B A 
C B C G C 
B I E H A C A F C I C A B E G F B E F A E A B G C G F A C D B E B C H 
F E A D H 
C A I E F E G E D H B C A D G E A D F E B E I G A C G E D A C H G E 
D C A B A F 
E F B C H D A C G B E H C D F E H A E I C E H C I E F H I C D B C G F 
D E B A E 
B G C G F A C D B E B C H F E A D H C A I E F E G E D H B C A D G E 
A D F E R S 
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B E I G A C G E D A C H G E D C A B A C F B C H D A C G B E H C D F 
E H A E I A 
G A C H E F B C A F E A B F C H D E F C G A C B E D C F A H E H E F 
D I C H A C 
B I E B C A H C D E F B A C B C G B I E H A C A F C I C A B E G F B E 
F A E A E 
B G C G F A C D B E B C H F E A D H C A I E F E G E D H B C A D G E 
A D F E F W 
B E I G A C G E D A C H G E D C A B A C F B C H D A C G B E H C D F 
E H A E I Q 
E D G C D A F C B I F E A D C B E A C G C C D G A C H E F B C A F E 
A B F C H A 
 
 
Thanks once again for participating in this study. 
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Appendix 4:  
 
  Confidential questionnaire for Colonoscopy 
 
You have now finished your procedure and are about to go home. We request you to 
kindly fill in the following questionnaire about what and how you felt regarding the whole 
procedure. Please read each question carefully before answering. We are interested in 
finding about your experiences during the procedure. 
 
Thanks for taking out time for filling this questionnaire. 
In terms of your satisfaction, how would you rate each of the following? 
 
1. The length of time you waited to get an appointment  
Excellent □ Very good □ Good □ Fair □ Poor □ 
2. Convenience of the appointment time for endoscopy 
Excellent □ Very good □ Good □ Fair □ Poor □ 
3. Length of time spent waiting at the endoscopy suite for the procedure  
Excellent □ Very good □ Good □ Fair □ Poor □ 
4. How were the instructions for the bowel preparation? 
Excellent □ Very good □ Good □ Fair □ Poor □ 
5. Attitude of the reception staff  
Excellent □ Very good □ Good □ Fair □ Poor □ 
6. The personal manner (courtesy, respect, sensitivity, friendliness) of the endoscopist who 
performed your procedure 
Excellent □ Very good □ Good □  Fair □ Poor □  
7. The time spent by the endoscopist with you 
Excellent □ Very good □ Good □ Fair □ Poor □ 
8. The manner in which the procedure was explained by the endoscopist 
Excellent □ Very good □ Good □ Fair □ Poor □ 
9. The technical skills (thoroughness, competence) of the endoscopist (your perception) 
who performed your procedure  
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Excellent □ Very good □ Good □  Fair □ Poor □  
10. General satisfaction with the endoscopist’s attitude and behaviour  
Excellent □ Very good □ Good □  Fair □ Poor □  
11. How much pain did you have during the procedure? (Please mark on the following scale 
from none to intolerable) 
      
0 100 
 None         Intolerable 
12. How satisfied are you with this type of pain relief and sedation (please mark on a scale 
of 0-100) 
           
0 (Dissatisfied)                 100(Very satisfied) 
13.  How satisfied are you with the endoscopist who performed your procedure? (please 
mark on a scale of 0-100) 
           
0 (Dissatisfied)                 100(Very satisfied) 
14.  Would you consider having this procedure done again under this type of sedation and 
pain relief?  
Yes  □   No  □ 
15. Overall rating of the visit  
Excellent □ Very good □ Good □ Fair □ Poor □  
 
16. Would you have the procedure done again by this endoscopist?  
 Yes □ No □   
 
17. Would you consider having this procedure done again at this hospital?  
   Yes □ No □  
18. Would you refer friends/ family to this hospital again for this procedure? 
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 Yes □ No □  
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Appendix 5 (Randomised controlled trials): 
 
Confidential questionnaire for Colonoscopy :24 hours post procedure 
 
Thank you very much for answering this questionnaire. It is now more than a day since 
you had your colonoscopy. We request you to kindly fill in the following questionnaire 
about what and how you felt regarding the whole procedure. Please read each carefully 
before answering. We are interested in finding about your experiences during the 
procedure. 
Thanks for taking out time for filling this questionnaire and sending it to us. Your answers 
are extremely vital to determine the quality of sedation. 
 
 In terms of your satisfaction, how would you rate each of the following? 
 
1. The personal manner (courtesy, respect, sensitivity, friendliness) of the endoscopist who 
performed your procedure 
Excellent □ Very good □ Good □  Fair □ Poor □  
2. The time spent by the endoscopist with you 
Excellent □ Very good □ Good □ Fair □ Poor □ 
3. The manner in which the procedure was explained by the endoscopist 
Excellent □ Very good □ Good □ Fair □ Poor □ 
4. The technical skills (thoroughness, competence) of the endoscopist (your perception) 
who performed your procedure  
Excellent □ Very good □ Good □  Fair □ Poor □  
5. How much pain did you experience during the procedure? (Please mark on the following 
scale from none to intolerable) 
      
1 100 
 6. How satisfied are you with this type of pain relief and sedation (please mark on a scale of 
0-100) 
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 Dissatisfied        Very satisfied 
7.  Would you consider having this procedure done again under this type of sedation and 
pain relief?  
Yes  □     No  □ 
8. How satisfied are you with this endoscopist? (please mark on a scale of 0-100) 
          
 Dissatisfied        Very satisfied 
9. Did you require additional sleep during the day after your procedure? 
  Yes  □      No  □   
10. How much sleep did you require? 
None      □  less than 2 h □  2-4h  □  4-6h  □    
11. When did you resume your normal daily activities? 
<2hours  □  2-4h  □               4-6h  □  >6h  □    
12. How did the sedation you receive compare with previous endoscopic procedures you 
have undergone? 
Better  □  Same   □  Worse   □ Not applicable  □  
13. Overall rating of the visit  
Excellent □ Very good □   Good □ Fair □ Poor □   
14. Would you have the procedure done again by this endoscopist?  
 Yes □  No □              
15. Would you consider having this procedure done again at this hospital?  
   Yes □  No □   
16. Would you refer friends/ family to this hospital again for this procedure? 
 Yes □  No □   
 
Thanks once again for your time. 
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Appendix 6: Endoscopists’ assessment of the procedure and sedation 
 
Name: 
Designation:     
Patient name:     DOB:   Unit No.: 
 
 
1  Degree of ease  1 2 3 4 5 
            Of colonoscopy     (Very difficult)   (Very easy) 
 
  
2          Patient pain      1 2 3 4 5 
            tolerance  (intolerant)    (very tolerant) 
 
3 level of sedation   0 1 2 3 4 5 
 (average for the procedure)

    
 
4. How do you think the patient will rate this procedural experience?  
Excellent/ Good/ Fair/ Poor 
 
5. Did you have difficulty manoeuvring the patient?  
a. patient was awake and responded to all commands 
b. patient responded to most of the commands(>50%) 
c. patient was able to move to some commands(<50%) 
d. quite difficult (<10%) 
 
6. How satisfied are you with this sedation?      
 
 
 
 
0(not satisfied at all)            100 (very satisfied) 
 
     
 
 Sedation scoring is as per the following: 
 0-   no response to painful trapezius squeeze 
1- responds only after painful trapezius squeeze 
2- responds only after mild prodding or shaking 
3- responds only after name is called loudly and/or repeatedly 
4- lethargic response to name spoken in normal tone 
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5- respnds readily to name spoken in normal tone 
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Appendix 7:  
 
Nurse’s assessment of the procedure and sedation 
 
A. Data collection: 
 
Name:     Designation:    
Patient name:    DOB: 
Unit No.: 
 
Sedation:  
Time sedation started? 
Time stopped: 
Time scope inserted: 
Time caecum reached: 
Was caecum reached: YES/ NO If no, was it deliberately stopped: Y/N 
Time scope came out:    
 
B. Assessment of sedation 
Please select the best answer for each of the following questions. 
 
1. Do you feel the patient had adequate sedation/ pain relief?  YES/ NO 
 
2. Which of the following best describes the patient’s sedation:  
Too heavy/  Just right/  Too light 
 
3. Do you believe the patient had discomfort?  YES/ NO 
 
4. Was the patient difficult to sedate? YES/ NO 
 
5. Was the patient alert before the completion of the procedure: YES/ NO 
 
6. Was the patient able to assist with moving during the procedure: YES/ NO 
 
7. Did you have difficulty manoeuvring the patient?  
e. patient was awake and responded to all commands 
f. patient responded to most of the commands(>50%) 
g. patient was able to move to some commands(<50%) 
h. quite difficult (<10%) 
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8. What was your perception of the depth of sedation?  
  
 level of sedation   0 1 2 3 4 5 
 (average for the procedure)

    
 
 
 
 
9. How satisfied are you with pain relief and sedation:   
 
 
 
 
0(not satisfied at all)            100 (very satisfied) 
 
10. How satisfied are you with the endoscopist? 
   
 1 2 3 4 5 
(not satisfied)    (very satisfied) 
 
 
Thank you very much for your time. 
 
 Sedation scoring is as per the following: 
 0-   no response to painful trapezius squeeze   
6- responds only after painful trapezius squeeze 
7- responds only after mild prodding or shaking 
8- responds only after name is called loudly and/or repeatedly 
9- lethargic response to name spoken in normal tone 
10- responds readily to name spoken in normal tone 
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Appendix 8: 
 
COLONOSCOPY QUESTIONNAIRE 
(For the ANN study) 
 
PRE-INVESTIGATION HEALTH AND SYMPTOM ASSESSMENT 
 
We are currently doing a study to determine if we can accurately identify which patients 
would need flexible sigmoidoscopy/ colonoscopy in our unit. We would like to invite you 
to participate and would be grateful if you could take the time to answer the following 
questions. You would only need to fill this questionnaire and there is no additional 
procedure/visit. 
  
Thank you very much for your time. 
 
Please note: this questionnaire will remain private and confidential. Any data used from 
this questionnaire will remain anonymous.  
 
 
 
This questionnaire should be completed prior to your consultation and returned to the 
nurse. Thank you once again for being part of the study. 
 
 
Could you please answer all the questions as they are all very important, thank you. 
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PART ONE:  
 
NAME:  
DATE OF BIRTH:  
AGE:  
SEX:  
 
 
PART TWO:  
  YES NO NA 
2.1 Do you smoke  
         1 
 
         2 
 
          0 
2.2 Have you ever smoked regularly  
         1 
 
         2 
 
          0 
2.3a Do you take Aspirin tablets  
         1 
 
         2 
 
          0 
2.4 Do you take regular painkillers  
         1 
 
         2 
 
          0 
3.1a Does your bottom bleed when you open your bowel  
         1 
 
         2 
 
          0 
3.1b If yes, is it bright red  
         1 
 
         2 
 
          0 
3.1c Has it ever been dark red  
         1 
 
         2 
 
          0 
3.2 If it has happened, has it been more than once  
         1 
 
         2 
 
          0 
3.3 Has it  been happening for longer than 6 weeks  
         1 
 
         2 
 
          0 
3.4 Have you passed any mucous or slime from your 
bottom in the last 6 weeks 
 
         1 
 
         2 
 
          0 
3.5 Have you passed any pus from your bottom in the 
last 6 weeks 
 
         1 
 
         2 
 
          0 
3.6 Does your stomach feel swollen before you open    
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your bowel          1          2           0 
 
PART FOUR:  
  YES NO NA 
4.1a Has your bowel habit changed over the last 6 weeks  
         1 
 
         2 
 
          0 
4.1b If yes, are you more constipated  
         1 
 
         2 
 
          0 
4.1c If yes, have you become more loose / watery  
         1 
 
         2 
 
          0 
4.1d Does your  bowel habit change between constipation 
and diarrhoea 
 
         1 
 
         2 
 
          0 
4.2 If no, has it happened to you within the last 12 
months 
 
         1 
 
         2 
 
          0 
4.3 Do you feel that you completely empty your bowel 
after you have had it open 
 
         1 
 
         2 
 
          0 
4.4 Do you need to strain to open your bowel  
         1 
 
         2 
 
          0 
 
PART FIVE:  
5.1 Have you had any pains in your back passage in the last 6 weeks 
     
YES1  NO2 
5.2 Have you had any stomach pains in the last 6 weeks        
 
YES1   NO2 
   
  YES NO NA 
6.1 Have your weight been steady  
         1 
 
         2 
 
          0 
6.2 Have you been losing weight  
         1 
 
         2 
 
          0 
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6.3 Have you gained any weight  
         1 
 
         2 
 
          0 
 
6.4 
 
Has you appetite been 
 
HIGH 
 
NORMAL 
 
LOW 
 
PART SEVEN:  
  YES NO NA 
7.1 In the last 6 weeks, have you felt tired or had 
very little energy 
 
         1 
 
         2 
 
         0 
7.2 Have you been short of breath when walking up 
stairs 
 
         1 
 
         2 
 
         0 
7.3 Have you been short of breath in general  
         1 
 
         2 
 
         0 
7.4 Have you been told you are anaemic  
         1 
 
         2 
 
         0 
 
PART EIGHT:  
  YES NO 
8.1 Have YOU ever had any polyps in the bowel   
             1 
 
         2 
8.2 Have YOU ever had any BOWEL cancers  
             1 
 
         2 
8.3 Have YOU ever had any OTHER forms of cancer  
             1 
 
         2 
 
8.4 
 
If yes, how old were you when you were diagnosed 
 
 
PART NINE:  
  YES NO 
9.1 Have YOUR mother, father, brothers or sisters ever had 
any polyps in the bowel  
 
             1 
 
         2 
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9.2 Have YOUR mother, father, brothers or sisters ever had 
any BOWEL cancers 
 
             1 
 
         2 
9.3 Have YOUR mother, father, brothers or sisters ever had 
any OTHER forms of cancer 
 
             1 
 
         2 
 
9.4 
 
If yes, how old were they when they were diagnosed 
 
 
PART TEN:  
  YES NO 
10.1 Have any other members of your family (aunts, uncles etc) 
ever had any polyps in the bowel  
 
             1 
 
         2 
10.2 Have any other members of your family (aunts, uncles etc) 
ever had any BOWEL cancers 
 
             1 
 
         2 
10.3 Have any other members of your family (aunts, uncles etc) 
ever had any OTHER forms of cancer 
 
             1 
 
         2 
10.4 If yes, what relationship to you were they  
 
10.5 
 
If yes, how old were they when they were diagnosed 
 
 
PART ELEVEN:  
  YES NO 
11.1 Have YOU ever been diagnosed with inflammatory bowel 
disease (ulcerative colitis or crohns’ disease) 
 
             1 
 
         2 
11.2 Has anyone in your family ever been diagnosed with 
inflammatory bowel disease  
 
             1 
 
         2 
11.3 If yes, what relationship were they to you  
 
 
Thank you very much for completing this questionnaire. 
